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ABSTRACT 
Background 
Physiotherapy is a central feature of organized stroke care but there is little direct 
evidence to support its use. In particular we do not know the optimum amount of 
physiotherapy for individual patients and recent trials have been inconclusive. We 
conducted an individual-p ati ent- data meta-analysis of trials testing increased levels of 
physiotherapy input. 
Methods 
We carried out a literature search (up to the end of December 2002) and included all 
randomised controlled trials of intensity of physiotherapy. We also contacted authors of 
four trials that were not fully published by that date but have subsequently reported. A 
Collaborative group was formed and trialists provided individual patient data for 
analysis. Using standard methods (Stewart and Clarke 1995), data were cleaned and 
categorized by patient details, intervention and outcomes. 
We compared intended physiotherapy dose against change in outcome for those studies 
with available data. We used multivariate logistic regression to examine the following 
outcomes in relation to patient characteristics (age, severity of disability and arm 
impairment at baseline) and treatment characteristics (target, total treatment contrast, 
time to start treatment, daily treatment contrast and duration of treatment), measuring 
differences between augmented and standard groups and interactions between the 
subgroups. 
Primary outcome: overall disability. 
Secondary outcomes: 
overall impairment 
survival 
improvement in arm and leg impairment 
improvement in arm and leg function 
change in activities of daily living (ADL) measured by the Barthel Index (BI). 
length of hospital stay 
treatment success - "Good recovery" - greater than median recovery (measured by BI) 
in the control group. 
treatment success - "Excellent recovery" - greater than the upper quartile of recovery 
(measured by BI) in the control group. 
Results 
We incorporated 9 trials (951 subjects). 
We found no statistically significant differences between patients receiving intensive or 
standard amounts of physiotherapy, in terms of overall disability or overall impairment 
scores, length of hospital stay or survival. 
Secondary analyses showed improvements in Motricity Index scores for the upper 
limbs (5.2 units, 95% CI 1.5 to 8.8, P=0.0058) and lower limb 1- s (6.8 units, 95% Cl ') -2- 
11.4, P=0.0042). Improvements were also seen in Action Research Arm Test scores 
(1.8 units, 95% CI -1.2 to 4.8, P=0.25) in younger patients (under 70 years) and those 
with higher baseline Barthel scores, and in recovery of walking speed (increase of 
0.056 m/s, 95% Cl -0.018 to 0.130, P=0.14) (when the target of treatment was lower 
limb or gait focused). 
There was no significant difference in change in ADL (measured by BI (7 trials)) 
between the groups (0.15 units of change in BI, 95% Cl -0.38 to 0.67, P=0.58).. 
There were increased odds of a "good recovery" i. e. (improvement of 6 points or up to 
the maximum of 20 / 20 on BI), (odds ratio 1.33; 0.96 - 1.85; P=0.09) and of "excellent 
recovery" (> 8 points or up to the maximum on BI), (odds ratio 1.47; 1.03 - 2.05; 
P=0.04) in the augmented group. 
The higher contrast trials in our study (typically 15 - 44 hrs additional physiotherapy, 
with earlier onset at 7-10 days after admission, higher daily contrast and longer 
duration) are more likely to show treatment effects than lower contrast trials, with 
respect to impairment measured by the Motricity index and disability measured by the 
BI. 
Conclusion 
Modest increases in the intensity of physiotherapy after stroke did not produce 
substantial changes in the primary outcomes. Targeted additional therapy in selected 
patients may improve limb impairment and walking speed. 
Our results confirm what might be expected and provide estimates of the modest 
treatment effect likely in these domains. 
Individual patient data meta-analyses provide the opportunity to explore subgroups in 
order to answer clinically relevant questions and guide further research. Large numbers 
of subjects are required for randomised controlled trials (RCTs) of intensity of 
physiotherapy. Considering the challenges involved in running such trials we 
recommend the use of similar outcome measures in order to facilitate future meta- 
analysis. 
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CHAPTER] 
INTRODUCTION 
Introduction 
This thesis examines the subject of the optimum intensity of physiotherapy input for 
patients after stroke. In this introductory chapter I describe some of the problems of 
stroke, how these are currently managed, including physiotherapy, before stating my 
hypothesis and the questions about intensity of physiotherapy that I aim to address. I 
also define some of the terms I will use, and finally, describe the structure of the thesis, 
laying out how I set out to address these questions. 
The problem of stroke 
Information on the importance of stroke and the potential impact of developing 
treatments that may reduce its effects is widely available and well described (Bonita 
1992, Warlow 1998, Warlow et al. 2001). However, it does bear repeating briefly in this 
introduction. 
Stroke is the third greatest cause of death worldwide (Warlow 1998)(Wolfe 2000) and 
one of the biggest causes of handicap in the community (Bonita & Beaglehole 
1988)(Khaw 1996)(Warlow et al. 2001). The incidence of first ever in a lifetime stroke 
(where it has been studied, in the predominantly white population of the world) is 
estimated at about two per 1000 per year and about four per 1000 per year in people 
aged 45 - 84 years. In the United Kingdom (U. K. ) it is estimated to be approximately 
145 per 100 000 (Rothwell et al. 2004). There are approximately 15,000 new, first ever 
strokes and 70,000 existing strokes each year in Scotland. The rate of stroke recurrence 
is about 5% per year (with a higher rate in the initial weeks and months after first 
stroke) (Warlow 1998). 
Some authors have described a small reduction in the incidence of stroke reported 
worldwide (Bonita 1992) though the exact explanation for this remains uncertain 
(Warlow 1998). This reduction may be attributable to the development of effectiN-e 
primary (and secondary) prevention strategies or to trends in risk factors for 
cerebrovascular disease. Alternatively, it may reflect difficulties in collecting accurate 
data over time in a number of countries. 
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Despite this apparent reduction, the number of patients presenting with stroke is still 
likely to be substantial. With life expectancy increasing, populations will contain larger 
proportions of elderly people. Increasing age is a risk factor for stroke, therefore the 
number of people with stroke in absolute terms is likely to increase (Bonita 1992). The 
problems associated with stroke seem set to continue to present themselves to patients 
and their carers, clinicians, those responsible for health service provision and the 
societies in which they live. 
In this thesis I use a widely accepted definition of stroke: "a clinical syndrome 
characterized by rapidly developing clinical symptoms and/or signs of focal, and at 
times global loss of cerebral function, with symptoms lasting more than 24 hours or 
leading to death, with no apparent cause other than that of vascular origin" (Hatano 
1976). 1 did however, exclude patients diagnosed with sub-arachnoid haemorrhage. 
In broad terms, patients with stroke can be divided into three groups; those that have a 
minor stroke with symptoms which are mild and are likely to make a speedy and 
complete or near complete recovery (approximately 30% of patients); a middle band of 
patients who have considerable deficits that require rehabilitation; and those with severe 
stroke that are unlikely to survive beyond the first month after stroke onset 
(approximately 20 - 28% of cases)(Warlow 1998) (Wolfe et al. 1999). 
Up to 50% of surviving patients are left with some sort of residual neurological deficit 
(Effective Health Care 1992) such as motor loss (hemiplegia), possibly with loss of 
upper limb function and the ability to walk, visual loss, altered muscle tone, loss of 
communication, loss of cognitive function and sensory or perceptual problems. These 
may result in difficulties in self-care and activities of daily living (ADL) (with about a 
third of all patients requiring some assistance with ADL up to 6 months after their 
stroke) (Bonita & Beaglehole 1988). 
In addition to the personal costs involved, these patients require considerable health 
service and community resources. Costs based on studies over the past 25 years, 
estimate that 4-7.6% of hospital expenditure can be attributed to stroke (Hakim & 
Bakheit 1998) or approximately two billion pounds in 1999 in the UK (Ebrahim 2000). 
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Health service costs vary between countries and estimates put costs at about t8,000 per 
patient in Sweden in 1983 and L6,000 per patient in a later study in Scotland in 1988 
(Isard & Forbes 1992). A more recent comparison of stroke care provision estimated 
costs for conventional hospital care in Newcastle, England to be E7480 per patient 
(McNamee et al. 1998). A more comprehensive estimate including communit, y and 
social services, family costs and loss of productivity may be more like E70 000 per 
patient in an estimate in the United States of America in 1990 (Taylor et al. 1996). 
The greatest proportion of acute hospital inpatient expenditure (more than 90%) can be 
attributed to nursing and "hotel" costs (Warlow et al. 2001). The length of hospital stay 
varies greatly from patient to patient, and can depend on a number of factors including 
clinical subtype of stroke, the patients' age, sex and functional dependency and the 
views of the consultant caring for them (Hakim & Bakheit 1998). 
Tackling the problem of stroke 
If some form of effective treatment was available for those patients requiring stroke 
rehabilitation then considerable improvements in patients' abilities, independence and 
quality of life might be made. 
The group of patients with a poor prognosis and high death rate are often the target of 
studies of interventions aimed at saving life. However, some researchers have 
reservations about developing interventions that may prevent deaths but result in very 
dependent survivors. If there were proven effective rehabilitation treatments, then this 
might encourage further development of promising acute treatments, safe in the 
knowledge that survival might not necessarily mean dependence and disability. 
Improved knowledge of effective treatments would also allow finite resources to be 
targeted to maximum effect and to reduce waste. Any method that reduces treatment 
times, in particular hospital inpatient stay, may be particularly useful in reducing costs. 
So far, the most effective way of improving stroke patient outcomes is with stroke units. 
This was recognised in an overview of methods of managing patients with stroke 
(Stroke Unit Trialists Collaboration. 1997). This overview provided good evidence of 
benefits to patients with stroke that are managed in a stroke unit as opposed to a general 
medical ward. These benefits included improved survival, decreased dependence in 
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activities of daily living, decreased institutionalisation and decreased length of hospital 
stay (by up to 8%). Compared to general medical management, for every 100 patients 
treated in a stroke unit, 3 deaths and 2 admissions to institutional care are avoided and 
an additional 5 patients are discharged home (Stroke Unit Trialists Collaboration 1997) 
(Stroke Unit Trialists Collaboration 2003). There is some further evidence that these 
benefits may be sustained over a longer period (up to 10 years after stroke) (Indredavik 
et al. 1999). 
Stroke Units are difficult to define precisely and vary widely between different health 
care systems. They do however, appear to have a number of common features, including 
a co-ordinated, multi- di scip linary team that is specialised in stroke care (Stroke Unit 
Trialists Collaboration 1997) (Langhorne & Dennis 1998) (Langhorne & Pollock et al. 
2002). Overall, this multi-faceted, complex intervention is, at present, poorly 
understood. In 1989 the World Health Organisation (WHO) Task Force on Stroke 
recognised this problem and stated that: "Controlled clinical trials are essential if the 
role of rehabilitation, its indications, and its contraindications are to be adequately 
understood" (WHO Task Force on Stroke 1989). There have been many more clarion 
calls echoing this statement over the past decade, giving rise to the term "unpacking the 
black box of rehabilitation". Though there are increasing numbers of trials and studies 
of rehabilitation, there remains a great deal to discover about the individual components 
of stroke unit rehabilitation and how they interact (Wade 2001) to produce their 
beneficial effect. 
One of the recognised core components of rehabilitation within a multi-disciplinary 
stroke unit team is physiotherapy (Stroke Unit Trialists Collaboration 1997) (Langhorne 
& Dennis 1998). Whilst it seems reasonable to assume that physiotherapists play a part 
in the restoration of patients' mobility after stroke, there are many aspects of 
physiotherapy intervention that require to be evaluated (Legg et al. 2000)(Pomeroy & 
Tallis 2000)(Pomeroy & Tallis 2002)(Scottish Intercollegiate Guidelines Network 
(SIGN) Guidelines 2002). Amongst these is the need to deten-nine which patients 
benefit, at which stage after stroke, from which treatments and in which setting. I was 
particularly interested in determining the optimum amount of physiotherapy that should 
be provided for patients with stroke. 
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Defining physiotherapy 
Before proceeding, it is worth defining physiotherapy as it will be used in this thesis, 
looking at its historical background and then describing current physiotherapy practice 
in the treatment of stroke. 
Physiotherapy is the process of treatment of disease and injury by physical means (as 
opposed for example to pharmaceutical and surgical means). Commonly, physiotherapy 
utilises treatment methods such as exercises, movement, thermal treatments e. g. heat 
packs or ice, electrotherapy, massage and education. Treatment is often given in order to 
resolve or minimise a patient's impairment, disability and handicap. Neurological 
physiotherapy is a sub-specialty focused on the treatment of patients diagnosed with 
neurological disease or disorders of the nervous system. It is usually administered by 
specialists but often draws on other branches of physiotherapy and the application of 
general principles. It often takes place in the context of a multi-disciplinary team and 
has a role focused on the restoration of movement or mobility and function. 
Neurological physiotherapists work worldwide in a number of settings including 
hospital in-patient and outpatient departments, in the community or patients' own 
homes (SIGN Guideline 2002). 
Historical context 
Historically, patients with stroke were not always treated with physiotherapy, even in its 
broadest sense. The diagnosis and pathology of stroke were not clearly understood and 
physical treatments were applied to patients for a wide variety of reasons (Warlow et al. 
2001). These included massage, heat and even electricity from natural or man-made 
sources. Some patients with mobility disability secondary to paralysis did receive some 
form of physical assistance in an attempt to compensate for their disability. 
In the UK, physiotherapy as we might recognise it, is first mentioned with the upsurge 
in the use of spa treatments and hydrotherapy that became popular in the late eighteenth 
century in England in spa towns such as Bath and Leamington Spa. Later, Scotland was 
to have the "Hydros" at Peebles and along Speyside. Hydrotherapy was a fashionable 
treatment for a whole host of ailments but there is little information on stroke specific 
treatment from this time. Treatments may have depended upon the patients' belief in its 
benefit or their budget, rather than any prescribed regime that was recorded. Massage 
and movement of the limbs were often incorporated into spa treatments. 
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Even with the development of the physiotherapy profession in the UK, there is 
remarkably little recorded about the treatment of patients with stroke. The Society of 
Trained Masseuses was established in 1894 to promote "medical rubbing" (mostly 
carried out by nurses) and to distinguish therapeutic massage from the unsavoury image 
that massage had at the time, and to some extent retains today. At the turn of the 
twentieth century the Swedish Institute a school for remedial exercise introduced 
Swedish exercise therapy to the UK and within 10 years the Incorporated Society of 
Trained Masseuses was also responsible for training and examining medical gymnastics 
and electrotherapy. Many of the techniques taught in those times persist to this day in an 
amended forin and are still the basis of today's physiotherapy treatments. 
The numbers of trained masseuses increased greatly during the First World War. In 
1943 the Chartered Society of Physiotherapy was formed and with the development of 
the National Health Service in 1947, it controlled standards and provided training for 
women and men entering the profession (Thornton 1994). Records of the training and 
treatment of stroke in the early days of the profession give little reference to the amount 
of therapy that should be given to patients. Early treatments still consisted of 
"therapeutic massage" and passive movements to the limbs. Often patients were given 
treatments allowing them to maximise the use of their unaffected limbs, e. g. 
strengthening exercises in order to compensate for a limb weakness on the opposite 
side. Splinting materials were employed to control abnon-nal muscle function and 
generally the use of callipers, splinting and wheelchairs appears to have been more 
commonplace than today. The aim of treatment was often "the attainment of a safe, not 
a non-nal, mode of travel" (Perry 1969). 
In contrast to this compensatory or functional approach, the 1950s and 1960s saw an 
increase in the popularity of methods broadly based on contemporary understanding of 
the physiology of the nervous system. Some of these methods are still practiced today 
with some modification and have some ardent followers despite there being little sound 
evidence to support their use. 
The Bobath approach (Bobath 1990)(Davies 1985) broadly follows a neuro- 
developmental sequence similar to that seen in a normal developing infant. A therapist 
promotes non-nal movement patterns and facilitates movement, with "abnon-nal" reflex 
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reactions being discouraged. Johnstone (Johnstone 1978) had a similar approach but 
focussed on stability of the proximal joints often employing inflatable plastic splints to 
support the limbs. In contrast such "abnormal" patterns and reflex movements are 
allowed and encouraged in another two approaches advocated by Temple Fay (Kidd et 
al. 1992) and Brunnstrorn (Brunnstrom 1970), who considered the mass movement 
patterns to be a necessary stage in developing motor control. 
The latter two approaches involved treating patients (both adult and children with a 
variety of neurological conditions including stroke) for "an hour or so per day or even 
every other day" (Kidd et al. 1992). A review by Bower describes the Bobath approach 
as lasting for 30 - 60 minutes per session, with I-5 sessions per week (Bower 1993). 
An alternative was a neuropsychological approach termed "conductive education" 
developed by Peto, in Hungary during the Second World War. In the Peto Institute in 
Budapest a continuous, 24 hour approach is taken to re-educate movement (though used 
largely in the treatment of cerebral palsy in children, adults with neurological disease 
are treated) (Cotton & Kinsman 1983). This approach places the emphasis on the 
patients' own efforts, with conceptualisation of tasks, verbalisation and feedback from a 
"conductor" and repetition, often in a group setting, along with the use of specialised 
equipment and furniture. 
In the late 1980s two Australian physiotherapists, Carr and Shepherd described a "motor 
relearning programme" for stroke based on an understanding of kinematics and kinetics 
of non-nal movement, motor control processes and motor learning. Although popular in 
Australia and increasingly employed and taught in the UK it is still less popular in the 
UK than the Bobath approach. It recommends that patients repeatedly practise 
movement tasks focussed on function in order to achieve recovery (Carr & Shepherd 
1987). 
Although there have been, and still are, several other recognised physiotherapy 
approaches to treating stroke e. g. Rood, Knott and Voss they are not widely practised 
(Bower 1993)(Partridge 1995)(Davidson & Waters 2000). 
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There have been many trends in physiotherapy treatment for stroke over the post-war 
period, with most, surprisingly, not specifying their intensity. Many al-C based on 
developmental work aimed at the treatment of children with cerebral palsy. Whilst some 
specific regimes were popular for children, ranging from some contact cý, ery few weeks 
with a physiotherapist, to 5 minutes treatment, 5 times a day, to several hours per daý', 
the same cannot be said for adult treatment. Many of the paediatric methods have been 
advocated and used in treatment of adult stroke, with claims that the physiological 
principles of treatment are similar. However without the emphasis of educational and 
physical development (and the necessary resources, often based in educational 
institutions) and practical difficulties involved in dealing with physically demanding 
disabled adults e. g. it is difficult to carry out passive movements to the limbs of a 100 
kg man for 6 hours a day, these rigid regimes have never been as popular in adult as 
paediatric envirom-nents. 
None of the popular proponents of contemporary physiotherapy, with the exception of 
Carr and Shepherd (motor relearning programme), clearly specify a dose of therapy or 
the manner in which it should be applied. Many merely put forward a philosophy or 
principles of treatment to be followed. Most suggest "as much as tolerated" or that 
exercises or therapy should be carried out "daily" or "as often as possible". The 
majority adhere to the idea of individual assessment and avoid giving a formula or a 
regime for stroke treatment. Such regimes were commonplace in the physiotherapy 
treatment of other conditions, for example the "DeLon-ne and Watkins" and 
"Macqueen" regimes to allow muscle strengthening after musculo- skeletal injury 
(Hollis 198 1). 
What does today's physiotherapy involve? 
Physiotherapy treatments with patients with stroke remain diverse (Pomeroy & Tallis 
2002) (SIGN Guidelines 2002). Typically they consist of exercises which may be 
active; with the patient participating and carrying out the movement under their own 
volition; or passive when the patient receives full assistance to carry out the movement 
from the therapist; or active/assisted which is somewhere between the other two types, 
usually the patient being asked to join in with the movement as much as possible. 
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The movements may be assisted or facilitated by the therapist or resisted by a number of 
means (e. g. manual resistance, body weight resistance, weight resistance). Generallv, 
the aims of the treatment are discussed with the patient and often goals are negotiated. 
These may be based around reducing impain-nent e. g. reducing abnormal muscle tone, 
reducing disability e. g. practising the functional task of standing up from a chair or 
reducing handicap e. g. practising walking outdoors in order to allow access to 
community facilities. 
There are differences of opinion as to the best exercise treatment approach 
physiotherapists should use with patients with stroke. In the UK the two most popular 
approaches are Bobath (also known as "Normal Movement") and the Motor Relearning 
Programme (MRP) (also known as "Movement Science"). There are some regional 
differences in the claimed use of these techniques (Davidson & Waters 2000). There is 
also considerable debate as to their efficacy and difficulties in discriminating between 
the approaches in order to define the interventions (Langhammer & Stanghelle 
2000)(van Vliet et al. 2001). Many therapists (up to 87% in a recent national survey in 
the UK (Davidson & Waters 2000)) admit to using an eclectic approach, varying their 
approach with and specifically around each patient's assessed needs. 
Other techniques may be employed such as the application of thermal treatments e. g. ice 
packs, the provision of mobility aids or equipment, splinting, electrotherapy treatments, 
or techniques aimed at relieving pain such as trans-cutaneous nerve stimulation (TENS) 
or acupuncture. Physiotherapists are also involved in multidisciplinary teams, helping 
patients to adjust to changes in their abilities and providing information to patients and 
their relatives. 
Example of physiotherapy treatment 
To illustrate how physiotherapy services are delivered an example of a typical 
physiotherapy treatment in a stroke unit is given below: 
Patients who are unable to stand due to hemiplegia, reduced muscle tone and a loss of 
standing balance reactions would be encouraged and physically assisted to stand up at 
an early stage after their stroke (as early as the first day after their stroke in some units 
(Langhorne & Pollock et al. 2002)). This process aims to assist regaining fuiictional 
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muscle control in the anti-gravity muscles in the trunk and lower limb and to stimulate 
the muscles that provide joint stability through weight bearing. The physiotherapist 
encourages symmetry of movement and weight bearing and discourages the use of the 
unaffected side merely to compensate for any weakness. The patient might repeatedlý, 
practise rising from a plinth (which may be raised to make the task easier) into a 
standing posture with assistance of the physiotherapist. If this is particularly difficult, 
more than one physiotherapist may be required or electrical hoisting equipment may be 
employed. Massage techniques (brushing or rubbing with the fingers) may be used 
directly on the weak muscle groups that would normally be involved in the movement, 
in order to stimulate contraction. The procedure would be explained to the patient and 
verbal feedback and encouragement would be given throughout the session. Several 
attempts to stand might be made and the patient allowed to take short rests between 
each attempt. The physiotherapist assesses the patient's posture and ability to control 
the movement and to maintain their balance. The upper limb would be supported 
throughout the treatment and time spent assisting the limb through passive or active / 
assisted movements in order to maintain range of motion at the joints. Further 
functional, goal-based movements (e. g. stretching out to reach for a cup then grasping 
this and lifting it towards the mouth) to stimulate the normal movement patterns would 
also be practised. The movement is supervised, assisted if necessary and corrected to 
minimise any abnormal movement patterns or associated abnormal reactions or reflexes. 
A typical treatment session might last 30 - 45 minutes and would probably occur once 
on a weekday. Time may also be spent recording assessments and treatment notes, 
encouraging the patient to perform exercises or activities on their own and discussing 
treatment with relatives and other multidisciplinary team members. 
Similar treatments are carried out throughout the country most days of the week. 
However, despite some encouraging results in the recent research (Langhorne et al. 
1996) (Kwakkel et al. 1999) it is still not known how many times the treatment should 
be repeated or for how long it should last. 
From these observations of current and historical practices, we are given little indication 
of how today's physiotherapists working in the UK have arrived at their level of 
intervention. Rather than being based on scientific evidence, current levels of intensity 
are likely to reflect customary work practices, exercise tolerance (for both the patient 
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and therapist), the patients' ability to take in new infon-nation, demand for servIces and 
available resources, clinical opinion and the time of onset of symptoms. GenerallY, most 
physiotherapy in the UK is available in the early stages after stroke. 
If we could determine the optimum physiotherapy input for patients with stroke Ný"e may 
have an impact on levels of impairment, disability, handicap experienced by patients, as 
well as health costs. It might also contribute to our understanding of the process of 
rehabilitation and physiotherapy. 
Difficulties in investigating physiotherapy 
Our uncertainty about the optimum intensity of physiotherapy may exist for several 
reasons: it may be in part due to a lack of research skills, experience and understanding 
within the physiotherapy profession; a lack of interest (some twenty or thirty years ago, 
stroke was seen as a "Cindarella service" - often overlooked and under-funded); a lack 
of time dedicated to the question, or the practical difficulties in implementing clinical 
trials. These possible reasons reflect those perceived by stroke rehabilitation 
professionals as barriers to implementing evidence-based practice (Pollock et al. 2000) 
and may indicate something of the UK's health care culture. 
One way of investigating the efficacy of physiotherapy would be to carry out a 
randomised controlled trial of physiotherapy with two groups of patients with stroke; 
one receiving treatment and the other receiving none, then comparing their outcomes. 
However, physiotherapy is now so well established (at least in the UK) as a key element 
to rehabilitation that this proposal is unlikely to gain approval from local ethical 
authorities (Rice-Oxley & Turner-Stokes 1999). Such studies, if they gained approval, 
may have difficulty in recruiting patients who might fear they were to miss out on 
treatment that patients and their relatives perceive to be beneficial. Indeed, the amount 
of physiotherapy received by patients is an area in which patients and their relatives 
have expressed satisfaction and dissatisfaction with their hospital care (Pound et al. 
1994(a))(Pound et al. 1994(b))(Wellwood et al. 1995(a)). 
In order to evaluate physiotherapy after stroke we therefore have to take a pragmatic 
approach (Roland & Torgerson 1998). In this thesis I am not concerned with any 
particular physiotherapeutic intervention, but with examining the effect of different 
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intensities of physiotherapy as it is currently, commonly provided in hospitals in the UK 
to patients after stroke. This approach reflects current practice and in turn allows rcsults 
to be readily interpreted, widely generalised and implemented. 
Unlike a trial of a drug where a clear prescription can be made, involving dose strength 
(concentration) and frequency of administration, there are difficulties when Nve try to 
compare intensities, doses or input units of physiotherapy. 
We need to define whether we are discussing the duration of treatment or the degree of 
effort or exertion (concentration) used during that treatment session. We also need to 
decide whether we are examining the direct intervention of the physiotherapist (face-to- 
face contact), or any indirect effects such as what the patient themselves carry out e. g. 
unsupervised exercise, practise of techniques or strategies taught by a physiotherapist 
but perhaps then used with other rehabilitation team members or carers. Most studies in 
the past have settled to measure the amount of face-to-face contact time the 
physiotherapist spends with a patient. Throughout this thesis I will use the term 
intensity to refer to the duration of physiotherapy treatment. This is the amount of time 
spent by the physiotherapist that can be directly attributed to each patient i. e. face-to- 
face contact and indirect contact time (such as record keeping or telephone 
conversations) in connection with delivering care for that individual patient. 
Both drug and physiotherapy trials may suffer from problems with compliance if the 
patients are not directly supervised, taking their medication or their prescribed exercise 
regime. 
In considering trial design, a placebo is often easy to design and administer as part of a 
drug trial. This is less easy to specify in physiotherapy trials especially to find "dummy" 
treatments that might be substituted in place of rehabilitation exercises. Standardisation 
of treatment is also reasonably easy in drug trials. The human interaction involved in the 
physiotherapeutic process, by its nature, makes the standardisation of the intervention 
and its delivery complex, though this is not altogether impossible for example by the 
use of strict treatment or trial protocols, following "care pathways" or standardised 
interventions such as home exercise regimes delivered in a standard way such as by 
booklet or video recording. 
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Attempts to examine intensity 
Several observational studies (Table 1-1) have attempted to quantify the actual amount 
of physiotherapy (or "therapy") that patients receive. These arose partly to investigate 
rehabilitation interventions and partly from concerns that patients apparently spent long 
periods of the day unoccupied. The duration of inpatient therapy ranged from an 
average 43 minutes (Newall et al. 1997), to 21 minutes on a medical xvard and 36 
minutes on a stroke unit (Lincoln et al. 1996), to 45 minutes (Wade et al. 1984). 
Physiotherapy ranged from 30 minutes (day hospital) to 90 minutes (outpatient 
department) (Gladman et al. 1991) with an average of 60 minutes on a domiciliary visit 
(Ballinger et al. 1999). Locally, an unpublished survey indicated that acute stroke 
patients in rehabilitation units in Glasgow received an average of 45 minutes of 
physiotherapy five days a week (Langhorne et al. - unpublished feasibility study). 
Table 1.1 Duration of physiotherapy treatment 
Study Setting Average treatment 
time (minutes) 
per weekday 
Wade et al. 1984 Inpatient 45 
Gladman et al. 1991 Day hospital 30 
Gladman et al. 1991 Outpatient 90 
Lincoln et al. 1996 Stroke unit 36 
Lincoln et al. 1996 Medical inpatient 21 
Newall et al. 1997 Inpatient 43 
Ballinger et al. 1999 Domiciliary 60 
Langhorne et al. 
(unpublished data) 
Stroke unit 45 
There are also considerable variations in physiotherapy service provision between 
countries (Beech et al. 1996)(de Weerdt et al. 2000). A direct comparison of clinical 
outcomes achieved in areas or countries where there is a difference in intensity is likely 
to be complex due to different service provision and constraints, case mix and 
heterogeneous interventions. 
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There may also be practical problems with data collection on the intensity of 
physiotherapy. Whilst some physiotherapy services routinely record the amount of time 
spent with patients, many do not, with data being limited to clinical records of treatment 
and a record of face-to-face contacts. 
Probably the most accurate and helpful way of assessing intensity is to carry out a 
randomised controlled trial (RCT). Those intensity RCTs that have been published are 
reviewed in the next chapter. They had an average intervention of 45 minutes per day 
for the "control" groups, reflecting general practice in the UK as described in the 
observational studies above. 
Research questions to be addressed in this thesis 
In this thesis I examine the uncertainty of the effect of intensity (i. e. the duration) of 
physiotherapy treatment on patients with stroke during their rehabilitation in hospital. 
To do this I will compare outcomes achieved with the provision of a standard amount of 
physiotherapy with those achieved when additional physiotherapy is provided. 
I put forward the hypothesis that intensive physiotherapy after stroke will produce 
benefits which: 
a) speed recovery in terms of impairment and disability. 
b) are greater when targeted (e. g. on upper limb recovery). 
c) are greater for patients with moderate impairment and little co-morbidity. 
d) are greater in the shorter (3 months) than longer terin (6 - 12 months). 
e) result in a reduced duration of inpatient rehabilitation. 
I will attempt to describe any benefits in mobility, function and cost in useful and easily 
understood tenns e. g. by relating to standard scales and giving cost savings per patient. 
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Structure of the thesis 
In chapter 2,1 examine the published evidence about intensity of physiotherapy after 
stroke. I describe how I selected and reviewed the available evidence. 
In chapter 3,1 describe the randomised controlled trial that aimed to address the 
hypothesis. 
In chapter 4,1 introduce the statistical technique of meta-analysis that may be a useful 
tool to further test the hypothesis. I describe a combined analysis of several trials of 
intensity (including data from the study in chapter 3). 
In chapter 5,1 describe forining a collaborative group in order to carry out a detailed 
individual-patient-data meta-analysis. 
In chapter 6,1 draw conclusions from the randomised controlled trial and the meta- 
analysis. I review to what extent I managed to establish satisfactory answers to the 
questions set out in this chapter. I also discuss some limitations of the work and indicate 
areas that could be developed for further research. 
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Summary 
* Stroke is a major worldwide health problem that will continue to effect IndIvIduals, 
their carers and society and poses a huge challenge to those charged with providing I 
effective clinical services in order to reduce impairment, disability and handicap. 
9 Currently, the most effective intervention in the treatment of patients with stroke is carc 
carried out in an organised stroke unit. 
e Most stroke units include physiotherapy as part of their treatment. We remain uncertain 
as to which patients might benefit most and in which ways in response to which type 
and amount of physiotherapy. We need to determine how best to deliver such services 
for optimum effect and value. 
9 Physiotherapy is a well-established part of many health services for people with stroke. 
It seems to offer some benefits to patients, however there is little evidence to support its 
routine use. There are practical and ethical difficulties in evaluating this rehabilitation 
intervention in a scientific manner. 
9 We know very little about the optimum intensity of physiotherapy either from historical 
records or reviewing current practice. We have some information from research into the 
area: observational studies about the intensity of physiotherapy currently delivered and 
interventional studies. The randomised controlled trials of intensity are reviewed in the 
next chapter. 
* In order to explore the issue of optimum intensity of physiotherapy, I propose a 
hypothesis and set out a number of research questions that I aim to address in this thesis. 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Introduction 
The questions posed in the previous chapter have been of interest to stroke researchers 
for many years and there have been several attempts to address them. In this chapter I 
describe some of the studies from over the past 30 years that have added to our 
understanding of intensity of physiotherapy after stroke. 
Aims 
In this chapter I aim to: 
1). Describe the important literature relevant to physiotherapy intensity. 
2). Describe desirable features of rehabilitation trials. 
3). Discuss difficulties in researching complex healthcare interventions. 
4). Discuss selected studies in relation to the research questions outlined in Chapter 1. 
The Literature 
Although research into stroke has been carried out for many years there have been 
relatively few specific studies of physiotherapy and rehabilitation and even fewer of 
intensity of physiotherapy. However, there has been an increasing amount of interest and 
number of scientific trials carried out over the past 15 years. This increase in research 
activity may be attributed to the increasing challenge presented to service providers due 
to the increasing burden of stroke. Enthusiastic, interested individuals have taken up this 
challenge at local, professional and political levels. They have largely been responsible 
for driving the research agenda, prompting initiatives from scientific, government and 
charitable bodies such as the Kings Fund and the Stroke Association. Many of these 
bodies made recommendations for action to attempt to reduce the burden of stroke, e., -,. 
guidelines from international bodies such as the European Stroke Initiative (EUSI) 
(EUSI 2003), from government departments; such as the National Service Framework 
(NSF) for Elderly People from the Department of Health in England and Wales 
(Department of Health 2001); and professional bodies such as the Royal College of 
Physicians (RCP) (Intercollegiate Working Party for Stroke 2002) and the Scottish 
Intercollegiate Guidelines Network (SIGN)(SIGN 2002). 
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Although there are moves towards basing such recommendations on scientific evidence 
many guidelines do not have a clear scientific foundation. Recognising this, many 
bodies have made recommendations for further investigation into areas including I 
therapy and rehabilitation. In turn, research bodies have, to some extent, responded to 
these recommendations and funded relevant projects. However the process from 
proposal to publication can be lengthy. 
Searching the literature uncovers a variety of papers, many of which appear relevant to 
the questions I set out in Chapter 1. However to fully address all my questions on 
physiotherapy intensity and in order to influence clinical practice and health policy 
decisions, any trial would have to produce results that are reliable and can be 
generalised. Unfortunately, such a trial does not appear to exist. 
It is difficult to estimate just how large such a trial would have to be in order to change 
clinical practice in physiotherapy. In an often-quoted example from the field of 
medicine, the use of aspirin after myocardial infarction was considered beneficial in 
early small studies (even these are relatively large in comparison to many rehabilitation 
studies) yet it was not until the large ISIS-2 trial (ISIS-2 Collaborative Group 1988) in 
the late 1980s, involving over 17,000 patients was conducted and reported that clinical 
practice started to change. There is little to suggest that therapists are any more liable to 
accept change than the medical profession and, given that treatment effects of physical 
therapy may well be more modest than in the last example, it seems likely that large 
numbers of subjects would need to be recruited in order to change clinical practice. 
Reviews of physiotherapy intensity 
I undertook a literature search using several electronic databases (Medline 1966 to 
present, CINAHL 1982 to present and the PEDRO and Cochrane Stroke Group 
Specialised Trials registers), by referring to recently published reviews and by 
discussing literature with other researchers and experts within this area. 
I found several reviews of the available literature on effectiveness and intensity of 
physiotherapy (up to 12 reviews over the past 15 years were identified recently by van 
der Lee et al. ) (van der Lee et al. 2001), some narrative in style e. g. (Ernst 
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1990)(Ashburn 1997), some following the more recent trend towards more fori-nal 
systematic reviews e. g. (Langhorne et al. 1996)(Kwakkel et al. 1997)(van der Lee et al. 
2001). Each considered slightly different aspects of intensity, identified and selected 
different trials and used different methods to appraise and in some cases analyse the 
available evidence. The reviewers found the trials to be mostly small, focused on 
various aspects of stroke e. g. functional ability or arm impairment, and at times arrived 
at different conclusions. With some exceptions, the earlier studies before 1990 were 
generally less methodologically rigorous, reflecting an earlier stage of clinical trials, 
clinical science and review methodology. 
The narrative reviews 
Ernst noted that many trials were not blinded, non-randomised and had potential for bias 
(Ernst 1990). He suggested that the physiotherapy approach was immaterial. He also 
noted that settings were different, interventions varied, outcomes were non-standard and 
that all subjects showed some early recovery. He came to the conclusion that "if an 
optimal treatment exists, we have, so far, failed to identify it. Until ftirther evidence 
emerges, we should therefore select therapies that are most cost-effective and that can be 
given to the largest number of patients. Well planned clinical trials aimed at finding the 
best approach and discriminating potential responders from non-responders are urgently 
needed. ". 
Pollock et al. (Pollock et al. 1993) and Ashburn in 1997 (Ashburn 1997), highlighted 
some of the shortcomings of rehabilitation studies: in general they were of poor quality; 
used insensitive outcome measures e. g. activities of daily living (ADL) scales may not 
be sensitive to change in motor and sensory impairment - often the level at which the 
intervention is aimed; lacked detail; used inconsistent definitions; poorly described 
outlying subjects, and selected different end points at which to measure outcomes. All of 
these were present on a background of spontaneous recovery after stroke. 
Ashburn (Ashburn 1997) recommended researchers include a broader spectrum of 
patients and use standard measures whilst recognising the limitations of some of the 
widely used, popular measures such as the Barthel Index. Doing so would allow 
comparison between studies and facilitate combination in meta-analysis. 
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Formal reviews 
Langhorne et al. used different methods in a well-conducted fon-nal revie,, N, (Langhome 
et al. 1996), and found, like Ernst (Ernst 1990), the evidence for improved outcome ýý'Ith 
increased intensity of physiotherapy to be lacking and of variable quality. They included 
a number of studies that would be relevant in answering my questions but included 
some out-patient based studies. They also concluded that further study was required in 
order to obtain a definitive answer. 
A year later, Kwakkel et al. in their study using clearly stated methods and broader 
inclusion criteria, concluded that a greater intensity of physiotherapy would lead to 
benefits (Kwakkel et al. 1997). However, their overview included some confounded 
trials. They highlighted that trials were small, had problems with blinding and were 
heterogeneous. Recognising that most recovery is probably spontaneous they 
recommended that treatment should start as early as possible and also suggested that the 
treatment approach may be immaterial. 
Van der Lee et al. 's review of upper limb physiotherapy had a broad scope and included 
a wide variety of interventions many of which could be defined as physiotherapy but 
might not be recognised as normal physiotherapy practice (at least currently in the UK) 
e. g. constraint induced therapy and robot assisted movement practise (van der Lee et al. 
2001). 
Individual studies and trials 
Even within the relatively small number of studies of intensity of physiotherapy there is 
remarkable diversity, reflecting a variety of perspectives on the subject; from service 
evaluation (Smith et al. 198 1), to consumer satisfaction surveys (Pound et al. 1994(a)) to 
investigation of novel treatment techniques (Feys et al. 1998). There are a corresponding 
variety of study designs to accommodate these perspectives with an increasing number 
of randomised control trials being conducted, in order to gain scientific credibility and 
better address clear scientific questions. There are also a wide variety of subjects and 
participants, interventions, settings, time points and outcomes: 
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Subjects andparticipants 
The subjects vary considerably in the studies from early acute in-patlents (e. g. KN,, -akkel 
et al. 1999), seen a few days after onset of symptoms, to patients receiving treatment 
over a year after stroke (e. g. Wade et al. 1992)(Green et al. 2002). Many studies recruited 
selected patients. In many cases this is because patients are required to give infon-ned 
consent which may be difficult or impossible to obtain when the stroke has resulted in 
cognitive or communication impairment. If the studies have been limited by ethical 
considerations or have not had the option of gaining informed consent from a relative or 
carer, the sample group can be skewed towards a less disabled group. Some revieNý, crs 
have commented (Ashburn 1997) that patients at the extremes of seventy are not well 
represented in trials as they are either too sick or too well to detect change or to be 
maintained in a study. 
On the other hand where all patients are included e. g. Partridge et al. 2000 included 
severely disabled subjects, this better reflects a typical clinical situation allowing results 
to be generalised. The disadvantage in this is that we would expect different prognoses 
for different patients after stroke, dependent on for example on their age or the severity 
of symptoms. Any potential treatment effect being investigated is likely to be diluted 
and possibly go undetected unless very large numbers of subjects are recruited. Only 
where there are large enough numbers can sub-group analyses be carried out and may 
identify groups that did respond or responded better to the intervention. 
Slade et al. (Slade et al. 2002) examined intensity of therapy in a mixed group where 
patients with stroke and patients with head injury were studied. Again this may reflect 
clinical practice in some mixed neurological rehabilitation units but needs careful 
interpretation in order to isolate the results that are relevant to patients with stroke. 
Some studies examined the intervention when delivered by different therapists. In one 
study (Lincoln et al. 1999), an experienced "expert" therapist was contrasted with 
trained therapy assistants working under supervision. Other studies examined 
"conventional" service provision (Partridge et al. 2000), aiming to reflect normal 
clinical practice. 
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In several cases, intensity of "therapy" was considered as "physical therapies"(as 
opposed to drug or psycho-social interventions) and included occupational therapy in 
addition to physiotherapy (Smith et al. 1981)(Slade et al. 2002). In these cases "physical 
therapy" would include the practise of physical tasks, in some cases undertaken by a 
variety of healthcare workers. 
Intervention 
Novel interventions have been trialed with a view to evaluating their effectiveness. e. g. 
the use of sensori-motor stimulation using a rocking chair and an-n splint (Feys et 
al. 1998) or patients practising exercises using a mirror (Altschuler et al. 1999) or robot- 
assisted movement (Volpe et al. 2000). In other studies current clinical practices were 
evaluated (Sunderland et al. 1992)(Lincoln et al. 1999)(Partridge et al. 2000). One study 
(Pollock et al. 2002) took an alternative approach, investigating the effect of 
independent practice of an exercise without direct supervision of a physiotherapist. 
Because of the complex nature of physiotherapy, involving interpersonal and physical 
components, many studies have experienced difficulties in describing what the 
intervention involves. Most have related intensity of therapy to a component of time. 
None have considered "intensity" to include how much effort the patient applies or has 
applied to them during the therapy session. Pragmatically, this reflects how therapy is 
delivered in a clinical setting and avoids the complex difficulties in attempting to 
measure therapeutic effort either on the part of the patient or therapist. Most studies 
have opted to increase the amount of time spent with the therapist by increasing the 
duration or the number of the sessions delivered. Even this latter approach has 
difficulties, as for example, delivering two half hour sessions of treatment may be 
different to delivering a single one hour session due to potential problems with fatigue 
or training effects that may develop during a single longer session. 
Some reviewers (Ernst 1990) argued that the content of the intervention itself was 
unlikely to be of importance but the duration of contact with the therapist may be. Even 
if this is the case, in order to be able to generalise results it is important to have a clear 
description of both the subjects and the methods used in the studies. 
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Setting 
Within the hospital setting there may be confounding from other services. The Stroke 
Unit Trialists Collaborative group in 1997 (Stroke Unit Trialists Collaboration 1997) 
shed new light on the effectiveness of stroke units. Their meta-analysis shoNved 
outcomes, in terms of survival, dependence and institutionalisation at 12 months after 
stroke, to be significantly better in patients managed in a stroke unit compared to 
"conventional care", often delivered in general medical wards. These results meall that 
some of the previous studies of physiotherapy intensity were in fact confounded, as they 
compared specialised stroke unit and general medical care (Peacock et al. 1972 - though 
no details of intensity of therapy are available - quoted in (Langhorne et al. 
1996))(Sivenuis et al. 1985) where we might expect a difference in outcome. Generally, 
better results were found in the stroke unit groups and this had partly been attributed to 
patients receiving more therapy, however there may be a much more complex 
interaction of interventions that provides the real explanation of the "stroke unit effect". 
With a change in focus from provision of healthcare in institutions towards provision in 
the community, several intensity studies have been carried out on an out-patient 
(Duncan et al. 1998) (Smith et al. 1981)(Werner & Kessler 1996) or domiciliary basis 
(Wade et al. 1992) (Green et al. 2002). 
As mentioned in Chapter I (page 13) the amount of therapy that is standard in one 
setting may well be different in another e. g. there are considerable differences in the 
average amount of therapy delivered in the UK, other parts of Europe (de Weerdt et al. 
2000)(McKevitt et al. 2000) and North America (Jette et al. 2005). Comparisons of 
intensity across national boundaries are difficult to carry out due to other constraints and 
likely confounding factors between the healthcare systems and cultures. Consequently, 
these studies rarely go beyond describing the differences. 
Timing 
In trying to determine the optimum time to deliver services some researchers have 
provided the intervention at a time when recovery 
is considered to have reached a 
plateau and conventional therapy has usually stopped. 
This may make controlling for I 
treatment effects easier, allow a different study design (e. g. interrupted time series 
23 
Chapter 2 
designs such as ABA crossover) (Wade et al. 1992) to investigate optimal timing or It) 
allow ethical considerations to be accommodated (e. g. concerns about denying patielits 
potentially beneficial interventions). As most patients are discharged from treatment 
soon after leaving hospital this often involves contrasting some treatment N"'ith the 
66non-nal" amount, which is often none (Green et al. 2002). 
Outcomes have also been measured at a variety of end points, e. g. two weeks after 
stroke, on hospital discharge, at six months or a year after stroke. The baseline for 
several studies varies and can be the date of admission into acute or rehabilitation 
hospital, date of recruitment or date of first intervention. These variables can make the 
comparison of results between studies complex. 
Outcomes 
To reflect the different interventions used in the studies a corresponding array of 
outcome measures were employed. Unfortunately, some of these are non-standard, have 
poorly established measurement qualities and are insensitive to changes likely to be 
attributed to the intervention. The Barthel index (BI) for example is widely used as a 
measure of activities of daily living (ADL) or as a disability scale, but is widely 
acknowledged to have limitations. One study estimates that the Barthel index may 
underestimate the patients' and carers' problems in up to a third of subjects (Wellwood 
et al. 1995(b)). With a marked ceiling and floor effect, it is clearly insensitive to certain 
disabilities e. g. subjects that are deaf, blind, unable to speak and have only one 
functional arm are able to score full marks on the scale. Some therapists argue that 
changes in ADL scores are not the primary focus of physiotherapy treatments that may 
be targeted more at the level of impairment (Ashburn 1997) (Pomeroy & Tallis 2000). 
A number of studies reported length of hospital stay as an outcome. With the majority of 
hospital inpatient costs attributed to nursing care (Warlow et al. 2001), length of stay is 
sometimes taken as a proxy measure of in-patient costs. Service providers do not want 
patients to be discharged earlier only to increase the burden on the community services 
or to be re-admitted. Although hospital costs could be reduced by reduced hospital stay, 
overall contact or treatment intensity with therapy staff may not be significantly affected 
if treatment continues after discharge from hospital. Where this outcome measure has 
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been used we require information about the blinding of "decision makers" (often 
consultant physicians or the multi-disciplinary team) that decide when the patient Nvill 
be discharged (e. g. Slade et al. 2002). 
Rationale 
Comparing the justification for the physiotherapy intervention or "schools of thought" 
has, to date, not resulted in a contrast of "intensity" in terms of time or duration of 
contact with a physiotherapist. For example, Langhammer and Stanghelle contrasted 
the Bobath approach with a motor relearning programme (Langhammer & Stanghelle 
2000). The main reasons for this are likely to be a conscious effort to standardise the 
interventions in as many respects as possible. Alternatively, it may be because the 
different approaches are generally poor at prescribing a strict treatment regime 
indicating the intensity of treatment. 
Taken as a whole, the literature is limited. It highlights many difficulties in this area of 
healthcare research and many authors recommend that more high quality studies be 
carried out. 
Difficulties in healthcare research 
The methodological difficulties that have been discussed mean that the quality of 
evidence on which clinical practice is based, may be limited or questionable. 
Physiotherapy is not unique in experiencing these methodological difficulties. Many 
branches of healthcare, certain aspects of medicine, surgery, nursing and therapies have, 
so far, been poorly researched. For example surgical procedures are half as likely to be 
based on randomised controlled trial (RCT) evidence as internal medicine interventions 
(McCulloch et al. 2002). 
Along with the methodological difficulties mentioned in Chapter I (page 3) and the 
professional barriers described by Pollock et al. (Pollock et al. 2000), there are a number 
of problems common to those wanting to study complex healthcare interventions (see 
table 2.1)(McCulloch et al. 2002). 
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Table 2.1 - Problems in researching complex healthcare interventions 
(McCulloch et al. 2002). 
Small trial size 
Complex (sometimes non-standard) interventions 
Difficulty in defining intervention 
Difficulties in monitoring the quality of intervention 
"Learning curve" for techniques. 
Blinding is difficult and impossible in some cases 
Testing established practice 
Patient uncertainty in consenting to clinical trials 
Interventions may develop gradually rather than being research lead. 
Difficulties accepting the requirement for RCTs and acknowledging clinical uncertainty. 
Limited funding, education, infrastructure and experience of clinical research 
Small trial size 
Many branches of healthcare research are typified by small, single centre trials that 
make their results difficult to generalise, or compare to other populations, settings or 
services. In the case of stroke the interpretation of results is made more complicated by 
the natural course of spontaneous recovery. Although this is usually dealt with by 
selecting a randomised controlled trial design, with random allocation of subjects to 
groups, if the numbers of subjects is small there may not be an even distribution of 
subjects that are making spontaneous improvement. 
Difficulties standardising interventions 
It is difficult to monitor the quality of interventions during trials of therapy (and other 
interventions such as nursing). The processes are often complex, lengthy and subject to 
variability. Clear definitions of interventions and procedures and pre-trial training to 
attempt to standardise interventions or gather infon-nation about non-standard 
interventions may be helpful in tackling this problem. Alternatively, sampling using 
direct observation or video recording may help to detect variations from the prescribed 
intervention. 
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Frequently there is poor contrast between treatment groups being in, "est'gated and anN, 
treatment effect that is dose-dependent may go undetected. Generally speaking, close 
monitoring of the intervention is required and variation from the treatment protocol 
should be recorded. Repeated problems in delivering the protocol should raise concerns 
with the researchers that action needs to be taken e. g. training or retraining, or in 
extreme cases that the trial should be discontinued. 
Some healthcare professionals learn specific techniques and trials may need to 
acknowledge that there is a "leaming curve" where new techniques are being compared 
or that there are differences in levels of training or experience between those 
undertaking the intervention. Such a "skill mix" usually needs to be accepted and at a 
minimum recorded and described. 
Blinding 
Often there are not suitable placebo or "sham" treatment techniques that can be offered 
to maintain patient blinding or blinding of the therapist. In some cases this is possible 
e. g. where equipment is being used, but generally with exercise or physical handling of 
the patient it is impossible to provide a double-blind intervention, so the single-blind 
design is common. Maintaining blinding of observation at follow up can be difficult and 
patients and therapists providing the intervention must take precautions to prevent 
disclosing the treatment allocation. 
Testing established practice 
Healthcare researchers have the problem of testing established practice e. g. testing 
accepted techniques against a placebo or no treatment may become ethically difficult. In 
the case of stroke, physiotherapy is an accepted component of stroke unit care (Stroke 
Unit Trialists Collaboration 2003)(Langhome & Pollock et al. 2002) and as such, it 
would be difficult to deny patients what may be an important part of their rehabilitation. 
Some patients may be reluctant to participate in trials of therapy, especially if they 
perceive these to be straying from established practice. Investigations into why patients 
make decisions to accept treatment, or to participate in clinical trials, may help in the 
design of RCTs, making sure that eligible patients understand their options and that 
recruitment is maximised. 
27 
Chapter 2 
Creeping changes in practice 
Healthcare may develop gradually rather than through a research base. In this way small 
incremental changes to process may be individually insignificant and often go un- 
researched. However over a period of time a significant change may have occurred. 
Regular clinical audit as part of routine service delivery may alert researchers to 
creeping changes in practice or outcomes and may be the basis for recognising the need 
to carry out RCTs. The trials I reviewed span nearly thirty years, though most were 
published in the last ten years. We need to assume that "physiotherapy" as an entity has 
not altered considerably within this period. It seems fair to make this assumption, 
despite different treatment methods being in vogue or different explanations of the 
mechanism of treatment being hypothesised at different times. The fundamental 
underlying physical nature of the use of exercise and movement for treatment appears to 
have changed very little. However without specific, clear descriptions or records of the 
interventions (especially in some earlier trials) for comparison, this has to remain an 
assumption. 
Resistance to change 
Just as there have been champions of research and scientific evaluation in individual 
professions there are also a small number of individuals with difficulties accepting the 
requirement for RCTs, and acknowledging clinical uncertainty. This small minority may 
refuse to participate in clinical trials or be hesitant to change their clinical practice in the 
light of sound research findings. 
Given that physiotherapy as a profession is still relatively young, small and developing, 
its current position in developing its research foundations is perhaps understandable. 
Along with some other professional groups its members might claim there is a lack of 
funding, education in clinical epidemiology, research infrastructure and experience with 
which to rapidly tackle these challenges. 
Tackling some of the problems 
The problems of carrying out research into complex healthcare interventions that ha,, ýe 
been discussed are not insunriountable. Campbell et al. (Campbell et al. 2000) haý, e 
described sequential phases of developing RCTs of complex interventions for those 
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embarking on research into complex interventions such as stroke rehabilitation. Thex,, 
comment that the "use of iterative, phased approach using qualitative and quantitatiVe 
methods should lead to improved study design, execution and generalisabilitý, of results" 
(see Table 2.2). They further recommend qualitative study of the processes of 
implementation of interventions in study arms as this may further show the validity of 
the study findings. 
Researchers should aim for adequately powered feasible studies. Preparatory work 
should establish availability of subjects and resources to deliver the intervention. Where 
this is likely to be difficult, co-operation between centres can assist in recruitment, 
however this requires a co-ordinated approach and communication between the centres 
and a network of researchers willing to concentrate on the same project. 
Piloting trials may help identify methodological difficulties before precious resources 
are committed to a large-scale trial. Where recruitment is likely to be difficult then every 
effort should be made to include eligible participants. Examining characteristics of 
subjects who chose not to participate in pilot studies may help identify reasons for 
difficulties in recruitment e. g. age, gender or method of recruitment approach. Careful, 
clear wording of recruitment literature and open discussions ensuring true inforined 
consent will often be rewarded with good rates of recruitment. Ashburn recommends 
including a broader spectrum of patients in terms of their abilities (Ashburn 1997) but 
this could lead to recruitment problems (because of the requirement for consent in even 
severely disabled patients) and a dilution of any treatment effect because we would 
expect different clinical outcomes from the different groups e. g. differences in age and 
severity of stroke. 
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Table 2.2 Phased development of RCTs of complex interventions (Campbell et al. 
2000) 
Stage Phase Possible actions 
Theory Pre-clinical examining previous studies. 
Modelling Phase I carrying out descriptive studies 
considering qualitative work around the topic 
carrying out a survey to look at possible 
implementation 
producing a description of services to be investigated. 
Exploratory trial Phase 11 . carrying out feasibility studies 
acknowledging the possible presence of a learning 
curve 
considering methods to ensure the intervention is 
applied in a standard way. 
arranging training if required in order to attain 
consistency. 
make recommendations for pilot work / exploratory 
trials. 
defining the control intervention. 
calculation of the sample sizes 
Definitive RCT Phase HI carry out the definitive study 
Long-term Phase IV dissemination of results, 
implementation considering generalisation of results 
planning leading to implementation of results 
Campbell et al. go on to recommend that the intervention should be monitored and 
standardised by pre-trial training. The production of written guidelines or manuals and 
handbooks can assist researchers to standardise the conduct of the trial. This can be 
particularly important when several centres are involved and many staff or a turn-over of 
staff (for long running trials) are likely to be involved in the trial on-going re-training 
may be required. 
Efforts should be made to establish and maintain blinding of the participants or 
observers. This could be simple measures such as reminding subjects or those who are 
aware of treatment allocation not to disclose this to the blinded assessor or to avoid 
documentation being available or out of sight from the observer. Carrying out follow up 
assessments at a different location to that where the intervention is provided may help to 
ensure that blinding is maintained. 
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The use of standard measures with established measurement qualities (Hobart et al. 
1996) allows comparison between studies, making interpretation and generalisation of 
results easier and facilitates combination in meta-analysis. 
Desirable features of a randomised controlled trial are summarized in Table 2.3. 
(Mulrow & Oxman 1997, Langhorne & Dennis 1998). 
Table 2.3 
Desirable features of randomised controlled trials 
Clearly stated aims and objectives (focussed question) 
Adequate number of subjects based on power calculation 
Explicit inclusion and exclusion criteria 
Description of groups at baseline 
Efforts to reduce selection bias e. g. concealed randomisation of subjects 
Monitoring of clearly defined intervention 
Subjects in groups receive similar treatment apart from the intervention 
Double blind intervention 
Reporting of adverse events 
Use of standardised outcome measures with known measurement qualities (reliability 
and validity) 
Blind assessments 
Complete follow up of subjects 
Intention to treat analysis 
In terms of reporting, the results from trials should be disseminated as widely as 
possible. However not all results are likely to reach the public domain due to publication 
bias (discussed in Chapter 4). This can perpetuate difficulties in carrying out trials as 
researchers are denied the opportunity to discover the difficulties experienced by other 
researchers and to discuss possible solutions. Additionally, where small trials could be 
combined in a meta-analysis, unpublished trials are likely to be missed or difficult to 
obtain by those carrying out secondary research. 
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Where formal research is difficult or impractical a culture of audit or descriptive studies 
may still provide important information and help to establish the foundations or basis of 
clinical trials. This may be as simple as getting staff accustomed to data gathering and 
handling and the rigour required to successfully run a trial in a clinical setting. 
Finally, Wade warns of the potential for Type III error - an error of interpretation of 
results (Wade 2001) when considering trials of complex interventions. Recommending 
that as "there are likely to be interdependent components of the rehabilitation "black 
box" and if individual studies find negative results then these should be further 
investigated in the context of the other components". 
Addressing my research questions 
My questions in Chapter 1 are best addressed using a randomised controlled trial design. 
When I tried to relate the available results of the RCTs in the literature to my questions, 
some trials were clearly more relevant than others. 
A number of trials focused only on outpatient interventions (Smith et al. 1981)(Werner 
& Kessler 1996) (Duncan et al. 1998) or were examining late intervention out-with the 
hospital setting (Wade et al. 1992)(Green et al. 2002). Some studies featured unusual 
interventions that did not reflect physiotherapy practice in the UK: using a rocking-chair 
and a splint to give sensory-motor stimulation (Feys et al. 1998); patients practising ann 
movement on their own with the use of a mirror (Altschuller et al. 1999) and self- 
practise of rising from the chair (Pollock et al. 2002). Some other studies, although 
contrasting intensity of therapy, appeared to be more focused on investigating the 
intervention rather than the intensity of the intervention (Carey 1990) (Walker et al. 
2000). 
The studies that seemed more relevant to establishing if intensive physiotherapy after 
stroke would produce benefits are described below. 
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Lincoln et al. 1999 
In what is clearly the largest physiotherapy intensity study to date, with 282 patients, 
Lincoln et al. carried out a high quality single-blind RCT comparing the effect of 
increased physiotherapy on arm function (Lincoln et al. 1999)(Parry et al. 1999(a)). 
Additionally they investigated the effects of this treatment when administered by a 
qualified physiotherapist or by a trained supervised assistant. Their study followed a 
typical approach found in UK practice, mostly based on the Bobath approach, though 
was limited to upper limb intervention and involved a highly experienced and motivated 
therapist. They aimed to give ten hours of additional therapy over a5 week period. 
They recruited acute patients up to 5 weeks after stroke. Subjects were randomly 
allocated to control, additional therapy with a qualified physiotherapist or additional 
therapy with a therapy assistant working under supervision. Outcomes were assessed at 
the end of intervention (5 weeks), 3 and 6 months after stroke using arm function and 
ADL measures (Rivermead Mobility Index (RMI), Rivermead Mobility Assessment 
(RMA) (Arm section), Action Research Arm Test (ARAT) and the Barthel Index (BI). 
They found no differences between the groups with no significant effect on arm 
function. This negative result may be due to the content of the therapy, patient selection, 
chance or possibly a lack of intensity, as only half of the patients allocated to the 
additional therapy groups completed the programme. 
A post-hoc analysis, examining sub-groups suggested that less severely impaired 
patients benefited from intervention from a supervised therapy assistant rather than a 
qualified physiotherapist. It is possible that there was more contrast in the content of the 
sessions delivered by the supervised assistant. The qualified therapist may have spent 
more time discussing treatment and negotiating with the patient whilst the assistants 
may have spent a greater proportion of the time actually carrying out exercises. 
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Kwakkel et al. 1999 
In a well conducted single blind RCT Kwakkel et al. investigated the effects of different 
intensities of arm and leg rehabilitation on the functional recovery of activiti I 'es of dail, y 
living, walking ability and dexterity of the paretic arm (Kwakkel et al. 1999). 
Within 14 days of onset of primary middle cerebral artery stroke, patients, recruited 
from seven hospitals, were randomly assigned to one of three groups: to receiN, e a 
rehabilitation programme with the emphasis on the arm; a programme with the emphasis 
on the leg and a control group that immobilised the arm and leg using an inflatable 
splint. The intervention was applied for 30 minutes per day for 5 days per week for a 
period of 20 weeks. This was over and above their normal rehabilitation programme. 
The intervention was described in treatment diaries (in blocks of 15 minutes). It was not 
reported who provided the treatment. 
Their primary outcome measures were ability in activities of daily living as measured by 
the Barthel Index (BI), walking ability described by functional ambulatory categories 
and upper limb dexterity assessed by the Action Research Arm Test (ARAT) at 6,12,20 
and 26 weeks after stroke. 
They found higher scores in the leg training group for all of the outcomes and a small 
improvement in dexterity in the arm group. These effects had disappeared by week 20. 
They concluded that increased intensity of physiotherapy produced short-term benefit 
and that exercise therapy produces benefit in the area at which it is aimed. They went on 
to follow up their subjects at 9 and 12 months (with un-blinded assessments) but found 
no significant differences between the groups. 
It is difficult to generalise from their results to the general stroke population. They 
recruited approximately 3% of patients admitted to their hospital, all of whom had 
marked disability (a BI score of 9/20 or lower) and were non ambulant. They achieved 
positive results though, taken overall, the study is probably not large enough to actually 
change clinical practice. Some other studies have had a limited contrast betXveen 
treatment groups and Kwakkel et al. 's results may reflect their ability to maintain 
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treatment contrast by immobilising the control group in inflatable splints and that their 
intervention started early. 
Partridge et al. 2000 
Partridge et al. carried out a single-blind, randomised controlled trial of physlotherapy 
intensity reported in 2000 (Partridge et al. 2000). They recruited 114 patients and 
followed them up at 6 weeks and 6 months using a variety of less frequently used 
outcome measures: timed walk (over 5m); profiles of recovery (POR); 2 arm function 
tests; the step: time ratio; a6 item ADL scale; a5 item quality of life scale, the 
functional reach test; timed sit to stand; the Hospital Anxiety and Depression index 
(HAD) and a measure of perceived locus of control over recovery (RLOC). 
In this pragmatic study the researchers included all patients referred to their stroke unit 
and aimed to contrast 30 minutes treatment with 60 minutes treatment. They could 
detect no significant difference between the groups using their outcomes. The 
intervention probably reflected UK practice, however their sample included many 
patients with poor prognosis (elderly, incontinent of urine, communication impaired and 
with low mood). The outcomes they selected make interpretation of the results difficult 
for those unfamiliar with the measures and comparison across studies is complex. Some 
elements were not reported with little detail of those patients that failed to complete the 
trial (21 / 114, approximately 17%). It is unclear whether those patients died, withdrew 
or were intolerant of the intervention. Although they had set out to tackle relevant and 
interesting aspects of stroke physiotherapy the researchers concluded that their study 
lacked precision. 
Richards et al. 1993 
In 1993 Richards et al. reported a pilot RCT to investigate the effect of early, intensive, 
gait-focused physical therapy on ambulatory ability in acute stroke (Richards et al. 
1993). 
Patients were randomly allocated to one of 3 groups: conventional physiotherapy; and 
groups that received intensive physiotherapy that either started early or at the usual 
(conventional) time. The subjects were assessed at entry, 6 weeks, 3 and 6 months later, 
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by a blinded independent evaluator using standard measures: gait analysis; gait speed;. 
Fugl-Meyer (leg and balance) and the ambulatory component of the Barthel Index. 
They reported modest short-terin benefit that disappeared at 3 and 6 months. This was a 
small study that was focussed on the lower limb and attempted to address several 
questions at once. Because of the small numbers involved (27 subjects in 3 groups) and 
the subjects being described only as "middle band" of severity it is difficult to generalise 
from the results. 
Slade et al. 2002 
In a study with a focus on reduction of length of hospital stay and costs, Slade et al. 
carried out a randomised controlled single-blind trial examining the cost effectiveness of 
increased intensity of "therapy" (physiotherapy and occupational therapy) on a mixed 
group of patients in a neurological rehabilitation unit (Slade et al. 2002). 
Their experimental group were younger than in many of the other studies, reflecting 
inclusion of head injured patients and those with multiple sclerosis (87 /141 (60%) were 
stroke patients). They aimed to deliver 67% enhancement of therapy, though actually 
provided 59% enhancement, the equivalent of one and a quarter hours of physiotherapy 
and occupational therapy. They looked to length of stay as a measure of cost 
effectiveness. 
They found an average reduction in length of hospital stay of 17 days with cost saving 
calculated as f 1737 per patient. The ability to generalise results to other stroke units is 
limited due to the limited reporting of sub-groups according to their condition. 
Sunderland et al. 1992 
Sunderland et al. conducted one of the earlier trials, reported in 1992, with many good 
features. It was a single blind RCT to investigate the effect of an enhanced physical 
therapy regime on upper limb recovery (Sunderland et al. 1992). 
It was a relatively large trial with 135 patients and featuring the use of high quality 
standard measures and blinded assessments. They contrasted two groups that received 
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therapy for the arm (32minutes v 20 minutes). They assessed outcome by. using tllc 
Extended Motricity index, Motor Club Assessment, passive movement and pain, 
Frenchay Arm Test (FAT), Nine Hole Peg Test (9HPT) and Barthel index at 1,3 and 6 
months. 
They found a small but statistically significant difference in recovery of strength, range 
and speed of movement in favour of the experimental group after 6 months. The 
treatment effect was more marked in the mildly impaired group and was still present at 6 
months but was lost at longer-term follow up at one year. Again, the two groups had a 
limited contrast (mean of 12 minutes). 
Do these studies answer my questions? 
Returning to my original questions in Chapter 1, it is worth discussing to what extent 
they are addressed by these studies. 
"Does the provision of intensive physiotherapy after stroke produce benefits which: " 
a) lead to reductions in impairment and disability. 
The results from several trials suggested small but significant benefit from increased 
physiotherapy intervention, at least in the short ten-n (Sunderland et al. 1992) (Richards 
et al. 1993) (Kwakkel et al. 1999), whilst others have reported little or no measurable 
benefits (Lincoln et al. 1999) (Partridge et al. 2000). 
Most studies do not address the effect of physiotherapy on "mobility", with many 
reporting outcomes in terms of activities of daily living or impairment using a variety of 
measures. 
b) are greater when targeted (e. g. on upper limb recovery). 
Three studies consider the arm in isolation (Sunderland et al. 1992)(Lincoln et al. 
1999)(Miller et al. 2000 (abstract)) whilst one (Richards et al. 1993) concentrated 
intervention only on the lower limb. Kwakkel et al. randomised subjects to upper or 
lower limb groups. 
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c) are greaterfor patients with moderate impairment and little co-morbidity. 
Sunderland et al. found most benefit for "mild" cases. 
d) are greater in the shorter (3 months) than longer term (6 - 12 months). 
Short term benefit was noted in the trials by Sunderland et al., Richards et al. and 
Kwakkel et al. The other trials either did not demonstrate a difference or did not have 
comparable follow up points. 
e) result in a reduced duration of inpatient rehabilitation. 
Slade et al. was the only trial to use length of stay as their primary outcome measure. 
Patients with greater intensity of therapy were discharged from hospital sooner than the 
control group, however we do not know if this resulted in a reduction of overall 
rehabilitation time. Rehabilitation treatment may have continued on an outpatient basis. 
The trials available in the late 1990s still did not appear to have adequately tackled the 
methodological problems or reached a clear answer to these questions. Therefore the 
issue of increased intensity of physiotherapy remains on the research agenda (Legg et al. 
2000). 
Conclusion 
There are several studies in the literature that examine physiotherapy intensity after 
stroke, however these are mostly relatively small, inconclusive and at times arrive at 
contradictory conclusions. The trials are varied and none seem to adequately address the 
questions set out in the first chapter. Many demonstrate the problems associated with 
physiotherapy trials and investigating complex healthcare interventions. This lack of 
evidence could be due to differences in trial methodology, patient selection, therapy 
technique, outcome measures or simply due to chance. It seems that Ernst's conclusion 
that "Well planned clinical trials aimed at finding the best approach and discriminating 
potential responders from non-responders are urgently needed. " despite some high 
quality trials in the intervening years still held true ten years later. 
With this in mind and acknowledging the methodological challenges, a group in 
Glasgow set out to complete a randomised controlled trial of intensity of physiotherapy 
after stroke. This trial is described in the next chapter. 
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Summary 
*I discuss and review some of the important papers that have examined intensit%, 
of physiotherapy after stroke in relation to the research questions. 
* Many trials have limitations and demonstrate problems common to research into 
complex healthcare interventions. 
9 Some solutions and desirable features in trial design are proposed. 
01 conclude that there is still a lack of evidence about the optimum intensity of 
physiotherapy and that further well-conducted, randomised controlled trials may 
be useful. I go on to describe such a trial in the next chapter. 
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CHAPTER 3 
THE GLASGOW AUGMENTED PHYSIOTHERAPY AFTER STROKE 
(GAPS) STUDY 
Introduction 
In this chapter I describe a randomised controlled trial of augmented physiotherapy 
that I helped develop and co-ordinate, aiming to address my questions. 
Background 
The systematic reviews discussed in the last chapter (Langhorne et al. 1996(a)) 
(Kwakell et al. 1997) (van der Lee et al. 2001) suggest that augmented 
physiotherapy may speed up recovery after stroke. The apparent effects were 
modest but could contribute to patients achieving their potential and returning home 
at an earlier stage. However, because the available studies were small and 
heterogeneous there was a lack of reliable, practical information on the relationship 
between physiotherapy intensity and patient outcomes. 
Few of the previous trials have specifically focussed on the recovery of mobility, an 
obvious choice since it is a core activity of physiotherapy and a key factor in 
determining functional outcomes after stroke. If the "natural" rate of recovery after 
stroke cannot be altered then increasing therapy input above conventional levels 
would be a waste of effort and resources. However if the period in which the patient 
remains dependent (and in hospital) can be reduced then a reduction in nursing and 
"hotel" costs (currently over 95% of hospital stroke costs) could be achieved 
through an increase in therapy input (currently accounting for only 1% of costs) 
(Warlow et al. 2001). 
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Having identified this issue (Langhorne & Dennis 1996), in 1998 a group led by 
Professor Peter Langhorne, successfully appli e 'ed for funding from the Strok 
Association to carry out a randomised controlled trial. I was employed by this group to 
develop the existing protocol and methods and co-ordinate the trial, setting out to 
answer the basic question 
"Does the provision of additional in-patient physiotherapy after stroke speed up the 
recovery of mobility? ". 
With mobility as our primary outcome, we wanted to use sound methods and 
attempt to address some of the limitations of the previous studies. 
We wanted specifically to develop and address five key questions: 
a). Does augmented physiotherapy speed recovery in terms of the achievement of 
mobility milestones, patient activity and quality of gait. 
b). Does augmented physiotherapy allow patients to be fit for and able to return 
home earlier. 
c). Does augmented physiotherapy improve patient satisfaction with care. 
d). Does augmented physiotherapy result in sustained benefits (in terms of mobility, 
activities of daily living, and quality of life) 
e). Does augmented physiotherapy result in cost recovery through improved patient 
outcomes or reduced length of hospital stay. 
Subjects 
We included patients admitted to stroke rehabilitation wards at Stobhill, 
Drumchapel and Lightburn Hospitals, in Glasgow. I visited each of the hospital 
sites once or twice a week to screen all new admissions. I did this by asking staff on 
the wards and physiotherapy department and checking the admissions register and 
the casefiles of all patients on the rehabilitation wards. In addition, the 
physiotherapy staff, including the project's research physiotherapists, were asked to 
contact me by telephone if any potential subjects were admitted. I was also aware of 
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some potential subjects that would be transferred from an acute hospital where I 
continued to have clinical duties. 
All subjects had a clinical diagnosis of stroke within the previous 1-4 weeks and 
were able to tolerate and benefit from mobility rehabilitation i. e. they had 
independent functional sitting balance, no major co-morbidities, no major 
communication deficit or cognitive impairment, and were previously independelit 
(pre-stroke Rankin score of less than 3)(Wade 1992). 
These criteria were determined by casenote review and discussion with relevant 
ward staff e. g. the treating speech and language therapist was consulted to estimate 
the patient's ability to understand recruitment information. Cognitive impairment 
was routinely recorded with the Abbreviated Mental Test (AMT) score, with a score 
of less than or equal to 8/ 10 being considered as impaired (Hodkinson 1972). 
Functional sitting balance, i. e. the ability to sit unsupported with the feet on the 
ground for a period of at least approximately one minute, was taken from the 
casenote or after discussion with the treating physiotherapist. Major co-morbidities 
were noted as recorded in the casenote by medical staff. These were: dementia; 
arthritis that limited activities of daily living; unstable angina that limited exercise; 
chronic obstructive pulmonary disease (COPD) that limited exercise; major surgery 
in the past 3 months; poorly controlled diabetes; myocardial infarction in the past 3 
months and peripheral vascular disease that limited exercise. 
We recorded the type of stroke (Bamford et al. 1991) and in the case of hemiplegia, 
the side affected. 
Methods 
Feasibility 
Several pilot investigations to support this project had been carried out before 
funding was awarded. The systematic reviews of the randomised controlled trials 
(RCTs) mentioned previously (Langhorne et al. 1996) indicated that a doubling of 
therapy time might produce measurable improvements in recovery. Physiotherapy 
input at the three sites was established as involving approximately 
30 - 45 minutes per day 
(Monday to Friday) direct therapy time. Pilot observations 
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indicated that over 900 patients would be admitted to the study sites during an Is 
month recruitment period of whom 25% (225 patients) would meet the trial 
inclusion criteria. Of these the majority (>80%) would regain independent walking 
taking a mean (SD) of 18 (11) days to recover walking over 10 paces, 26 (15) days 
to recover walking over 10 metres and 45 (25) days to return home. The peak 
walking speeds averaged 0.32 (0.08) metres/sec. 
Power calculation 
Based on these figures and taking into account possible attrition, we estimated that 
recruiting 100 patients would give the study an 80% power (at 5% level) to detect a 
7-day reduction in the time taken to recover independent walking and 0.05 
metres/sec increase in walking speed. The trial was unlikely to have adequate power 
to show a significant improvement in activities of daily living (ADL). It was 
designed to be compatible with previous RCTs of intensive physiotherapy to 
facilitate a combined prospective meta-analysis. 
Ethical approval 
We applied for and obtained ethical approval on all three hospital sites. 
Randomisation 
After giving informed consent, patients were randomly assigned (through a 
telephone randomisation procedure based at the Roberson Centre for Biostatistics at 
the University of Glasgow) to one of two groups: a) conventional in-patient stroke 
services including conventional physiotherapy input (30 - 40 minutes per day, 5 
days per week), or b) conventional stroke services plus additional physiotherapy 
input (to approximately double the total daily physiotherapy time to 60 - 80 minutes 
per day, 5 days per week). 
Randomisation was stratified by site, age (75 years or over), and disability level 
(Barthel Index greater than or equal to 10) at recruitment. 
Due to limited resources to supply the intervention, patients were only put forward 
for randomisation when we could ensure that the intervention could be delivered. 
Thus when several patients were receiving additional intervention we delayed 
randomisation for suitable subjects. Once resources were available patients were put 
forward for randomisation as soon as possible. 
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Intervention 
Because of the great diversity of symptoms that stroke patients experience, Nve 
considered it impossible to designate in advance a standard treatment for all 
patients. The three centres were chosen as they have similar physiotherapy 
approaches representative of normal UK practice (Sackley & Lincoln. 1996) 
(Davidson & Waters 2000). Outline treatment schedules were developed based on 
the approach of Edwards et al. (Edwards et al. 1991) by the trial management group 
to ensure consistency of treatment categories. Treatment was broadly based on the 
"Nom-ial Movement" (Bobath) approach i. e. using a knowledge of normal 
movement to inform a problem solving approach to the assessment and treatment of 
the individual patient. The range of techniques included non-nalising tone and 
sensory input, re-education of balance reactions and facilitating selective movement 
to achieve functional independence. The overall goals were to improve, maintain or 
prevent deterioration of physical skills. Specific functional objectives included the 
establishment of independent sitting balance (already achieved in our patients), 
standing balance, upper limb function and walking. 
Recording the treatment 
A standard format for recording the type and amount of therapy was also developed 
and tested (see Appendix 1). These recorded patient identification details, the 
treating therapist, position and activity of the intervention, the focus of the treatment 
e. g. upper limb functional re-education, and the number of minutes spent with the 
therapist in the various components of the treatment session. Time was split into 
"direct" contact time e. g. "hands-on" treatment, direct supervision of exercises and 
discussion, or "indirect" contact time e. g. written recording, reporting at case 
conferences, telephone conversations. The number of minutes was taken to the 
nearest 5 minute "unit". These timesheets were completed for each contact with the 
patient. I collected these sheets on my visits to the hospitals, checking they were 
completed correctly. Therapists were encouraged to complete the forins as soon as 
possible after contact with the patient. 
Monitoring the treatment 
I inforinally monitored the amount of time the therapists were spending with the 
patients, depending on their treatment allocation. Where patient treatment times 
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were less or more than expected I would discuss the therapists' reasons for this 
being the case. Without influencing the content of the therapy, the treating 
physiotherapists were reminded to try to maintain a treatment contrast of twice as 
much therapy for those subjects in the treatment arm of the trial. 
By this monitoring and having research physiotherapists on two of the sites we 
attempted to maintain consistency of intervention and accuracy of records by 
reducing any delay in completion of data collection. Monitoring the intervention 
was complex, as staffing levels normally fluctuate according to staff leave for 
holidays, sickness and training. Therefore at certain times during the study some of 
the intervention group would receive less therapy input than at other times. We had 
to accept that this would be the case and concentrated on maintaining a contrast 
between the groups within the available physiotherapy service at any one time. To 
try to minimise this problem the two half-time research physiotherapists that we 
employed provided "back fill" time support for physiotherapists delivering the extra 
therapy. This resource could be drawn on to ensure the trial was seen as a priority 
by those providing the clinical service. This "pooling" of these staff also allowed us 
to examine treatments being provided by a broad variety of physiotherapists e. g. 
junior staff, senior staff, and therapy assistants and undergraduate students working 
under supervision. This reflects how services are normally provided to patients 
rather than an intervention that is provided by a single highly trained and skilled, 
enthusiastic specialist. 
Other interventions 
Patients in both groups had the nonnal access to occupational therapy, speech and 
language therapy, nursing and medical interventions whilst inpatients and after 
discharge in the community. 
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Outcome measures 
We used the following outcome measures (see table 3.1). Copies of the data 
collection fonns are given in Appendix 11 along with references, a description and 
rationale for the use of these measures. 
Table 3.1 Outcome measures for each domain and the timetable for follow up. 
Measure Baseline Weekly while 
inpatient up to 
10 weeks 
4 
weeks 
3 
months 
6 
months 
Impairment 
Motricity Index 
Trunk control test 
10 metre walking test 
(preferred gait speed) 
Functional reach test 
9 hole peg test 
Rivennead. Visual Gait 
Assessment (RVGA) 
Gait analysis 
Disability (activities) 
Barthel Index (BI) 
Nottingham Extended 
Activities of Daily Living 
Index (NEADLI) 
Mobility milestones 
Action Research Ann Test 
(ARAT) 
Rivermead Mobility Index 
(RMI) 
Portable electronic activity 
monitor 
Once 
at 3 
weeks 
Handicap (participation) 
Rankin (Oxford Handicap 
scale) 
Quality of Life 
Euroquol 
Patient satisfaction scale 4 weeks 
after dis- 
charge 
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We selected these measures because they are established, reflect the domains that 
interested us, have (in general) known measurement properties (reliability, validity, 
sensitivity) and are practical to administer to patients in a hospital environment 
(with the exception of the patient satisfaction scale which was sent as a postal 
questionnaire). In addition to these we assessed patients' medical complications, use 
of equipment and use of community resources. 
We used the following methods related to the key questions. 
Question a). Does augmented physiotherapy speed recovery in terms of the 
achievement of mobility milestones, patient activity and qualiti, ofgait? 
We carried out the follow up schedule, gathering data on the two groups as outlined 
in Table 3.1. 
We examined the Mobility Milestones (Partridge et al. 1987, Smith and Baer 1999) 
for differences in terms of levels of achievement, time taken to achieve each 
milestone and the change in status ("how many milestones were passed on the 
journey to recovery" e. g. from having no milestones Oust able to sit) to walking 10 
metres involves "gaining" 3 milestones, whereas being able to take 10 steps to 
being able to walk 10 metres involves gaining just the one milestone. ). We also 
tested to see if those changes were sustained. 
Patient activity was measured using an "activity monitor" developed by the 
Bioengineering Unit, University of Strathclyde (Suckalingham 1993). The "activity 
monitor" was able to classify, on a continuous basis, the activity of the patient into 
the two primary classifiers - sitting and standing - using the output of a single 
sensor attached to the patient. This sensor consisted of a commercial miniature 
pressure transducer connected to a flexible, fluid-filled tube. The fluid-filled tube 
and sensor were taped to the lateral side of the patient's unaffected leg (Fig. 3.1). 
The pressure measured depends on the end-to-end length of the tube, which changes 
during activity. The transducer produces a simple output that is characteristic of the 
posture or activity of the subject (Fig. 3.2). Data were recorded on a data logger 
[Biomedical Monitoring Ltd, UK] on a single occasion, 3 weeks after 
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randomisation. The patients wore the monitor from early morning to just before 
going to bed at night (their "waking day"). The outcome measures of "proportion of 
time spent upright" and "number of transitions between sitting and upright per 
hour" were recorded for the patients' waking day. 
In addition to this, we divided the day into the period before 4: 30pin (the time 
during which activity was considered to be directly influenced by the 
physiotherapists) and after 4: 30pin (the time during which activity was dependent 
on the patient's own ability and motivation, and nursing staff assistance) to look for 
differences in activity. This allowed us to compare patient activity during the period 
therapy staff were on duty with the period they were not, in order to establish if 
there is a difference. It also allowed us to compare the activity before 4-30pm 
between the two groups of patients to see if the augmented group were indeed more 
active. Comparing the two groups after 4-30pin would also indicate if the 
augmented group were less active later in the day, perhaps due to fatigue. 
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Figure 3.1 Activity monitor attached to patient's unaffected leg 
(image - T. Egerton) 
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Figure 3.2 Output from the activity sensor. Different output levels are seen 
for sitting, standing and walking. 
We compared the patients' quality of gait using walking speed and a "body worn 
gait analysis system". This system (Granat et al. 1995) consisted of shoe insoles that 
incorporated four force-sensitive resistors [Interlink Electronics, Luxembourg], 
acting as switches, placed at the position of the heel, head of the first metatarsal, 
head of the fifth metatarsal and the big toe. They were mounted on thin plastic film 
cut to the shape of the subject's feet. The subjects walked along a walkway of 12m 
and all data were collected on a data-logger [Biomedical Monitoring Ltd, UK] wom 
around their waist. This allowed us to measure speed and symmetry. Symmetry 
was calculated as the ratio of the swing time of the unaffected leg to the swing time 
of the affected leg. Again, we examined for differences between the two groups in 
ternis of levels of achievement, speed to achieve these levels and to see if those 
changes were sustained. 
Question b). Does augmented physiotherapy allow patients to befit for and able to 
return home earlier? 
We recorded the patients' length of stay in hospital, reasons that might have delayed 
discharge and the frequency of complications and adverse events. 
Although we did not expect to see statistically significant changes in these domains 
we included two commonly used measures; the Barthel Index and the Rankin 
Handicap Score. 
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Question c). Does augmented physiotherapy improvepatient satisfaction with care? 
We compared responses from the two groups to a patients' satisfaction 
questionnaire sent to them four weeks after discharge from inpatient rehabilitation. 
Question d). Does augmented physiotherapy result in sustained benefits On ternis of 
mobility, activities of daily living, and quality of life)? 
We examined all of these variables for differences between the two groups over 
time. We expected the amounts of data to vary considerably from patient to patient 
depending on their length of stay in hospital. We therefore identified "key" time 
lines as being: randomisation, 4 weeks, 3 months and 6 months after randomisation 
to examine if change was sustained. 
Question e). Does augmented physiotherapy result in cost recovery through 
improvedpatient outcomes or reduced length of hospital stay? 
We measured levels of impairment, disability, handicap, dependency and quality of 
life as described above. 
With the vast majority of acute stroke costs being related to inpatient nursing care 
and hospital overheads we compared length of hospital stay as our main estimate of 
cost. Outwith this, any cost differences between the groups were likely to be 
attributable to the following events: 
i). complications whilst the patients were in hospital, 
ii). community support being requested at discharge, 
iii). the provision of equipment and adaptations, 
iv). the rate of adverse events in the months after stroke, 
v). use of community services. 
The first two were monitored during the patients' stay by notes review and discussion 
with the treating therapists and then from reviewing their notes on discharge. 
Complications were considered to have been present if noted in the patients' medical 
records. We did not attempt to define, quantify or verify any of the complications. 
Adverse events were recorded at patient follow up interviews at 3 and 6 months, where 
we asked directly "Since leaving hospital have you had any falls? " and "Haý, e you had 
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any other problems or illnesses since leaving hospital? ". We relied on the patients' self- 
report for data on these and the provision of equipment and services as we did not have 
resources to confirm these data e. g. by consultation with the patients' general 
practitioner or social services. 
We were also interested in possible differences in the patient groups that may be 
attributable to their treatment allocation: 
a). Survival 
b). Discharge destination 
c). Complication rates, e. g., falls, fractures, depression, pressure sores, painful 
shoulder, extension (recurrence) of stroke 
d). Use of services, e. g. follow up in the community (particularly physiotherapy), 
day hospital referral. 
e). Use of equipment e. g. adaptation to home, wheelchairs. 
We specifically monitored for adverse events and the possible complications of pain, 
falls and fatigue at patient interview by the blinded assessor at weekly, 3 and 6 month 
follow up. During the weekly follow-up interviews whilst in hospital, patients were 
asked: "During the past week have you had any pain?, During the past week have you 
had any falls? During the past week have you been feeling tired? ". We did not attempt to 
specifically define or quantify these areas but asked the patients to report what they had 
experienced. 
The primary outcome measures used to answer our questions were: the Mobility 
Milestones, Rivermead Mobility Index, gait speed and length of hospital stay 
(thereby costs). We used other outcome measures to monitor the effects of treatment 
e. g. did increased intensity of physiotherapy lead to a decrease in the rate of 
complications or onward referral to community services such as day hospital. 
Blinding 
All assessments were carried out in an area separate from where treatment was 
delivered. Ms Egerton was not allowed access to patients' notes, treatment timetables or 
the ward areas where she might have become aware of the treatment allocation. 
Physiotherapy assistants brought the patients to and from the assessment area. Patients 
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were reminded not to disclose their treatment group allocation before each assessment 
and staff members were instructed not to discuss patient care when Ms Egerton was 
present. 
Analysis 
Data were gathered on each of the sites for infon-nation on input and outcomes. The 
blinded assessor, Ms Thorlene Egerton, left her assessments in a file and these were 
collected at least weekly. Once the assessments were made she had no access to 
previous assessments for comparison. All other data such as time sheets and 
registration documents were collected by me and kept in a secure central location 
for safekeeping, to be checked for completeness and to avoid unblinding. I had 
regular meetings with Ms Egerton to ensure that all documentation had been 
submitted and received. Data were then "masked" to remove any patient names, 
photocopied, batched and delivered to the Robertson Centre for Biostatistics at the 
University of Glasgow for management and analysis. The data were "double 
entered" to reduce the chance of errors and a code used to indicate treatment 
allocation. We remained blinded to the code of the data until all analyses were 
completed. 
All analyses were according to the intention-to-treat principle, using all available 
data for each measurement at the appropriate visit. No formal adjustment was made 
for multiple comparisons. 
The Bioengineering Unit at the University of Strathclyde interpreted, analysed and 
reported on data gathered from the activity monitor and gait analysis system using 
custom written software. Ms Egerton gathered all these data, then delivered the 
downloaded data directly to the University of Strathclyde, remaining blinded to 
treatment allocation. 
We analysed the data at the Imonth, 3 month and 6 month outcomes. Patients were 
assessed weekly (up to a maximum of ten weeks) during their hospital stay or until 
discharge. For those subjects discharged within ten weeks, their best scores for the 
following outcomes were used in the analyses: fastest 10m walking speed; 
maximum RMI score, maximum Motricity index score; maximum trunk control test 
and best functional reach. Other outcomes were only measured at 1 month, 3 month 
and 6 month assessments. 
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Results 
Between 22 July 1999 and 12 February 2001,1 screened 708 patients (Drumchapel 
267, Lightbum 203 and Stobhill 238) from which we recruited 70 (9.9%) to our 
study. Thirty-five patients were randomised to each arm of the study (figure 3.3). 
Thirteen eligible patients refused to enter the study. 
Figure 3.3 GAPS study recruitment and randomisation 
Patients Admitted with stroke to 
North Glasgow Rehabilitation Units 
imchapel 267 
bhill 238 
. 
htbum 203 
otal 708 
Eligible 83 
13 RandoMised 70 
Standard 
35 
Followed up 
At 4 weeks 
At 3 months 
Excluded 625 
(see Table 3.2) 
Augmented 
Dhvsiothera-Dv 35 
Followed up 
35 At 4 weeks 34 
34 At 3 months 32 
At 6 months 34 
(34 complete, I refused) 
Died 
At 6 months 31 
(29 complete data, 
2 partially complete data, 
1 refused, I unwell) 
Died 2 
The reasons patients were excluded from the study are given in Table 3.2 
(categories are not mutually exclusive). Some patients could not be randomised 
because we had limited resources e. g. when the sites had several subjects on 
augmented treatment they sometimes felt that if another patient was randomised to 
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augmented therapy by the randomisation centre they would not have sufficient 
resources to maintain the target treatment times. However, when resources became 
available or subjects were discharged we immediately reconsidered these subjects. 
Although we did not formally record the number of subjects excluded in this 
manner they were considered to be small in number. 
Seven patients were lost to follow up. Two (3%) patients died during the study, one 
of these during the intervention stage (soon after randomisation, but considered not 
to be related to physiotherapy treatment). Two patients (3%) were too unwell to be 
followed up, due to stroke-related illness. Three (4.5%) patients refused to complete 
the follow up schedule. No patients were withdrawn from the intervention. Blinding 
of the assessor was maintained in 556 / 579 (96%) of the follow up assessments. 
Table 3.2 Reasons for exclusion from study 
Exclusion (categories not mutually 
exclusive) 
Number of 
patients 
Communication impairment 237 
Previous history of stroke 171 
Cognitive impairment (AMT<=8) 169 
No sitting balance 101 
Pre-stroke Rankin >2 39 
Dementia 26 
Unconfirmed stroke 24 
Carcinoma 24 
Arthritis limiting ADL 23 
Unstable angina (limits exercise) 21 
COPD limiting exercise 16 
Major surgery (3 months) 14 
Poorly controlled diabetes 13 
Recent MI (3 months) 10 
PVD limiting exercise 6 
AMT = Abbreviated Mental Test score, ADL = Activities of daily living 
COPD = Chronic Obstructive Pulmonary Disease, MI = Myocardial infarction 
PVD = Peripheral vascular disease 
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The randomisation was stratified by centre (Drumchapel, Lightbum, Stobhill) and 
disability level (dichotomised as Barthel < 10, or ý! 10) and age (<75 years, ý! 75 
years), and the number of subjects within each of these stratum are reported in 
Table 3.3. 
Table 3.3 Number of subjects per group stratified by study centre, disability 
level and age 
Standard 
(n= 35)(%) 
Augmented 
(n = 35)(%) 
Study centre 
Drumchapel 14(40.0) 15(42.9) 
Lightburn 5(14.3) 6 (17.1) 
Stobhill 16(45.7) 14(40.0) 
Disability level 
Baseline Barthel < 10 12(34.3) 11(31.4) 
Baseline Barthel >=10 23(65.7) 24(68.6) 
Age 
Age < 75 27(77.1) 28(80.0) 
Age >=75 8(22.9) 7(20.0) 
The baseline characteristics of the subjects are surnmarised, split by randomised 
treatment group in Table 3.4. Continuous covariates, such as age, were reported as 
means (with standard deviation) whilst categorical covariates, such as gender, were 
reported as numbers (with percentage) of subjects. No formal comparison of baseline 
equality between the randomised groups was perfonned. 
Note: All baseline values are expressed as percentages unless otherwise stated. 
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Table 3.4 Baseline characteristics of subjects in GAPS study* 
Standard 
(n= 35) 
Augmented 
(n = 35) 
Age (mean, SD) 66.9(10.4) 67.8(10.6) 
Sex - Female 51.4 31.4 
Days after acute admission (mean, SD) 25.4(17.9) 21.9(14.1) 
Days after admission to rehabilitation unit (mean, SD) 15.26 (14.0) 13.1(10.9) 
Stroke classification 
R side of brain 42.9 45.7 
TACI 20.6 17.1 
PACI 50.0 42.9 
LACI 23.5 28.6 
POCI 2.9 5.7 
Other 2.9 5.8 
Barthel Index score (mean, SD) 10.3(3.1) 11.8(3.3) 
Trunk Control Test (mean, SD) 68.4(24.1) 71.9(23.0) 
Motricity Index (mean, SD) 100.4 (43.4) 110.4 (43.2) 
Pre-stroke Rankin =0 48.6 51.4 
Pre-stroke Rankin =1 40.0 28.6 
Pre-stroke Rankin =2 11.4 20.0 
*Values include all patients with available data; n is the maximum number in each group. 
SD = Standard deviation 
Intensity of treatment 
The intensity of physiotherapy input between the randomised groups is summansed in 
terms of the total number of hours and the average number of hours per study day 
(defined as the ratio of total hours of physiotherapy by total days in study) in Table 
3.5(a). The columns show the overall (total) number of treatment hours per patient and 
within this figure the number of hours the treating physiotherapists considered they 
were specifically treating the upper or lower limbs or other areas. 
Table 3.5 (a): Intensity of physiotherapy input in GAPS study: hours 
Total Upper Limb Lower Limb Other 
Stand Aug Stand Aug Stand Aug Stand Aug 
(n=3 5) (n=35) (n=35) (n=35) (n=35) (n=35) (n=35) (n=35) 
Number of 21(16) 33 5 10 5 9 11 15 
hours mean (21) (5) (7) (4) (7) (10) (11) 
(SD) I 
Number of 0.41 0.73 0.12 0.18 0.11 0.21 0.19 0.34 
hours / study 
days 
Stand = Standard, Aug = Augmented, SI) = manclar(l (leviation 
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The mean (95% confidence interval) number of physiotherapy sessions per patient 
was greater in the augmented therapy (43; 35-51) than the standard therapy group 
(32; 24-40) (Table 3.5(b)). This equated to an average number of physiotherapy 
treatment hours in the augmented therapy group (34 hours total; 10 hours on upper 
limb work; 9 hours on lower limb; 15 hours other work) which was greater than that 
of the standard therapy group (21 hours total; 5 hours on upper limb; 5 hours on 
lower limb; 11 hours other work). The average number of treatment hours per 
weekday differed by 0.45 hours (i. e. 62 vs 35 minutes - 27 minutes). No formal 
comparison was made of these rates since the augmented group was intended to 
receive about double the physiotherapy of the standard group. 
Table 3.5(b). Intensity of physiotherapy input in GAPS study: sessions 
Standard 
(n=: 35) 
Augmented 
(n=35) 
Number of sessions mean (SD) 32(24) 43(26) 
Number of sessions /study days 0.61 1.00 
SD = Standard deviation 
Activity levels 
Activity monitoring data were available for 41 (58%) patients (19 standard, 22 
augmented). These were analysed in terms of the patient's average number of 
transitions to the upright position per hour. Upright events are changes from a non- 
upright position (sitting or lying) to upright (standing or walking). The mean for the 
standard group was 1.7 (SD 1.26) upright events per hour ranging form 0.25 to 5.62 
per hour. The mean for the augmented group was 2.6 (SD 1.21) per hour ranging 
from 0.73 to 5.76. There was a significant difference between the two groups 
(Mann-Whitney U, p=0.007) where the augmented group appeared to be more 
active in terms of how frequently they stood up. 
We also examined the mean proportion of time spent standing or walking. The 
average proportions for the standard and augmented group respectively were 4.8% 
(SD 7.8, minimum 0.4%, maximum 34.6%) and 8.0% (SD 5.7%, minimum 0.7%, 
maximum 18.9%). There was a significant difference between the two groups 
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(Mann-Whitney U, p=0.002) where the augmented group appeared to be more 
active in terms of how much of the time they were standing or Nvalking. 
When we analysed the activity over different periods of the day we found the 
augmented group were more active (more transitions and a greater average 
proportion of their time spent standing or walking) during the day (from 8-30am 
until 4-30pm). There was no significant difference in activity between the groups in 
the period after 4-30pm. indicating that the increased patient activity occurred 
during the period therapy staff members were at work. 
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Primary Outcomes - Mobility 
Mobility disability - "Mobility Milestones" 
Disability as assessed by Mobility milestones (visit at which subject achieved 
standing, walking 10 paces, and walking 10 metres) was visualised (Figures 3.4 - 
3.6) by plotting the proportion of patients having achieved the milestone at each 
visit (baseline, 4 weeks, 3 months, 6 months). 
The time to achieving each milestone was fonnally compared using a log-rank 
statistic (Table 3.6) by ascertaining the visit (baseline, weeks 1-10,3 month or 6 
month) at which the milestone was achieved, and assuming the milestone was 
achieved on the day of that visit. Subjects who did not achieve the milestone were 
censored at either their death, end of study, or withdrawal. 
Table 3.6 GAPS study. Comparison of achievement of "Mobility Milestones" 
Milestone Standard 
(n=3 5)(%) 
Augmented 
(n=35)(%) 
P-value 
(log-rank) 
Hazard ratio 
(95% Cl) 
Standing 35(100.0) 34(97.1) 0.25 1.34 (0.81,2.23) 
10 paces 31(88.9) 32(91.4) 0.20 1.39 (0.84,2.30) 
10 metres 32(91.4) 33(94.3) 0.12 1.48 (0.90,2.43) 
Cl = Confidence interval 
The hazard ratios give the overall relative chance of an event on treatment as 
compared to control and account for both censoring and time-to-event. The results 
show an increased chance of patients receiving augmented physiotherapy achieving 
each "milestone". However the confidence interval is wide and the estimated 
differences do not reach statistical significance. 
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Figure 3.4 
Proportion of patients achieving standing at each visit in standard treatment 
and augmented physiotherapy groups 
100 
go 
80 
70 
60 C2 0. 
14- 50 0 
c 40 0 30 
20 
0 lo 
OL 0 
Visits 
M Standard 
MAugmented , 
61 
Baseline Week 4 Month 3 Month 6 
Chapter 3 
Figure 3.5 
Proportion of patients achieving 10 steps at each visit in standard treatment and 
augmented physiotherapy groups 
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Figure 3.6 
Proportion of patients achieving 10-metre walk at each visit in standard 
treatment and augmented physiotherapy groups 
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Mobility disability - Rivermead Mobility Index (RMI) 
The Rivermead Mobility Index scores were compared between the two randomised 
treatment groups using two-sample t- tests (Table 3.7). We were unable to compare 
change over baseline as this was not recorded at randomisation. Howe\-er, a 
comparison was made with the scores from the Week I follow up assessment. 
Table 3.7 GAPS study. Rivermead Mobility Index (RMI) scores 
Standard Augmented Mean Difference P-valuc 
Mean (SD) Mean (SD) (95% Cl) 
Week 1 4.56(2.64) 5.18(2.43) 0.62 (-0.61,1.85) 0.32 
n=34 n=34 
Maximum achieved at 8.26(2.81) 8.79(3-03) 0.54 (-2.50,1.94) 0.45 
weeks 1-10 n=35 n=34 
4 weeks 6.97(3.49) 7.39(3.30) 0.42 (-1.23,2.08) 0.61 
n=34 n=33 
3 months 8.06(3.65) 9.66(3.33) 1.60 (412,3.32) 0.07 
n=34 n=32 
6 months 9.06(4.03) 10.20 (3.08) 1.14 (467,2.95) 0.21 
n=34 n--30 
Change from week 1 to 3.54(2.80) 4.69(2.75) 1.14 (423,2.52) 0.10 
3 months n=33 n=32 
Change from week 1 to 4.45(3.15) 5.07(2.74) 0.61 (-0.88,2.10) 0.41 
6 months n=33 n=30 
SD = Standard deviation, CI = Confidence interval 
The mean differences between the groups shows a small improvement in RMI score for 
those patients receiving augmented physiotherapy. These differences do not reach 
statistical significance at any timepoint, though the 3-month follow up approaches 
statistical significance. 
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Mobility impairment - Walking speed 
Impairment as measured by the median 10 metre walking speed was compared 
between the two randomised groups at 4 weeks, 3 month and 6 month visits by 
Wilcoxon rank sum tests and approximate 95% confidence interval for the 
difference in medians calculated. A further variable was derived by taking the 
fastest speed (m/s) to complete the 10m walking test in any of the first 10 weeks, 
and then comparing between the groups as above (Table 3.8). 
Table 3.8 GAPS study. 10 metre walking speed (m/s) 
Standard 
Median 
Augmented 
Median 
Median Difference 
(95% Cl) 
Wilcoxon 
P-value 
Fastest speed achieved 
weeks 1-10 
0.53 (n==28) 0.63 (n=31) 0.04 (-0.16,0.23) 0.70 
4 weeks 0.56 (n--21) 0.60 (n=24) 0.00 (-0.19,0.23) 0.97 
3 months 0.53 (n=27) 0.54 (n=30) -0.03 (-0.19,0.15) 0.77 
6 months 0.45 (n=29) 0.65 (n=26) 0.09 (-0.11,0.28) 0.42 
CI = Confidence interval 
The differences between the groups were small at all timepoints and did not reach 
statistical significance. 
Length of stay 
To assess the impact of augmented treatment on resource utilisation, length of 
hospital stay was compared between the two randomised groups using both two 
sample t-tests and Wilcoxon rank sum tests. Approximate parametric 95% 
confidence intervals for the difference in mean stay were calculated. 
As randomisation took place on average two weeks after transfer to rehabilitation, 
and rehabilitation was on average about ten days after admission for stroke, the total 
length of stay contains a considerable period prior to randomisation. We therefore 
compared the time from admission for stroke to discharge for rehabilitation, and 
then admission to rehabilitation to randomisation, and then randomisation to 
hospital discharge, using the same method as for total length of stay (Table 3.9). 
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The results show a reduction in the mean length of stay (total length of stay, from 
rehabilitation admission and from randomisation) for patients in the augmented 
group, however there was a wide distribution of length of stay and the differences 
did not reach statistical significance. 
Twelve (17.1%) patients were considered to have had their discharge delayed for 
some external reason (e. g. awaiting social work intervention). 
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Secondary outcomes 
Impairment 
Results from the Motricity Index, Trunk Control Test, Functional Reach Test, or the 
9 Hole Peg Test are given in Tables 3.10 to 3.13 respectively. 
Table 3.10 GAPS study. Motricity Index scores 
Standard Augmented Mean Difference P-value 
Mean (SD) Mean (SD) (95% CI) 
Baseline 100.4 (43.4) 110.4 (43.2) 
n=3 5 n=3 5 
4 weeks 111.2 (45.4) 119.1 (46.5) 7.9 (-14.6,30.3) 0.49 
n=34 n=33 
Maximum weeks 1- 10 124.8 (44.8) 130.1 (45.7) 5.3 (-16.4,27.1) 0.63 
n=35 n=34 
3 months 120.4 (42.2) 130.1 (44.1) 9.7 (-11.7,31.1) 0.37 
n=3 3 n=32 
6 months 121.5 (51.3) 124.2 (41.6) 2.7 (-20.9,26.2) 0.82 
n=34 n=30 
Change at 6 months 22.6(27.3) 20.0(20.4) -2.6 (-14.8,9.6) 0.67 
from baseline n=34 n=30 
Cl = Confidence interval, SD = Standard deviation 
Table 3.10 shows no statistically significant differences in mean Motri city Index scores 
between the groups at any time-point or in change from baseline measurement at 6 
month follow up. 
Table 3.11 GAPS study. Trunk Control Test scores 
Standard Augmented Mean Difference P-value 
Mean (SD) Mean (SD) (95% CI) 
Baseline 68.4(24.1) 71.9(23.0) 
n=35 n=3 5 
4 weeks 84.2(21.9) 85.2(17.5) 0.9 (-8.8,10.6) 0.85 
n=34 n=3 3 
Maximum weeks 1 -10 90.5(17.1) 93.6(9.6) 3.0 (-11.9,9.7) 0.37 
n=35 n--34 
Change at week 4 16.0(23.9) 14.5(23.1) -1.5 (-20.1,10.0) 0.80 
from baseline 
Cl = Confidence interval, SD = Standard deviation 
Table 3.11 shows no statistically significant differences in mean Trunk Control Test 
scores between the groups at any time-point or in change from baseline measurement at 
4 week follow up. 
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Table 3.12 GAPS study. Length of functional reach (cms) 
Standard Augmented Mean Difference P-value 
Mean (SD) Mean (SD) (95% Cl) 
Baseline 17.0(7.7) 19.7(5.9) 
n=19 n=22 
Maximum reach weeks 24.0(7.0) 25.1(6.5) 1.2 (-2.1,4.4) 0.49 
1-10 n--34 n=3 3 
4 weeks 20.6(7.3) 20.9(7.5) 0.3 (-3.4,4.1) 0.87 
n=32 n=30 
3 months 21.5(6.1) 21.2(7.4) -0.3 (-3.7,3.2) 0.87 
n=31 n=31 
6 months 22.8(7.6) 21.5(5.4) -1.3 (-4.7,2.2) 0.46 
n=31 n=29 
Change at 6 months 8.3(9.4) 3.1(6.6) -5.1 (-10.3,0.1) 0.05 
from baseline n=18 n=21 
Cl = Confidence interval, SD = Standard deviation 
Table 3.12 shows no statistically significant differences in mean length of functional 
reach between the groups at any time-point. There was however, a statistically 
significant difference in change from baseline measurement at the 6 month follow up. 
Table 3.13 
GAPS study. Nine Hole Peg Test affected side - time to achieve one peg (seconds) 
Standard 
Median 
Augmented 
Median 
Median Difference 
(95% Cl) 
Wilcoxon 
P-value 
4 weeks 3.4 (n= 12) 2.8 (n= 10) -0.3 (-1.7,1.0) 0.38 
3 months 3.1 (n=14) 2.8 (n= 13) 0.0 (49,3.1) 0.96 
6 months 3.2 (n= 15) 1 3.2 (n-- 13) 0.1 (-1.2,1,8) 0.89 
CI = Confidence interval 
Table 3.13 shows no statistically significant differences between the groups for median 
times for Nine Hole Peg test at any time-point. 
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Disability 
Further measures of disability were compared between the two randomised 
treatment groups using two-sample t- tests for the Barthel Index, (Table 3.14) 
(including change over baseline at 6 months) and the Nottingham Extended 
Activities of Daily Living Index (Table 3.15). 
Table 3.14 GAPS study. Barthel Index scores 
Standard Augmented Mean Difference P-value 
Mean (SD) Mean (SD) (95% CI) 
Baseline 10.3(3.1) 11.8(3.3) 
n=35 n=35 
4 weeks 14.1(3.7) 14.6(3.4) 0.5 (-1.2,2.2) 0.55 
n=34 n=3 3 
3 months 16.1(3.3) 16.6(2.8) 0.7 (-0.9,2.2) 0.39 
n=33 n=32 
6 months 16.2(4.2) 16.9(2.7) 0.7 (-1.1,2.3) 0.45 
n=34 n=31 
Change at 6 months 5.9(4.1) 5.1(3.7) -0.9 (-2.8,1.1) 0.37 
from baseline n=34 n=31 
Cl = Confidence interval, SD = Standard deviation 
Table 3.14 shows no statistically significant differences in mean Barthel index scores 
between the groups at any time-point or in change from baseline measurement at 6 
month follow up. 
Table 3.15 
GAPS study. Nottingham Extended Activities of Daily Living (NEADL) Index 
Standard Augmented Mean Difference (95% Cl) P-value 
Mean (SD) Mean (SD) 
3 months 22.2(11.0) 27.6(12.8) 4.0 (-2.0,9.9) 0.19 
n=34 n=32 
6 months 26.2(13.1) 29.1(11.5) 1.5 (-4.6,7.7) 0.54 
n=34 n=30 
Cl = Confidence interval, SD = Standard deviation 
Table 3.15 shows no statistically significant differences in mean Nottingham Extended 
Activities of Daily Living Index scores between the groups at either time-point. 
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Action Research Arm Test scores for the affected arms for the two groups of 
patients are compared and presented in Table 3.16. 
Table 3.16 GAPS study. Action Research Arm Test scores - Affected Arm 
Standard 
Median 
Augmented 
Median 
Median Difference 
(95% Cl) 
Wilcoxon 
P-value 
4 weeks 23 (n=: 35) 22 (n=34) 1(-4,14) 0.52 
3 months 30 (n=33) 29 (n=32) 0(-6,14) 0.78 
6 months 30 (n=33) 29 (n=28) 1(-6,12) 0.67 
ý,, l - k., UllilUCIIL; C IIILCTVUI 
The median differences in Action Research Am Test scores did not reach statistical 
significance at any time-point. 
Handicap 
Handicap (as measured by the Rankin score) was dichotomised as 0-2 or 3-5 and 
compared between the two randomised groups using a Chi-square test (Tables 3.17 
& 
Table 3.17(a). GAPS study. Rankin Handicap Score 3 months 
Rankin Handicap Score Standard Augmented Chi-squared test 
(n=34)(%) (n=29)(%) P-value 
0-2 8(23.5) 7(24.1) 0.95 
3-5 26(76.5) 22(75.9) 
Table 3.17(b). GAPS study. Rankin Handicap Score 6 months 
Rankin Handicap Score Standard Augmented Chi-squared test 
(n=34)(%) (n=3 1)(%) P-value 
0-2 13(38.2) 11(35.3) 0.82 
3-5 21(61.8) 20(64.5) 
The number of subjects that required some fon-n of assistance (scores 3- 5) reduced 
over time as patients regained independence, however the differences between the 
groups did not reach statistical significance at either time-point. 
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Quality of life 
Quality of Life was analysed by two sample t-tests on the visual analogue score on 
EuroQoL at 6 months (Table 3.18). Change over baseline at 6 months was also 
compared. 
Table 3.18 GAPS study. Quality of life (visual analogue scale from Euroqol) 
Standard Augmented Mean Difference P-value 
Mean (SD) Mean (SD) (95% CI) 
Baseline 52.4(18.9) 53.7(18.2) 
n=29 n=32 
6 months 51.8(23.5) 62.3(24.6) 10.5 (-1.8,22.8) 0.09 
n=32 n=29 
Change -2.0(20.8) 9.78(30.8) 11.7 (-2.8,26.3) 0.11 
n=26 n=27 
CI = Confidence interval, SD = Standard deviation 
Table 3.18 shows no statistically significant differences in mean EuroQual scores 
between the groups at any time-point or in change from baseline measurement at 6 
month follow up. 
We sent out 64 patient satisfaction questionnaires at 4 weeks after the patients' 
discharge from inpatient rehabilitation. Six patients were not followed up with a 
questionnaire (one patient died in hospital, five patients remained in care facilities 
beyond their hospital stay). Forty-seven (67%) patients responded, seventeen failed 
to respond. We grouped the responses (strongly agree/agree and strongly 
disagree/disagree) for the analysis and used Fisher Exact Tests to compare the 
groups (Table 3.19). 
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Table 3.19 
GAPS study. Patient satisfaction questionnaire at 4 weeks post discharge 
Question Standard Augmented Fisher's 
Exact 
Test 
P-N-alue 
SA/A SD/D SA/A SD/D 
n(%) n(%) n(%) n(%) 
Happy with amount of 20(95.2) 1(4.8) 19(76.0) 6(24.0) 0.11 
recovery 
Satisfied with type of therapy 20(95.2) 1(4.8) 24(96.0) 1(4.0) 1.00 
I have had enough therapy 7(35.0) 13(65.0) 12(50.0) 12 (50.0) 0.37 
SA/A = "Strongly agree" / "Agree" SD/D = "Strongly disagree" / "Disagree" 
Table 3.19 shows no statistically significant differences in responses to the questions 
between the two groups. 
Complications 
Data on complications were listed (Table 3.20). We further analysed those we 
considered to be particularly relevant to rehabilitation physiotherapy (falls, shoulder 
pain, other pain and fatigue). These were compared between the randomised groups 
using tabulated Fisher Exact Tests at 4 weeks, 3 months, 6 months and at any time 
during the study (Table 3.21). 
There were no serious adverse events (i. e. serious injury or deaths directly 
attributable to the intervention) during the trial. 
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Table 3.20 GAPS studv. ComDlications whilst natients. wp. rt,. in hn,. nitni 
Reported Illness Standard (n=34*) Augmented (n=35) 
Patients reporting any illness 25(78.1) 29(82.9) 
Events 
Deep venous thrombosis 0(0) 1 (2.9) 
Pulmonary embolus 0(0) 0(0) 
Urinary tract infection 1 (2.9) 2(5.7) 
Chest infection 2(5.9) 0(0) 
Other infection 0(0) 1 (2.9) 
Fracture 0(0) 0(0) 
Depression 5(14.7) 2(5.7) 
Anxiety 4(11.7) 2(5.7) 
Confusion 0(0) 0(0) 
Pressure sore 1 (2.9) 2(5.7) 
Painful shoulder 3 (8.8) 5(14.3) 
Other pain 13(38.2) 18(51.4) 
Recurrence/extension of stroke 0(0) 2(5.7) 
Cardiac condition 5(14.7) 1 (2.9) 
Seizure 0(0) 0(0) 
Fall 10(29.4) 10(28.6) 
Other 17(50.0) 19(54.3) 
* One patient still in hospital after 6 months - no discharge forms completed. 
Table 3.21 Number of patients (%) experiencing "Complications" / adverse 
reactions possibly related to physiotherapy input at any time during the GAPS 
study 
Standard 
(n=35) 
Augmented 
(n=34) 
Fisher Exact 
Test P-value 
Falls 20(57.1) 20(58.8) 1.00 
Shoulder pain 27(77.1) 26(76.5) 1.00 
Other pain 30(85.7) 31(91.2) 0.71 
Fatigue - 
ý32 
(91.4) 32(91.2) 1.00 
Across all the follow up time-points there were no statistically significant 
differences in the number of complications reported by the two groups. 
Resource use 
Further data on resource utilisation (community support requested at discharge 
(Table 3.22), provision of equipment and adaptations at discharge (Table 3.23), and 
use of community services at 6 months post stroke (Table 3.24)) were compared 
between the two randomised groups using Fisher Exact Tests. We found no 
statistically significant differences between the groups in these areas. 
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Table 3.22 GAPS study. Community support being requested at discharge 
Service Standard 
(n=32) 
Augmented 
(n=34*) 
Fisher's Exact 
Test P-value 
Homehelp 11(34.4) 11(32.4) 1.00 
District nursing 6(18.8) 2(6.1) 0.15 
Day hospital 28(87.5) 28(82.4) 0.73 
Outpatient physiotherapy 1 (3.1) 2(5.9) 1.00 
Physiotherapy home visit 6(18.8) 5(14.7) 0.75 
Day centre 0(0) . 0(0) N/A 
Meals on wheels 2(6.3) o(o) 
_0.23 *data available on 33 subjects for district nursing. N/A = Not applicable 
Table 3.23 GAPS study. The provision of equipment and adaptations at discharge 
Standard 
(n=32) 
Augmented 
(n=34) 
Fisher's Exact 
Test P-value 
Aids or appliances 22(68.8) 17(50.0) 0.14 
Adaptive equipment or 
alterations to property I 
25(78.1) 22(64.7) 
I 
0.28 
Wheelchair 1 19(59.4) 21 (38.2) 1 1.00 
Table 3.24 GAPS study. Use of community services at 6 months after stroke 
Service Standard 
(n=34) 
Augmented 
(n=3 1) 
Fisher's Exact 
Test P-value 
Home help 7(20.6) 8(25.8) 0.77 
District nursing 5(14.7) 1 (3.2) 0.20 
Day hospital 16(47.1) 13(41.9) 0.80 
Outpatient physiotherapy 4(11.8) 2(6.4) 0.67 
Physiotherapy home visit 5(14.7) 1(3.2) 0.20 
Day centre 1(2.9) 0(0) 1.00 
Meals on wheels 1(2.9) 0(0) 1.00 
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Discussion 
We were unable to demonstrate any significant differences between the two groups 
of patients in any of the main outcome domains we studied. Notably there was a 
lack of difference in mobility outcomes, where we might reasonably have expected 
differences and where our efforts were concentrated. 
It could be that increasing the intensity of physiotherapy with the type of patients 
we recruited has no effect on the outcomes we measured. Alternatively, there may 
be a difference which we have failed to demonstrate, i. e. type 11 error. There are 
several possible reasons that our study might have this type of error: 
]). Number of subjects (Lack ofstatistical power) 
In our feasibility study we overestimated the numbers of patients that would be 
admitted with stroke; we admitted just over 700 patients in 19 months (we estimated 
900 in 18 months). We relaxed our entry criteria several months into the study to try 
to improve our randomisation rate. We accepted patients who were admitted more 
than 4 weeks prior to screening (one of our initial criteria), allowing "slow starters" 
to be included. However, most of our patients were randomised within the original 
time "window". We also accepted patients with "mild" communication and 
cognitive impairment. Unfortunately, these changes had little effect on our 
randomisation rate. Finally, we extended the randomisation period as much as 
possible within the available funding, in order to recruit more patients. 
We were also constrained by limited resources to provide augmented treatment. 
Eligible patients arrived in batches and some were excluded or started late because 
we were unable to guarantee that if they were randomised to the augmented arm of 
the trial, we could provide the intervention. In our feasibility study we 
overestimated the number of eligible patients. Our patients were more disabled, 
took longer to walk and return home than we planned for and therefore our power 
calculation was imprecise. 
Although our number of subjects was small our drop-out rate was lovk, in 
comparison to some other studies e. g. Lincoln et al. 1999, Partridge et al. 2000. We 
were selective in our inclusion criteria. This gives the problem of being able to 
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generalise any findings but we felt that if even the "fittest" 10% of stroke patients 
can be identified as potentially benefiting from a more intense treatment then this 
should be pursued. 
If the fittest group could be shown to benefit from increased physiotherapy then this 
may be of clinical significance and provide persuasive evidence for an ethics 
committee to allow more disabled patients, particularly those with more significam 
communication and cognitive deficits to participate in similar trials, based on 
informed consent from relatives. These patients are often excluded from clinical 
trials. There is little evidence so far that increased physiotherapy with this subgroup 
of stroke patients is effective. Several techniques used by physiotherapists require 
the patient to be aware of instructions or to understand a treatment technique. 
Physiotherapy intervention with this group requires investigation in the future. 
Relatively few patients eligible for the study refused to take part. This indicates that 
patients can be persuaded to participate in trials with random allocation of 
rehabilitation treatments and that they are willing to accept uncertainty of efficacy 
of treatment. Although some patients expressed a preference to be in one group over 
another, no patients withdrew during the treatment phase of the study. 
2). Inadequate differences in physiotherapy intensity 
Despite our attempts to standardise our interventions it proved difficult to maintain 
a treatment ratio of 2: 1 (augmented to standard) treatments. We managed to provide 
a ratio of about 1.6: 1 overall. This may well have diluted any expected treatment 
effect. 
The potential for variation in a complex human interaction makes monitoring and 
regulating behaviour in a rehabilitation environment difficult. For example at times 
treatment was interrupted because the patient felt unwell or treatment was extended 
because they were performing well or have made progress within the session. On 
one of the hospital sites (Lightbum) there were no specific resources available to 
provide additional treatment. 
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We speculate that many therapists, used to a high degree of professional autonomy, 
do not find it easy to follow a tightly structured treatment regime. It was therefore 
difficult to guarantee the delivery of different intensities of treatment, especiafly 
over several hospital sites with many changes of members of staff over a prolonged 
period. 
Our intervention seems likely to reflect normal UK practice, involving a broad 
spectrum of individual interventions, delivered by different clinicians. In our study 
we avoided the subjects being treated exclusively by an "elite", specialised, highly- 
trained and motivated research clinician. Our patients were treated mostly by senior 
and junior qualified physiotherapists, occasionally by physiotherapy undergraduate 
students and assistants - both under supervision, in addition to the senior 
physiotherapists specifically employed by the study. There is no suggestion that one 
staff group provided a different intensity whilst working with the patient. 
3). Outcome measures lacked sensitivity 
In our follow up assessments we were looking for differences in the levels of 
achievement of mobility milestones (overall and in relation to the baseline 
measures), speed of these achievements and whether they were sustained. Most of 
the weekly follow up visits were conducted seven days apart. They therefore may 
have been sensitive to changes in performance on a weekly rather than a daily level. 
We administered a large battery of follow up tests. Patients may have experienced 
either fatigue or a learning effect when carrying out the tests, but these phenomena 
should be evenly distributed between the groups at randomisation. Despite the 
length of the follow up tests (the longest administered at 6 months took about an 
hour to complete), very few patients dropped out of our study during the follow up 
phase. 
The definitions used by Smith and Baer in their Milestones paper (Smith and Baer 
1999) were amended during the study. We kept our working definition the same 
throughout the study for consistency. The Mobility Milestones appears to be a 
useful measure but may have a ceiling effect with our patients (over 90% achieved 
10 in walking) and is not sensitive to change in higher-level mobility. 
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We did not expect to see significant differences between the groups based on their 
survival or ADL scores in any sample this small, and this turned out to be the case. 
Another of our secondary outcome measures, complication rates, showed slightly fewer 
falls and more shoulder pain than reported in some other studies (Davenport et al. 
1996)(Langhome et al. 2000) but with little difference between the groups. The 
complications of pain, falls and fatigue were all assessed by simple interview question 
e. g. "In the last week have you had any falls? Yes / No". We depended on the patients' 
responses and only attempted to quantify falls by their seriousness in the "key" time 
lines of 4 weeks, 3 and 6 months. Our measures of complications may be insensitive to 
the actual levels of adverse events due to our use of non-standardised measures, our 
dependence on patients' recall and that we did not include alternative methods of 
confirming clearly defined complications due to limited resources. 
4). Error or bias 
We aimed to minimise bias by using remote telephone randomisation. 
By chance, despite the randomisation process, there were differences between the 
groups in baseline levels of disability (about 1.5 points on the Barthel index) and 
impairment (about 10 points on the Motricity index) (Table 3.4, page 57). These 
differences may have produced a baseline bias that influenced our results. We did not 
adjust our analysis in order to correct for these baseline differences. The factors we 
considered to be predictive of outcomes were identified a priori in the statistical plan 
and were stratified at randomisation (centre, age, Barthel index score). In a larger 
sample these should be more evenly distributed. We did not pursue what would be a 
more complex secondary analysis of the variables that appeared to differ at baseline. 
Our analyses did include change over baseline scores and this may have helped interpret 
our results. However, the best method of reducing the potential for baseline bias is to 
randomise a large sample. 
We tried to maintain blinding of our assessor by following a strict protocol avoiding 
contact with treating therapists and carrying out assessments away from treatment 
areas. Despite this we were still unblinded in a small number of cases. Where 
possible if one assessor had been unblinded another assessor who remained blinded 
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was brought in to regain blinded status for the remainder of the patient's follow up 
assessments. 
We attempted to reduce measurement error by selecting standard measures and 
applying them in a standard manner, using a training programme and manual 
designed by the prmcipal assessor, Thorlene Egerton. The majority of assessments 
were undertaken by the one assessor in an attempt to reduce inter-rater error. 
Although our independent assessor was blinded the treating physiotherapists Nvere 
not. They were encouraged not to disclose or discuss the patients' allocation Nvith 
other members of the multi-disciplinary rehabilitation team but at times the patients' 
allocation would have been obvious. This could have influenced decisions to 
discharge the patient at an earlier or later stage thus biasing our length of stay 
results. 
Patients' reports of uptake of services, recall of complications and healthcare events 
can be inaccurate. We did not have resources to confirm these reports with their 
general practitioner or with a carer or through hospital admissions register but any 
inaccuracy should be evenly distributed between the groups by the randomisation 
process. 
5). Technical problems 
We experienced considerable technical problems with two of our secondary 
outcome measures the activity monitor and gait analysis system. These problems 
may lead to incomplete or "missing" data sets in the majority of patients. 
The two groups in the study were compared, looking for differences in activity 
levels, with more time spent upright being assumed to be more active. We were able 
to establish whether our patients were sitting or upright. The monitor is able to 
differentiate activities (e. g. walking, sitting standing) more accurately in other 
patient groups e. g. orthopaedic patients after total hip replacement. However, the 
complex data received by the monitor when a stroke patient is walking is difficult to 
typify and differentiate a gait pattern from a standing pattern. 
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One useful function of the monitor is its ability to examine selected patients' 
activity during different parts of the day. Generally, the activity monitor was well 
tolerated by the patients and they were able to wear it for several hours at a time. 
However, as we only have a single "snapshot" of our patients' activity, we are 
unable to examine change over time or speed of any change. Patients were assessed 
around 3 weeks after randomisation, but varied in the length of time since their 
stroke event. A number of patients were discharged before their assessment at 3 
weeks. This may bias our available results towards a more disabled (and possibly 
less active) group. 
We also had technical problems with our gait analysis equipment. The readings 
were not available for some of our patients due to breakdown of equipment and the 
severity of gait abnormalities in some others made them difficult to analyse. The 
analysis was unable to pick up on some key points of gait quality such as scuffing 
of the foot on swing-through phase, and foot symmetry during stance phase of the 
gait cycle. The equipment would seem better suited to small scale studies where 
there is easy access to technical support and study designs that allow re-testing of 
patients should there be any difficulties. Our study required robust equipment that 
would be used on several clinical sites with patients that were attending on a single 
occasion as an outpatient. 
This was the first use of this equipment in a clinical trial with stroke patients and 
has contributed to the further development of the system. 
The results obtained by Ms Egerton and the group at Strathclyde University, 
although limited to a "snap shot" sample in a limited number of patients, help to 
confirm that the augmented group were more active. We can assume that this was, 
at least in part, due to the increased time spent with the physiotherapist. 
Other measures and methodological issues 
Length ofstay 
We did not see any statistically significant reduction in the length of hospital stay, 
therefore the vast majority of costs will be similar for the two groups. Actual 
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hospital costs could be calculated on a simple cost per bed per day in a 
rehabilitation unit basis, but these were assumed to be similar across the three 
hospitals. 
There were no significant differences in additional marginal costs between tile two 
groups. The frequency of provision of equipment, referral for health and social 
services in the community and the occurrence of major complications (e. g. hip 
fracture) was similar between the groups or so infrequent as to be attributable to 
chance. 
The Euroquol is a widely used quality of life scale, but it was generally not Nxell 
completed by our patients. In particular many patients struggled to complete the 
visual analogue scale, confirming Price's findings (Price et al. 1999) that this type 
of scale can be difficult for patients after stroke. Unfortunately there are few 
alternatives that we could have used that are as straight- forward and quick to 
administer. 
The postal satisfaction questionnaire was reasonably well received by patients with 
47 of the 64 (73.4%) we sent being returned. We waited four weeks after discharge 
from inpatient rehabilitation before contacting the patients. We believed this would 
be a reasonable length of time for them to be settled, yet not too long for them to 
have forgotten their hospital experience. As with all questionnaires it is possible that 
the responses reflect the views of the person that completes them (in some cases this 
may not have been the patient due to their disability). 
Our comparison was based on the total amount of time spent by the physiotherapist 
on the patients' care. In addition to this we monitored and described our 
intervention in some detail. To do this we developed a simple tool to record 
physiotherapy intervention beyond simple timing of contact with our patients. 
Although there were no apparent differences in intervention between the two groups 
this has not been formally compared. Our recording tool would need to be 
investigated with regard to its measurement properties before further data could be 
analysed with any degree of confidence. 
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One of the reasons for monitoring the intervention was to see if the therapists "N-ere 
focussing their treatments in such a way that might influence our outcomes. For 
example were all efforts being made to discharge patients in the augmented group 
earlier perhaps by issuing them with wheelchairs and encouraging early home 
discharge or focussing purely on gait re-education (largely speaking ambulant 
patients with an upper limb weakness can be discharged and followed up as an 
outpatient for their continuing therapy needs). There is no indication that this was 
the case. 
There may be a difference in the delivery of the intervention. There is little known 
about the effect of delivering the augmented dose over different sessions e. g. are 
two half hour sessions the same as one full hour session? The augmented dose was 
delivered over more than one session in a number of subjects. There may be a 
threshold of benefit in any one dose of physiotherapy and this would be worth 
exploring as fatigue or training effects may influence the efficacy of treatment. 
In comparison to some earlier studies we recruited relatively late after onset of 
stroke. This represents the normal time spent by patients in the acute setting prior to 
transfer to a rehabilitation facility and is probably fairly typical of LJK service 
provision. This may have reduced our ability to detect early change (though this is 
likely to be largely spontaneous recovery) or to target a time "window" when 
therapy may be more beneficial. As mentioned this was partly due to our 
requirement to recruit more patients. 
Although we targeted the fittest subjects we reasoned that they were most likely to 
tolerate treatment and demonstrate any treatment effect. We would then have been 
in a position to consider the effect on less able patients in further trials. 
Some patients had discharge delayed because of difficulties in service provision or 
environmental adaptation e. g. delays in social services. These should have been 
evenly distributed across the groups but we do not know this. 
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Conclusion 
Increasing the intensity of physiotherapy in hospital with the selected patients in our 
study did not produce statistically significant benefits in terms of their mobility, 
length of hospital stay or patient satisfaction. No significant effect on patients' 
mobility was noted during their hospital stay or up to follow up at 6 months after 
randomisation. Length of hospital stay with these patients is not significantlý' 
reduced when physiotherapy intensity was increased by about 60% over standard 
levels. We were unable to recommend any change in current clinical practice based 
on our results. 
We had difficulties with patient recruitment and in maintaining a sufficient 
difference in intensity between the two intervention groups. Our assessors 
succeeded in following up our patients, gathering large amounts of data and 
remaining "blinded" in most cases. The trial was sustained over an extended period 
with limited resources. In this time we gained considerable co-operation from 
patients and clinical staff on all the sites. The technology we used to assist in the 
measurement of patients' performance had some technical limitations. However, it 
has a role to play and should be developed further and tested for use in clinical trials 
in the future. 
Some of our difficulties, and perhaps our results, highlight that physiotherapy after 
stroke is a complex and challenging intervention to investigate. Our study did not 
set out to achieve the definitive answer to the intensity question. Any one small trial 
is unlikely to change clinical practice. However, we specifically tried in our study 
design (by selecting common outcome measures, administered at common end- 
points) to allow the results to be pooled in any future meta-analysis of intensity of 
physiotherapy. This is what I go on to describe in the following chapter. 
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Summary 
In 1999 the GAPS Collaborative group set out to ansN,,, er the basic question 
"Does the provision of additional in-patient pki'siotherapy after stroke 
speed up the recovery of mobility? ". 
We carried out a randomised controlled trial across three centres in 
Glasgow, using sound methods and attempting to address some of the 
limitations of the previous studies. We aimed to provide twice the standard 
amount of physiotherapy input to those patients in the intervention group. 
Our primary outcomes were mobility disability (achievement of mobility 
"milestones", Rivennead Mobility Index), mobility impairment (as 
measured by 10 metre walking speed) and length of hospital stay. Our 
secondary outcomes included measures of impairment, disability and 
handicap. 
Over an 18 month period I screened over 700 patients of whom 70 were 
recruited and randomised (35 to each group) to the trial. A blinded assessor 
regularly followed these subjects up to 6 months after randomisation, 
administering a battery of standard outcome measures. 
Our analyses showed that increasing the intensity of physiotherapy in 
hospital with the selected patients in our study did not produce significant 
benefits in terms of their mobility, length of hospital stay or patient 
satisfaction. No significant effect on patients' mobility was noted during 
their hospital stay or up to follow up at 6 months after randomisation. 
Length of hospital stay with these patients is not significantly reduced when 
physiotherapy intensity was increased by about 60% over standard levels. 
Although we were unable to recommend any change in current clinical 
practice based on our results, they contribute to the pool of data and 
knowledge in this area. 
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CHAPTER 4 
SYSTEMATIC REVIEW OF PUBLISHED LITERATURE ON 
INTENSITY OF PHYSIOTHERAPY AFTER ACUTE STROKE 
Introduction 
From the previous chapters it can be seen that there are many difficulties and challenges 
in carrying out research into physiotherapy and rehabilitation after stroke. None of the 
previous studies have been definitive and our own study, whilst successfully addressing 
some of the previous problems, highlighted the fact that all of the trials are relatively 
small and lack statistical power. Research has, so far, failed to give clear guidance to 
service providers and clinicians. 
In this chapter I describe the process of systematic reviews of trials and the statistical 
approach of meta-analysis. This is a more rigorous method of evaluating the trials that 
were described in Chapter 2.1 now describe a systematic review and meta-analysis of 
the available trials of intensity of physiotherapy. 
Aims 
In this chapter I aim to: 
1). Describe the process of systematic review and meta-analysis. 
2). Carry out a systematic review of the published literature on intensity of 
physiotherapy after stroke in which 1: 
a). Define my criteria for inclusion in the review. 
b). Find all relevant trials of intensity of physiotherapy. 
c). Carry out the review of the published data in a systematic fashion. 
d). Describe the trials. 
e). Analyse the results of the published trials and draw conclusions. 
3). Discuss the findings. 
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Description of systematic reviews 
A systematic review can be defined as "an overview of primary studies that contains an 
explicit statement of objectives, materials, and methods and has been conducted 
according to explicit and reproducible methodology. " (Greenhalgh 1997). 
Systematic reviews have several advantages over conventional narrative reviews like the 
one carried out in Chapter 2 (Mulrow 1994). By explicitly stating their methods, bias in 
identifying and rejecting studies is limited. Additionally, conclusions can be more 
reliable and accurate because of the methods used. They may lead to quantitative 
systematic reviews (meta-analyses) that increase the precision of the overall result. 
Results of different studies can be formally compared to establish generalisability of 
findings and consistency (lack of heterogeneity) of results. Reasons for heterogeneity 
(inconsistency in results across studies) can be identified and hypotheses generated 
about subgroups. Systematic reviews can also improve access to information for 
healthcare providers, researchers and policymakers, thereby possibly reducing delays 
between research discoveries and implementation of effective diagnostic and therapeutic 
strategies. Figure 4.1 outlines the process of systematic review of randomised controlled 
trials. 
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Figure 4.1 Methodology for a systematic review of randomised controlled trials 
(Greenhalgh 1997) 
State objectives of the review of RCTs and outline eligibility ýcriteria -1 
earch for trials that seem to meet eligibility criteria 
Tabulate characteristics of each trial identified and 
assess its methodological quality 
ply eligibility criteria and justify any exclusions 
semble the most complete dataset feasible, 
th assistance from investigators if possible 
alyse results of eligible RCTs, using statistical synthesis 
data (meta-analysis) if appropriate and possible 
ompare alternative analyses if appropriate and possible 
Prepare a critical summary of the review, stating 
aims, describing materials and methods 
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Assessing validity 
Systematic reviews should include an assessment of both the internal and external 
validity of the included trials (Juni et al. 2001). 
1). Internal validity in studies. 
Internal validity reflects the degree to which a trial has avoided error and bias, Thus the 
way that the trial has considered bias, and incorporated methods to reduce or minimise it 
within the trial, can be evaluated. This is usually done by careful and explicit trial 
design, conduct and analysis. The Cochrane Collaboration handbook sets out simple 
criteria against which trials can be judged as having low, moderate or high risk of bias 
(Mulrow & Oxman 1997). An alternative is to use a quality scale related to a checklist 
of criteria that the reviewers consider important. Such checklists can be used, sometimes 
producing a summary score, with or without weights e. g. the Jadad and Chalmers 
quality assessment scales (in Juni et al. 2001). In practice there are over thirty such 
scales but no accepted "gold standard" quality assessment score and most of the rating 
schemes that are employed are arbitrary. Until a "gold standard" is developed the 
Cochrane Collaboration handbook recommends that reviewers should use simple 
methods. 
Reviewers require to understand the validity of the trials, and what steps, if any, the 
researchers took in order to reduce bias. Four different types of bias in trials are 
described (Mulrow & Oxman 1997): 
Selection bias: This describes systematic differences in the groups being compared, e. g. 
there is a problem at randomisation leading to the non-random allocation of subjects to 
one group rather than another. 
High quality randomisation procedures reduce the possibility of selection bias at the 
stage of assignment of treatment. Ideally, someone that is remote from the trial should 
carry out the randomisation, reducing the possibility of influencing the randomisation. 
This might be the case for example when open random number lists or other methods 
are used, that potentially allow the randomising researcher to anticipate treatment 
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allocation and make a conscious or subconscious decision that could influence the group 
allocation. 
Performance bias. - This describes systematic differences in the care provided, other than 
from the intervention being evaluated. Performance bias may Include: contamination, 
where the intervention being investigated is provided to both groups, and / or co- 
intervention, i. e. the provision of an unintended intervention to either group. 
Attrition bias. - This describes systematic differences in how withdrawals from the trial 
are handled, e. g. there is an inconsistent or incomplete approach to pursuing subjects 
being followed up. 
Detection bias: This describes systematic differences in outcome assessment. The 
process of blinding of subjects and researchers may reduce perfon-nance and detection 
biases where both the subject and the investigator are unaware of the allocation of 
treatment or intervention being provided. Any placebo effect from the intervention 
should be evenly distributed between groups if the trial design is double blind. These 
effects are often complex and subtle. Double blind trials may be more complex to 
organise and in some situations may not be feasible, e. g. due to the nature of the 
intervention or for ethical reasons. None of the intensity of physiotherapy trials 
discussed in Chapter 2 were double blinded. Whilst double blinding is possible in some 
physiotherapy trials, most only achieve single blinding (blinding of outcome 
assessments). 
Although there is an emphasis on the methodological quality of trials, only concealment 
of randomisation and blinding of assessments have been empirically demonstrated to 
affect outcomes (Schulz et al. 1995). There remains a considerable amount of research 
to be carried out into the various methods that can be utilised in the systematic review 
process. 
2). External validity (generalisability) in studies. 
The external validity of a tnal i. e. the extent to which results of a trial provide a correct 
basis for applicability to other circumstances, can be more difficult to establisli and is a 
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matter of judgement. This should include a consideration of the subjects, the 
intervention, the setting and the outcomes that were selected by the researchers (Jum et 
al. 2001). This in turn will be dependent on the availability of this information to the 
researchers carrying out the meta-analysis. Guidelines on the content of reports of trials 
and recommendations on minimum reporting standards (e. g. Begg et al. 1996) may be 
helpful in standardising the availability of such information, allowing judgements to be 
made (Altman & Bland 1998). 
Sources of data to be used in meta-analyses 
When performing a meta-analysis, there are several different sources from which the 
data can be based: 
1). Published data 
II). Published data and supplementary additional information or data provided by the 
authors that were not included in the publication. 
III). Individual patient data (IPD) supplied by the trialists. 
I). Meta-analyses based on published data 
These have the advantage of being relatively quick to carry out but may be limited by 
the quality of the data available for the synthesis (Egger et al. 2001). 
However, important trials may be as yet unreported or awaiting publication and small or 
pilot studies may not be fully reported e. g. published only in abstract form. Authors are 
often limited by journals as to what they can report. Most trials have considerably more 
information that cannot be presented within a limited space or format. Just because an 
aspect of a study was not reported, does not necessarily mean it was not carried out. 
Added to this, many trials without a "positive" result may not get into print. So-called 
publication bias is common, with positive results increasing the likelihood of 
presentation and publication, especially in high profile journals (Egger & Davey 
Smith 
1998). 
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This latter point is debated and a larger study of publication bias in trials in the USA 
(Dickersin et al. 1992) did not find sample size or type of study design to be important 
factors. Instead they found that trials with external funding (especially those funded bv 
government agencies rather than commercial interests such as phan-naceutical 
companies), multiple data collection sites and significant results ývere positi\-clý, 
associated with publication. They also proposed that many studies, rather than being 
rejected by journal editors, were in fact, never submitted by their authors for publication. 
One solution to avoid publication bias is to require all research to be registered before 
starting allowing reviewers to search for topics and studies that have been carried out 
but not widely reported. This may be tied in with ethical or funding approval but may 
also be down to the diligence of the researchers recognising the importance or potential 
importance of combination of trial results in meta-analyses. There is general acceptance 
that there is now improved access to information on trials with data held on electronic 
registers such as the Cochrane Trials Register and "Register of Registers" being readily 
searched. 
If publication bias (or other biases such as English language bias, multiple publication 
bias and inclusion bias) is a concern there are methods by which it can be estimated, 
e. g. plotting of results in a funnel plot, and in some cases a statistical adjustment made 
to allow for non-included studies (Egger & Davey Smith 1998) (Sterne et al. 2001). 
11). Meta-analyses based on published data and supplementary additional information 
Alternatively, researchers may contact the authors and ask for further information or 
clarification on points that are unclear. Further unreported information may be available 
by using this approach and results can be updated and potentially more data can be 
included in the dataset. 
In a study of attitudes towards meta-analysis (Cook et al. 1993) there Nvas acceptance 
amongst the meta-analysts surveyed that where available, unpublished results should not 
be systematically excluded from meta-analyses. In this case the trial's results should 
be 
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handled in the same manner but the results of the meta-analysis should be presented as 
including and excluding the unpublished results 
Some authors may be reluctant to release results for inclusion in meta-analyses because 
they fear it may jeopardise publication of their results in their own right. This fear may 
be justified; in Cook et al. 's survey, nearly half of the journal editors surveyed, stated if 
they were considering a study for potential publication, prior publication in a meta- 
analysis would have a bearing on their decision (Cook et al. 1993). 
111). Meta-analyses based on individual patient data (IPD) 
Probably the most infon-nation can be gathered by asking the authors to submit their 
original "raw" data for meta-analysis. Often considered the "gold standard" method, its 
real strength is that it provides the opportunity to review all the available data, for each 
study to be re-analysed, then compared to the other trials in the dataset. It allows 
subgroup analyses and time-to- event analyses that may not be available when dealing 
with summarised or compound data based solely on published results. However IPD 
meta-analysis is considerably more time consuming and requires more resources. 
EPD meta-analyses are better if there is a consensus between the trialists and they all 
agree to submit their data. If there is a lack of co-operation, or for some reason the 
trialists are unable, or do not wish to collaborate, then the analysis can continue but the 
situation should be made explicit. 
Every effort should be made to include all the relevant trials as the advantages of this 
method are lost if trials are excluded from the meta-analysis. Detailed searching should 
uncover published results, but is dependent on the search skills of the researcher 
(Dickersin et al. 1994), their access to librarian assistance and methods of indexing and 
searching the various databases. Hand searching and checking registers of trials, 
personal correspondence and discussion amongst researchers, many of whom are 
involved in reviewing grant applications or journal articles as well as undertaking 
primary research, can also assist in uncovering trials that have been carried out, or are 
ongoing, but have not been published. 
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The advantages and disadvantages of aggregate data and EPD meta-analyses are outlined 
in Table 4.1 (Stewart & Clarke 1995). 
Table 4.1 
Possible benefits and disadvantages of reviews of aggregate data and individual 
patient data (IPD) 
(Stewart & Clarke 1995) 
Possible benefits of collecting aggregate datafrom trialists 
Include unpublished trials 
Include all randomised and non-randomised patients 
Analyse on the basis of allocated treatment 
Analyse common outcomes 
Analyse common patient subgroups 
Improve the overall follow-up 
Ensure equal follow -up for the randomised groups 
Possible additional benefits of involving the relevant trialists in the conduct of the 
review 
Better identification of trials 
" Better understanding of the trial intervention 
" More balanced interpretation and understanding of the results of the review 
" Wider endorsement 
Increased possibilities for dissemination of the results of the review 
Better clarification of the implications for future research 
9 Possibilities for collaboration in future research 
Possible additional benefits of using IPD 
" Analyse by time to event 
" Increase statistical power 
" More flexible analysis of patient subgroups 
0 More flexible analysis of outcomes 
Might be easier for trialists to supply IPD than to prepare tables 
Easier for trialists to supply small amounts of additional or new data 
Data can be checked and corrected 
Possible disadvantages ofIPD reviews 
May take longer and cost more 
Reviewers need a wider range of skills 
Inability to include EPD from all relevant trials 
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The process of meta-analysis 
Meta analysis is a process that occurs in two stages: 
Firstly, a summary statistic is calculated for each of the trials to be entered into the 
meta-analysis. Then these summary statistics are combined to form a weighted average. 
Most meta-analyses are carried out by computer programme that will calculate an 
estimate of precision (a confidence interval) and a measure of statistical significance (a 
P value). A test statistic (z) is given for the overall effect and P value for statistical 
significance. 
Different types of data can be summarised (Deeks et al. 2001): 
9 binary data - where a 2x2 table can be constructed and odds ratios, risk ratios 
and risk differences calculated for the strength of association between for 
example exposure to an intervention or risk factor and presence of a clinical 
outcome or diagnosis. 
9 continuous data, either calculated as differences in means or, where different 
measurement scales have been used as standardised difference in the means. In 
the later case, the standardised mean difference (SMD), the size of the treatment 
effect in each trial is expressed relative to the variability observed in that trial. 
9 time-to-event analyses where hazard ratios (again an estimate of the degree of 
association) are surnmarised. 
These data summaries are then analysed using either a fixed effects model or a random 
effects model. The choice of model is given as an option on most meta-analysis 
statistical software packages. The decision is largely dependent on: the type of data 
being analysed; the choice of summary statistics; the amount of heterogeneity that is 
observed between the trials and any limitations of the computational methods. 
Fixed effect model - this approach assumes a single "common" effect and can use a 
range of possible methods: Inverse Variance method; Mantel-Haenszel method and the 
Peto (also known as Peto and Yusuo method. Fixed effect models can be used to 
calculate study weights dependent on the contribution made by each of the trials to the 
meta-analysis. 
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Random effects model - this includes an estimate of between-study-variation 
(heterogeneity), sometimes considered as the "combinability" of the trials, and usuall%- 
uses the DerSimonian and Laird method. 
Deeks et al. describe the models in detail and considered that "There is no consensus 
regarding the choice of fixed or random effects models, although they differ only in flic 
presence of heterogeneity, where the random effects model will usually be more 
conservative. " Peeks et al. 2001). 
The same authors consider errors can anse for the fixed effect models in the following 
instances: - 
e Inverse variance method - this is considered less robust and reliable when trials 
are small (and is rarely preferable to the Mantel-Haenszel method). 
* Both the inverse variance and Mantel-Haenszel methods are considered less 
robust and reliable when the rate of events is very low. 
* Peto's method is considered less robust and reliable when treatment effects are 
large and when there are severely unequal numbers of subjects in treatment and 
control groups in some or all of the trials. This last situation would be unusual 
when dealing with randomised trials. 
None of the methods compensate for publication bias or deal with bias introduced 
through poor study design or execution. A table of considerations in choosing a method 
of meta-analysis is given in Appendix IV. 
In the second stage of the meta-analysis process, the weights of each study are 
calculated as the contribution they make to the combined result. The weights used are 
often the inverse of the variance of the treatment effect i. e. the square of the standard 
error. This usually relates closely to sample size, with larger samples being allocated 
greater weight. 
Considering heterogeneity 
When selecting trials to enter into the meta-analysis, we should consider 
how consistent 
are treatment effects across the primary studies. 
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Trials may be fundamentally different in their alms, patient group, setting, other 
(concomitant) care or how the intervention was delivered. This "clinical" heterogeneity 
may lead to variability of results. A decision to include trials often depends on clinical 
experience and background knowledge of the patient groups, the interventions and the 
disease. If trial results are consistent this tends to corroborate generalisation of any 
treatment effect. However, Type 11 error (false negative) may anse where there is a small 
number of studies which may not detect excess variation (Mulrow & Oxman 1997). 
Heterogeneity may arise within a group of trials that appear to be clinically similar. 
Statistical testing for heterogeneity is available in the form of the 12 statistic. This is the 
percentage of variability in point estimates that is due to heterogeneity rather than 
sampling error (Higgins et al. 2003). 
There are limitations of the X' test of heterogeneity as it is sensitive to the number of 
studies in the meta-analysis. Where there are few studies, as is the case with most meta- 
analyses, it is underpowered to detect differences between the studies, yet when there 
are many studies it may overestimate differences and detect differences that are 
unimportant. 
If significant or substantial heterogeneity is identified by reviewing the trials or in 
performing statistical tests of heterogeneity we should attempt to find a reason for it or 
abandon pooling the estimate and use another method. As an alternative we can consider 
a stratified meta-analysis or "meta-regression" in order to test potential associations 
between study factors and the estimated treatment effect. The important point is that we 
are able to estimate the amount of heterogeneity and consider how it might impact on 
the findings of the meta-analysis (see Table 4.2). 
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Table 4.2 Consideration of heterogeneity can affect: 
(Deeks et al. 2001) 
" whether a meta-analysis should be considered, depending on the similarity of tile 
trial characteristics. 
" whether an overall summary can have a sensible meaning, depending on the 
degree of disagreement observed between the trial results. 
" whether a random effects method is used to account for extra betýveen-trial 
variation and to modify the significance and precision of the estimate of overall 
effect. 
whether the impact of other factors on the treatment effect can be investigated 
using stratified analyses and methods of meta-regression. 
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The systematic review of published data on the intensity of physiotherapy after 
stroke. 
Objective 
Using some of the methods I have been discussing, I set out to review the published data 
on intensity of physiotherapy after stroke (most of which were described in Chapter 2). 
In my review I describe in a systematic manner, how I selected and critically appraised 
the available evidence using methods employed in a Scottish Intercollegiate Guidelines 
Network (SIGN) guideline review of the management of patients with stroke (SIGN 
2002). The SIGN methods (SIGN 2004) largely reflect those laid out in the Cochrane 
Collaboration Handbook (Mulrow & Oxman 1997). 
Parts of this work contributed to the publication of the national clinical guideline (SIGN 
2002). 
Trial selection - Inclusion I Exclusion Criteria 
In order to limit the area of study and focus on the questions of interest, I wanted to 
develop a specific literature search strategy yet avoid missing any potentially relevant 
papers. I limited variations due to methodology, by only including randomised 
controlled trials in the review. All trials needed to satisfy the following criteria. They 
should: 
1). be randomised controlled trials. 
2). compare different intensities of "physiotherapy" or "physical therapy". 
3). contain interventions that reflect current physiotherapy practice 
in the UK. 
4). include patients in the acute and rehabilitation stages of treatment after stroke. 
5). be mostly in-patient based. 
99 
Chapter 4 
Finding the relevant trials of intensity ofphysiotherapy 
The search for relevant trials was based on the Cochrane Stroke Group Trials Register 
with assistance from the Stroke Therapy Evaluation Programme' (STEP) based at the 
University of Glasgow. The Stroke Group Trials Register is compiled from highlý 
sensitive searches of databases including Medline, EMBASE, BIOSIS, Derwent Dru,,, 
File, Scisearch, AMED, CINAHL, Cochrane Controlled Trials Register, Dissertation 
Abstracts, Healthstar, National Research Register, Psych INFO, SIGLE. This is 
supplemented with hand-searching of over 40 journals, over 100 textbooks and several 
hundred conference proceedings. It includes articles in all languages. The main search 
strategy is given in Appendix V. 
I initially excluded obviously irrelevant studies before two reviewers independently 
screened relevant publications for inclusion (see review profile - Figure 4.2). We 
identified 34 potentially relevant trials (See Appendix V, Table A5.1). We repeated our 
search during the period of study (up to end of December 2002) in order to identify any 
new trials. Trials that were excluded and the reasons for exclusion are described in 
Appendix V (summarised in Table A5.2, Appendix V). We also contacted existing 
trialists for additional information and approached specialist groups such as The British 
Stroke Search Group, Society for Research and Rehabilitation, and the Chartered 
Society of Physiotherapy. 
STEP is a project based in Glasgow Royal Infinnary, 
funded by the charity Chest, Heart and Stroke 
(Scotland). 
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Figure 4.2 Review profile 
Titles reviewed 
n= 4772 
v, cluded 
= 4537 
Abstracts reviewed 
n= 235 
Excluded 
On = 201 
Papers retrieved for detailed 
evaluation (n = 34) 
tudies included in the 
.v , iew (n = 9) 
Studies excluded from review n= 25 
Secondary publications 
ate intervention 2 
Intervention rather 
than intensity was 
focus of trial 5 
Novel intervention I 
Non or Quasi-randomised 3 
Confoundedinterventions 3 
Community / outpatient - 
based 3 
Ongoing pilot study I 
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There were three existing systematic reviews identified by the search (Langhorne et al. 
1996, Kwakkel et al. 1997, van der Lee et al. 2001) all used slightly different methods to 
review their selected papers and have already been described briefly in Chapter 22. 
We selected nine trials, in five cases a trial had more than one publication (Table 4.3). 
Table 4.3 Trials considered to fit the inclusion criteria 
Trials are grouped to indicate the main study (underlined) and secondary papers. 
GAPS (unpublished) 
Kwakkel et al. 1999 
Kwakkel and Wagenaar 2002 
Lincoln et al. 1999. 
Lincoln et al. 1999. 
Parry et al. 1999(a) 
Parry et al. 1999(b) 
Miller et al. 2000 (abstract only) 
Partridge et al. 2000 
Rodgers et al. (paper was being prepared and was published in 2003) 
Richards et al. 1993 
Malouin et al. 1993 
Slade et al. 1999 (abstract) 
Slade et al. 2002 
Sunderland et al. 1992 
Sunderland et al. 1994 
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This group includes the results from the GAPS study from the previous chapter 
(subsequently published in 2004) and results from the trial by Rodgers et a]. that had not 
been published at the time of the literature review. We were aware of this trial and 
considered it suitable to be included at this stage to allow comparison of data. 
The trials have been described in Chapter 2 and are characterised in Table 4.4. 
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Systematic review 
I used existing review criteria - the Scottish Intercollegiate Guidelines NetN, ý, ork (SIGN) 
criteria and rating system (see Appendix VI). 
The review was considered in three sections: 
I Description of the study (where the study intervention, outcome measures, 
number of subjects and scale and direction of the measured effect are described). 
2. Internal Validity; (where the clarity of the study, its attempts to minimise bias 
and rigour of its analysis are assessed). 
I Overall assessment of the study (where the study quality is rated). 
Each section is shown in tables 4.4 - 4.6. 
I reviewed the nine selected trials along with an experienced, expert, independent 
reviewer, Lynn Legg, from the related field of occupational therapy in stroke 
rehabilitation, based at the Stroke Therapy Evaluation Project (STEP) at the University 
of Glasgow. This had the advantage of reducing potential bias that may anse when 
reviewers of a similar professional background examine a trial. Neither of us was 
blinded to the authors of the papers. This would have further reduced potential bias in 
our review but was impractical due to the small number of papers and the fact that we 
were both familiar with a number of the studies due to previous work in this field. An 
adjudicator, Professor Peter Langhorne, was appointed, but in practice was not needed 
as any differences in opinion on the criteria were easily resolved by discussion. 
106 
Chapter 4 
w2 
cu 
. M. 0 
10 
10 
10 
Iti 
tn 
F--( 
"0 
cz v 
- C) Z 
00 (L) 
Fj 00 : 
ý ýa 
rn u ut -D ýu u "Z .2 
ýD IU ýD < 00 1 
u 
CD r- bo (U al CD u 
, 
CD 
Z ' 
9 2 
(U 
" 
g> - 
ýz E a 
Ec » 
9ý, 'ý, .7 "Ci 
r 0 -i> ('L) 
LI öz 
c: P. CN . >ý 
ýn 
u 
>ý 
Z 
(D 
>ý 
u 
>ý 
- =Aý cu 
Z zi ýc clIG 
ý 
: >ý 
CD 
CD 
>. 
r_ 
ýn- 
ký 
c> ýq 2 
Q) 
IDJ) 
CD C> 2. : 
"C 
u 0 
2- >ý >. >- :1 < ýý >ý Z 00 > i cn 
- . 
00 
cn 
CD 
CD 
(f> 
(D r1q 
U 
>ý 
u 0E 
85 m"- <ý :g >'ý >ý >. Z) 
" 9 
u2 > t- a ' CU 
a 
Z] 
2 In 
E -0 c-. .. m l£ Mr 
E 
n0 , 
0 "Ci 
r_ 
= C- 0 
ýg 
0 cu 
ý: Z 
c7 
- 92. "a 
Z r- 
Q) 
(D 
CU 
U 
- 5 - . - 
:s 
0 
-0 - . 12 - w u0m J 
ýö 2- ce 
.9tk. 1 > . cl. 9" " 
-' i : 
(L) 2 
czs 
r_ n. - z=2 
cu 0 ZU .- (L) -0 - -0 
" 
cli 
d) 
, C lj , zi ", 2 ' :9 ý- - E -u -u Z u 0m Bu t) . 7 J, - - ce P. r- u Ei - -0 J u- -ýg > r- Z ,z tn : e_ r -- 0 r_ 
0 
, ce cr ce ce c 
-U 0> 92. 
' 
t (L) C-- -7j ý9 
Z; (V - -0 * r- uo 'E £- 4. - Z: 2 ZJ 
2 0 u2 ( ) 1- :j 
g 
V ýu k; um w-- m "0 .2 IM ce j , 
2ý uu 
umZZ 
c) 
E, 
Q) 
cu 
> 
L P. U 0 
2Z r_ t - r. C 
m 9 
> 
92. lý r- e < 
2r 
lu 
0 : 3: im ;, 
= 
M, 73 
:0t, 
O 
107 
Chapter 4 
m 
i-w rA 
10 
F-0 
C 
0 
ýsi "0 
"0 f, 1 
cý 
u 
-r- c, 
+ 
(1) 
, zi rq 
;. Z 
UU 
. j= e-) 
ut 
C> + 
+ 
CD 
r, 1 
r. Cl\ 0 
Z 
CD (3 
0 
Z 
, r« 9) >, 2 4ý Cý; 0 
=i "0 
. 5 
cl- 
=uZ +7 0- iv ru .-- N- 
0 
- .- - 
CU 
ZJ 
cd ýu 
CU 4-, -0 0 
f ýg cý = ,u -ci zi » E- ý it ýc3 - 0 C, 2 CJ = u (n G; J 
ý2 
rA ß- =u 
C) " 
108 
Chapter 4 
Trials excluded from the review 
The trials excluded from the review are given in Appendix V along with the reasons for 
their exclusion. 
"Combin ability" (clinical heterogeneity) of trials 
Considering how suitable the selected trials are for combination in the meta-analysis 
raises a couple of issues. Firstly, whilst most of the trials were published within the last 
ten years, we need to assume that "physiotherapy" as an entity has not altered 
considerably within this period. Secondly, one of the trials (Kwakkel et al. 1999) 
suggested significant benefit from increased physiotherapy intervention while others 
have reported little (Sunderland et al. 1992) or no measurable benefits (Partridge et al. 
2000, Lincoln et al. 1999, Rodgers et al. 2003). This discrepancy could be due to 
differences in trial methodology, patient selection, therapy technique, outcome measures 
or simply due to chance as all these trials are relatively small. 
Outcomes 
Returning to my original research questions (Chapter I page 14) 1 analysed the data for 
differences in groups in terms of reduction in upper and lower limb impairment (in the 
short and longer term), reduction in disability (in the short and longer terin), survival 
and reduction in hospital length of stay. 
Changes in levels of impairment and disability and timing of effect- there are mixed 
results from the studies. Different measures were used, particularly to measure 
impairment, there are trends towards reductions in both impairment and disability, bUt 
these are seldom statistically significant. Kwakkel et al. suggested benefit in the short 
terin (Kwakkel et al. 1999), but benefits may be short lived and more readily detected in 
the acute phase of treatment, with other studies showing no significant differences. 
Targeting of treatment The majority of the studies (5/9) focussed on treating the upper 
limb, whilst two focussed on treating the lower limb. The others were looking for 
general effects. Only Kwakkel et al. specifically split their subjects allocating additional 
treatment for the upper or lower limb. 
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Are any treatment effects greater for patients with moderate impairment and little co- 
morbidity. 
This is inadequately addressed with a wide variety of patients being Included and 
Sunderland et al. being the only group to report results of analyses of their "mild" and 
44severe" groups. There are difficulties in defining co-morbidity and a lack of 
standardised measures used and reported in the other trials. 
Survival - analyses of rates of death are normally calculated, and although we do not 
expect significant differences it is important to identify potentially harmful 
interventions. 
Reduction in hospital length of stay - Slade et al. reported a reduction in the length of 
hospital stay but their results may be biased as their sample included other 
neurologically impaired patients. The available data from their paper does not allow 
figures to be entered into the meta-analysis. Different studies use different points in time 
and interventions commenced at various times. Generally there was a lack of 
information about blinding of "decision makers" regarding decisions of when patients 
should be discharged home. 
Assumptions 
In order to carry out the analysis a number of assumptions were made. I needed to 
consider the balance between on one hand, including a small number of studies with a 
complete data set and on the other hand including a large number of studies but making 
assumptions where data were not available or explicitly reported. I decided to adopt an 
inclusive approach that would reduce bias associated with excluding trials. In taking this 
approach, it is important to make the assumptions explicit (Greener & Langhorne 2002). 
However, this inclusive approach means that the data should be used with caution as 
their quality may be called into question. 
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By detailing my assumptions and making conservative estimates, the limitations of the 
data have been made explicit (see Table 4-7). Table 4.8 describes the data selected for 
analyses of impainuent, disability, death and length of hospital stay. 
Table 4.7 Assumptions made of the published data for all analyses 
We have assumed a Normal distribution of outcomes selected. 
Where interventions have been split into subgroups e. g. upper and lower limb 
treatment we have divided the control group evenly. 
For secondary outcome measures 
Where only the median is reported we have taken this value as an estimate of the 
mean. 
Where the standard deviation (SD) was not reported, we have estimated this by 3 
methods (Langhorne et al. 2005): 
Where only inter quartile range (IQR)is given - 
SD = (IQR - 0.7) divided by 2 
Where only range is given - 
SD = Range x 0.25 
Where only SEM is given 
SD = SEM x ýn (standard error of mean times square root of no of observations) 
Where means and SD have been calculated from available data rather than the 
original number of subjects in groups i. e. not an intention to treat analysis, figures 
based on available data have been used. 
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Table 4.8 Data selected and assumptions for analyses of death, impairment, 
disability and length of hospital stay. 
Unless specified data, mean and standard deviation were routinely available from the 
text. 
_Trial 
Impairment Disability Death Length of stay 
GAPS Motricity index Barthel index Calculated from date of 
randornisation to discharge 
Kwakkel Upper limb used Barthel index One death reported Not available 
ARAT (mean & but group not 
IQR) specified - allocated 
Lower limb used to lower limb 
maximum gait treatment 
speed 
Lincoln RMA (median Barthel index Not available 
&IQR) 
Miller No available data None reported None reported - Not available 
assumed to be none 
Partridge 6 week follow up Profile of Reported 21 subjects Not available 
used as 3 month. recovery (POR) as dead or lost to 
Used gait speed follow up at 6 months 
no further data. 
Assumed no deaths. 
Richards 6 week data used Barthel index None reported - Not available 
as 3 month. Used assumed to be none. 
gait speed Included all baseline 
6 month data not patients 
repo ed 
Rodgers Barthel index Not available 
Slade No data available Barthel index No deaths reported - Not available 
assumed none 
Sunderland 100 day follow up Barthel index Compared at 6 Reported as weeks of 
(estimated from months inpatient therapy. 
figure in paper) Reported 2 deaths in 
experimental group, 8 Reported figures are not 
109 patients deaths in control split by mild / severe 
assumed to be group but no detail of categories. 
evenly distributed subgroup - assumed Labelled "severe" for the 
to be evenly analysis. 
experimental 54 distributed 
control 55 
ARAT = Action Research Arm Test, IQR = Inter-quartile range, KMA = Rivermeact Mobility Assessment, 
* Richards et al. 's study was not analysed on an intention to treat basis, therefore means and SD were 
based on available data. 
Egger and Davey Smith recommend routinely testing for bias using funnel plots aild 
sensitivity analyses (Egger & Davey Smith 1998). Due to the small number of trials in 
the meta-analyses we did not formally test for publication bias. 
I went on to analyse the aggregate (published and unpublished) data 
from the above 
trials using RevMan software (Version 4.2) (Review Manager 
2004). 
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Figures 4.3 - 4.8 show the summary statistics, meta-analyses and forest plots for each of 
the six outcomes. These are summarised in Table 4.9 below along with heterogeneity 
statistics and interpreted in the following section. 
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Table 4.9 Summary of effects 
Outcome n Method Effect size P value Hetero- 
(95% CT) geneity 
12 
Disability 3 805 SMD 0.15 0.09 21.5 
months (random) (-0.02 to 
0.31) 
Disability end 780 SMD 0.10 0.19 0 
of study (random) (405 to 
0.24) 
Impairment 3 703 SMD 0.07 0.48 23.4 
months (random) (-0.11 to 
0.25) 
Impairment 674 SMD 0.05 0.70 67.6 
end of study (random) (-0.22 to 
0.33) 
Death 1016 OR 0.91 0.76 9.9 
(random) 0.50 to 1.67 
Length of 202 Not 
hospital stay estimable 
SMD = Standardised Mean Difference, Random = Random effects model 
OR = Odds ratio, Cl = Confidence interval 
Interpretation of results 
We can see from Table 4.9 that there is variable heterogeneity between the studies 
entered into the analyses. Interpretation of results of the I'statistics is a matter of debate. 
Higgins and Thompson suggest that as a general rule I'values of 30% and 50% can be 
used as guidelines. Mild heterogeneity might account for less than 30% of the variability 
of point estimates and notable heterogeneity substantially more than 50%. Using this as 
a guide it was reasonable to combine the trials in most of our selected analyses, 
impairment at 6 months being the only comparison with substantial heterogeneity. 
Impairment 
The analyses indicate a trend towards a positive effect on impairment with most 
summary data being on the right hand side of the line of no effect though the confidence 
intervals tend to be wide. 
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The combined figure (diamond plot) though mostly favouring treatment, is small and 
crosses the line of no effect. This may reflect small numbers and the difficulties in 
obtaining full data collection when measuring this outcome using a variety impairment 
measures. These are possible reasons for the statistical tests for heterogeneity in the end- 
of-follow-up analysis identifying "notable" heterogeneity. 
Disability 
There is a trend towards positive results but not large enough to be statistically 
significant. This analysis had the best availability of a common outcome measure, the 
Barthel index, but the numbers are still limited. The outlying data from Kwakkel et al. 
may have arisen due to their ability to have early intervention and maintain treatment 
contrast by immobilising the limbs of the patients in the control group. 
Survival 
As expected, survival appears unaffected by the intensity of physiotherapy. This analysis 
acts as a check that the intervention does not appear to be producing an excess of deaths, 
for example by exercise induced death due to repeated physiological stress on patients. 
The assumptions I made may underestimate the number of deaths (by assuming no 
deaths where deaths were not reported and that "lost to follow up" did not necessarily 
mean "dead"), but without specific data we cannot be certain. The group lost to follow 
up in the trial of Partridge et al. are likely to include a few deaths and it might be more 
likely that the deaths that Sunderland et al. reported were largely in the "severe" 
subgroup. 
Length of hospital stay 
These data have problems of definition of terms and only two studies were able to 
contribute length of stay data. Interestingly, data from Slade et al. - the only study to 
have this as its primary outcome measure, could not be included as they did not include 
original data in their report. The meta-analysis could not be undertaken. Out of all the 
studies, only Slade et al. report a reduction in mean length of stay that reaches statistical 
significance. 
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Conclusion 
Using our inclusion criteria and a considerable number of assumptions of the data, I 
could not detect differences between the groups in our overview based on combined 
analyses of impainnent, disability, death and length of stay. Although there XN'as a trend 
towards short-term advantage with increased intensity of physiotherapy the confidence 
intervals were wide. 
With other methods of meta-analysis offering potential benefits (Table 4.1), we set 
about fonning a collaborative group to carry out an IPD meta-analysis. We aimed to 
repeat the review using all available data and using EPD methods. This would give us 
the opportunity to carry out subgroup analyses that might address our questions. The 
IPD meta-analysis is described in the next chapter. 
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Summary 
* In this chapter I outlined the process of systematic review then go on to carry out 
such a review based on aggregate data (published and unpublished) relating to 
intensity of physiotherapy after stroke. 
*I determined the criteria used to select trials from the body of available evidence. 
eI carried out a literature search with assistance from the STEP team and the 
Cochrane Stroke Group and identified 9 key studies from the 34 papers that were 
identified that fitted the criteria for inclusion. 
Using recognised review criteria (the SIGN review criteria) I reviewed the 
papers along with an independent assessor. Our appraisal of the main studies is 
tabulated and described. 
*I discuss the review of the papers and the other available reviews in relation to 
the research questions. 
9 We made explicit assumptions about data that were not directly available. The 
aggregate data were then entered into the meta-analysis and forest plots 
generated. 
* From the available results I conclude that there is still a lack of evidence of 
benefit, in terms of death, reductions in impainnent, disability and length of 
hospital stay, with an increased intensity of physiotherapy after stroke. With this 
uncertainty in mind and potentially more useful methods of meta-analysis 
available, we set out to form a collaborative group to carry out an individual 
patient data meta-analysis. 
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CHAPTER 5 
THE "PINTAS" INDIVIDUAL PATIENT DATA META-ANALYSIS 
Introduction 
The results from the previous chapter's aggregate data meta-analysis indicated a lack of 
evidence of benefit, in tenns of death, or reductions in impairment, disability and length 
of hospital stay, with an increased intensity of physiotherapy after stroke. Despite some 
limitations, meta-analysis appears to offer a unique and efficient use of the available 
information gathered from physiotherapy trials at a fraction of the cost of an adequately 
powered new trial. Whilst a large prospective RCT would be ideal, it seems unlikely to 
happen in the foreseeable future due to financial and practical constraints. We therefore 
wanted to explore meta-analysis further and examine some of the subgroups of patients. 
Given the available data and our aims, it seemed reasonable for us to select the 
individual patient data (IPD) method (see Table 5.1). We set out to form a collaborative 
group, the Physiotherapy Intensity After Stroke (PINTAS) group, to carry out an 
individual patient data meta-analysis. 
Table 5.1 Factors that may influence the systematic review approach 
(Stewart & Tiemey 2002) 
When IPD may be beneficial When IPD may not be beneficial 
Poor reporting of trials: information Detailed and clear reporting of trials 
inadequate, selective or ambiguous (CONSORT quality (Moher et al. 2001)) 
Long term outcomes Short term outcomes 
Time to event outcome measures Binary outcome measures 
Multivariate or other complex analyses Univariate or simple analyses 
Differently defined outcome measures Outcome measures defined uniformly 
across trials 
Subgroup analyses of patient-level Patient subgroups not important 
characteristics important 
Individual patient data available for high Individual patient data available for only 
proportion of trials / individuals a limited number of trials 
IPD = individual patient data 
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Collaborative EPD meta-analysis, by involving the primary trialists in a more thorough 
analysis, can greatly improve the quality of the information gathered and of the 
interpretation of results (Stewart et al. 1995). We successfully applied for funding from 
the charity Chest Heart and Stroke Scotland to carry out the meta-analysis still aiming 
to address the hypothesis set out in Chapter 1. 
Aims 
We aimed to carry out a collaborative IPD meta-analysis of randomised trials that 
compared standard physiotherapy with an increased amount of the same approach 
(intensive physiotherapy). 
Design 
We used standard methods (Stewart et al. 1995) to define the analysis and formed a 
collaborative group (comprising the contact authors of the primary trials) to pen-nit 
comprehensive data collection, analysis and interpretation. 
The project had three phases: 
Preparation - complete trial searching; liaison with collaborators; refining the meta- 
analysis questions. 
Database management - request for and transmission of individual datasets; creation 
of combined study analysis database; grooming and cleaning of data; categonsing data 
sets; forinal meeting with collaborators to finalize questions and meta-analysis strategy. 
Analysis - statistical analysis and writing up; presentation of results. 
1. Preparation 
Literature search strategy 
We used the same search strategy as in the previous chapter in order to identify all 
relevant trials, including studies identified up until the end of December 2002. 
Trial selection - Inclusion lExclusion Criteria 
We used the same criteria as in Chapter 4, applying the same inclusion criteria to 
unpublished studies to determine whether they should be included in our analysis 
(Cook 
et al. 1993). 
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Forming the collaborative group 
During the pilot phase of the study we made informal contact with potential 
collaborators. All the potential collaborators (primary authors of the trials) were willing ltý 
to participate in the study (see Appendix VII). 
Refining the meta-analysis questions 
In this type of analysis it is important to pre-set the questions to be addressed and make 
judgments about categorising the data. This was done after categorising the data (but 
prior to any analysis) and further discussion at a meeting of the collaborators. 
The formal meeting of the collaborating trialists was held at the headquarters of the 
Chartered Society of Physiotherapy in London on the 29th November 2002. The aim of 
the meeting was to confirm the questions and assumptions to be made in the meta- 
analysis, and to decide about the dissemination of the results. 
At the meeting we discussed the potential analyses, considering availability of data and 
our original research questions. We selected activities of daily living (ADL) disability 
and impairment as our primary outcomes and wanted to explore subgroups in secondary 
analyses. 
The ma . or advantage of this study has over a meta-analysis based on published data is J 
the availability of patient level data. This allows the potential for adjusting treatment 
effects for covariates of interest, and for examining treatment effects within subgroups. 
Additionally, fewer assumptions need to be made of the data. However, forcing data 
from many studies carried out in different places at different times using a variety of 
patients, with various outcomes and differing sets of explanatory covariates creates a 
challenge. Clearly such data are not identical to a very large unified study conducted at 
one place at one time using consistent methods. 
This challenge has two complementary parts: - to create a unified database of the 
individual studies data, and to conduct a statistical analysis that in some sense best 
addresses the questions in the hypotheses, whilst accommodating the limitations of the 
data. 
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2. Database Management 
Grooming and cleaning data 
We developed an outline database (see Table 5.2) to provide a structure for the many 
variables in each of the studies. 
To reduce the barriers to participation in the pooling of the data, we sought to minimise 
the effort required by the individual principal investigators and their research teams. We 
therefore allowed data to be sent in any fonnat on any media, with the only stipulation 
being that the data were first anonymised before transmission. The Robertson Centre for 
Biostatistics at the University of Glasgow has the facility to convert data from virtually 
any format into a standard fon-nat allowing the meta-analysis to go ahead. This helped 
to minimize, the workload of the collaborating trialists. 
Table 5.2 Outline database used in PINTAS meta-analysis 
Component Variable Example 
Patient Demographic Age, sex, 
Frailty Pre-stroke dependency, co-morbidities 
Baseline severity - general Barthel index at randonusation 
- upper limb Motricity index, Action Research Arm Test (ARAT) 
- lower limb Motricity index, Rivermead mobility index 
Intervention(s) Physiotherapy type Philosophy / approach (qualitative description) 
aims Target (eg. balance, upper limb dexterity) 
amount Minutes per day (average) 
Outcomes Upper limb impairment Motricity index, ARAT, peg test 
Lower limb impairment Motricity index 
Mobility Functional ambulation category, Rivermead 
Gait Gait analysis 
Activities of daily living Barthel index 
Quality of life E oquol 
Resources Inpatient stay, number of contacts, treatment time 
Our simple draft version of this database was, however, different in most cases to the 
fonnat in which the trialists' data were stored. The heterogeneous data therefore needed 
to be categorized to produce a meaningful and manageable database. 
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Categorizing data sets 
We used standard methods (Stewart & Clarke 1995, Mulrow & Oxman 1997) to define 
subgroups that would be clinically relevant and identify common outcome measures. 
We requested assistance from the collaborators to help with the interpretation of their 
data. 
The data set needed to be simplified in order to find common denominators. These 
needed to reflect physiotherapists' interventions with patients with stroke in order to 
help clinicians and service managers alike, understand the implications of increasing the 
intensity of therapy. Inevitably we had to find a compromise between the high quality 
detail of the specific studies and the general inforination available to all the studies 
when they are combined. 
For each eligible trial the principal investigator was asked to provide the following basic 
information for all patients randomised (see Table 5.3). 
Table 5.3 Core data requested for all trials in PINTAS meta-analysis 
Patient data 
Date of birth or age at randomisation 
Sex 
Baseline levels of disability and impairment 
Intervention data 
Date of randomisation 
Treatment allocation 
Quantity (intensity) of intervention - intended 
- received (dates, durations, intensities) 
Outcome(s) data 
Survival status 
Date of death (if dead) 
Date of last follow up (if alive) 
Performance status (outcomes) 
- at end of intervention 
- at medium term (e. g. 3 months) 
- at long term follow up (e. g. 6 months, one year) 
Exclusionsfrom trial analysis 
Reason for exclusion (if applicable) 
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Data checking procedures 
The data centre for the project was the Robertson Centre for Biostatistics at the 
University of Glasgow. The collaborators' data were loaded into a new, unified analysis 
database. All published results for all trials on all relevant data were reproduced in so 
far as possible, and any anomalies or inconsistencies queried to the individual study 
investigators. 
Further infonnation is presented in the Statistical Appendix (Appendix VIII). 
3. Analysis 
Statistical Methods 
All statistical analyses were approved by the Study Steering Committee and performed 
using SAS 8.2 for Windows on the central study analysis database and Review Manager 
(RevMan 4.2) (Review Manager 2004) for additional analyses. 
Statistical analysis began with a general description and summary of key data. As 
indicated these were then checked against published data to ensure comparability and 
any queries directed back to the primary trialists. The primary analyses (the effect of 
intensive physiotherapy on disability and impairment scores) used all available data. 
The secondary analyses were restricted to individual patient data for which the relevant 
outcome information were available i. e. included only subjects with complete data on 
the selected groups of covariates. These analyses were adjusted for explanatory 
covariates. With the exception of length of hospital stay data, we did not use any 
missing data techniques to explore the robustness of the findings to missing data or to 
impute data for those subjects missing observations. 
After discussion with the Collaborative group we decided on the following analyses 
(Table 5.4): 
Primary outcome analyses: The primary outcomes were overall disability (recorded at 
3 months), measured using the Barthel index (Mahoney & Barthel 1965, Wade 19921) 
where this was available or a comparable disability measure, and overall impain-nent 
(recorded at 3 months) measured using the Motricity index (Demeurisse et al. 1980) 
where this was available or a comparable impainnent measure. 
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Secondary outcome analyses: Secondary outcomes were: death from all causes; 
improvement in arm impairment; improvement in leg impainnent (both measured by 
change in the relevant sections of the Motricity index; improvement in upper limb 
function measured by change in the Action Research Ann Test (ARAT) (Lyle 1981); 
lower limb function by walking speed (Wade 1992); improvement in disability \N'as 
measured by change in Barthel index score. We also examined length of hospital stay 
and treatment success. 
We first explored the influence of each covariate in a univariate logistic regression 
model. Next we examined the influence of covariates on modifying the treatment effect 
by fitting each covariate in the presence of treatment. Finally we examined the joint 
influence of any covariates on the treatment effect found to be significant at P<0.05. 
The battery of covariates felt to be influential and of interest was identified prior to 
beginning the modelling process and was written down in an agreed statistical analysis 
plan. 
If data were approximately normally distributed, parametric Wests were used to 
compare the two treatment groups with normal linear models used to adjust the 
treatment differences for covariates. If data were non-normally distributed, then non- 
parametric rank tests (such as Wilcoxon rank sum test) were used. 
We modelled mean change over baseline score using a Normal linear model. After 
fitting a model just with treatment (in the presence of study), we then looked at a study 
by treatment interaction. Then, age and gender were added, and all the interactions 
between treatment, age, gender and study were explored. 
Treatment success: The final analysis defined a treatment success as a subject who has 
a change over baseline Barthel index greater than or equal to the stated threshold change 
over baseline (or a subject who has achieved the maximum score on the measure). We 
defined "good recovery" as an improvement in activities of daily living (ADL) score 
greater than the median recovery in the control group (increase from baseline of 6 or 
more Barthel units). Similarly, "excellent recovery" was defined as an improvement in 
ADL score greater than the upper quartile of the control group (increase from baseline 
of 9 or more Barthel units). 
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Treatment success was then modelled as a binary outcome in a logistic regression using 
study, age, gender, and treatment group as covariates. These logistic regressions xvere 
fitted separately for the 3 months data (patterns were similar at I and 6 months). 
Subgroup Analyses: Several pre-defined subgroups were identified (Table 5.4) and 
analysis carried out as outlined above. The one exception was the subgroup analysis, 
analysed at the level of the trial (total treatment contrast). This was analysed using 
RevMan 4.2 software to calculate subgroup effects and between-subgroup 
heterogeneity. 
We were aware of the potential of finding spuriously significant relationships due to 
carrying out multiple subgroup analyses (Counsell et al. 1994, Mulrow & Oxman 1997). 
We therefore kept the number of subgroups small and clearly recorded them in the 
analysis plan. Any other analyses would be considered exploratory, and any significant 
results treated with caution. 
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Table 5.4 PINTAS meta-analysis - Outline of analysis plan. 
Outcome Measure Timine Sub2roups 
Primary analyses _ 
Disability Activities of daily 3 months Target of therapy 
living score (Barthel 
index or comparable 
score) 
Impain-nent Impairment score 3 months Target of therapy 
(Morticity index or 
comparable score) 
_Secondary 
analyses 
_Death 
All cause death End of follow up Target of therapy 
Improvement in Change in an-n From Target of therapy, age, 
arm impairment Motricity index randomisation to initial stroke severity, 
point of follow up initial arm 
impairment, total 
treatment contrast 
Improvement in leg Changeinleg From As above 
impain-nent Motricity index randomisation to 
point of follow up 
Improvement in Change in Action From As above 
arm function Research Arm Test randomisation to 
point of follow up 
Improvement in leg Walking speed From As above 
function (gait) randomisation to 
point of follow up 
Improvement in Change in Barthel From As above 
disability index randomisation to 
point of follow up 
Good recovery Change in Barthel From None 
index greater than the randomisation to 
trial median point of follow up 
Excellent recovery Change in Barthel From None 
index greater than randomisation to 
trial upper quartile point of follow up 
Length of stay Length of stay Duration after Target of therapy 
randomisation 
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Definitions of the subgroups are given in Table 5.5. 
Table 5.5 Subgroup definitions used in PINTAS meta-analysis 
Domain Subgroup Definition -StFat-us 
Patient characteristics 
Patient age Younger Age <70 years Pre- 
Older Age >70 years specified 
Stroke severity Moderate Baseline Barthel >10 Pre- 
Severe Baseline Barthel <10 specified 
Ann impainnent Moderate MI arm score > 15 or 
ARAT score >0 
Pre- 
specified 
Severe Severe = MI arm < 15 or 
ARAT =0 
Co-morbidity Minor Proved difficult to define Dropped 
Major ftom 
analysis 
Treatment characteris tics 
Physiotherapy target Upper limb Upper limb Pre- 
Mixed Lower limb + upper limb specified 
Total treatment 
contrast 
Lower Lower contrast trials: 
10 (7-12) hours 
Pre-planned 
but not pre- 
Higher Higher contrast trials: 
32 (15-44) hours 
specified 
MI = Motricity index, ARAT = Action Research Arm Test 
Treatment contrast: The treatment contrast subgroup was defined according to 
whether the mean difference in physiotherapy contact time between intervention and 
control patients was above or below the median for all included trials. Lower treatment 
contrast trials had a physiotherapy treatment contrast ranging from 7-12 hours per trial; 
higher contrast trials ranged from 15-44 hours per trial. These two subgroups of trial 
tended to cluster by other characteristics. The lower treatment contrast subgroup also 
tended to contain the trials with a later treatment onset (12-47 days post-stroke), lower 
daily treatment contrasts (30-45 minutes per patient, and shorter treatment duration (5-6 
weeks). The higher contrast subgroup tended to cluster as earlier onset trials (7-10 days 
post-stroke), with higher daily treatment contrasts (53 - 70 minutes) and longer 
treatment duration (10 - 20 weeks). 
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"Clinically" significant improvement 
In order to aid interpretation of the results, before undertaking the analyses, NN, e sent out 
a questionnaire to the Collaborators. We asked for their opinions on what might be 
regarded as a "clinically" significant change in Barthel index score for patients Ný'Ith 
stroke (see Appendix VIII). The Collaborative group's responses varied widely and 
were difficult to interpret. We therefore did not pursue this category. 
Testing for heterogeneity: As before, we tested the data set for heterogeneity, testing 
the level of inconsistency in the results from the studies to detennine whether it ývas 
reasonable to combine the trials. The 12 statistics were calculated for overall disability, 
overall impairment, survival and length of hospital stay outcomes. 
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Results 
Trial selection 
Essentially we had the same set of trials as in Chapter 4 but with much more detailed 
data. 
Study characteristics 
Table 5.6 shows the key characteristics of the included studies which are described 
further in Table 5.7. These included 9 randomised trials with 951 participants (Figure 
5.1). The average participant age was 69 years and there was a relatively equal split of 
males and females (ranging from 43% to 62% men). Three studies contained more than 
one treatment group, which resulted in slightly more subjects receiving augmented 
physiotherapy than standard physiotherapy. The upper limb was targeted for 62% of 
participants with a lower limb target in 6% and a mixed target for 33%. 
All the studies demonstrated a recovery curve in relation to mean levels of disability 
(measured by Barthel index). The change in mean Barthel index score over time is 
shown in Figure 5.2. 
The treatment approach in the trials was broadly similar, with physiotherapists aiming 
to restore normal movement and function through regular exercise, with or without 
physical assistance or adaptive equipment. 
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Figure 5.1 Number of patients in trials in PINTAS meta-analysis 
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Figure 5.2 Change in mean Barthel index score over time in trials in PINTAS 
meta-analysis 
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Primary Analyses 
Disability: The primary analyses included all identifiable data addressing disability 
within the first 3 months after stroke (median 3 months, range 6 weeks -3 months). 
Seven of the nine trials used an ADL score providing the largest group of pooled data 
(805 patients at 3 months). 
Overall there was no significant difference in ADL score at 3 months (Standard1sed 
Mean Difference (SMD) 0.15; 95% Confidence Interval (CI) -0.02 to 0.31; P=0.09) or 
at end of follow up (SMD 0.10; 95% CI-0.05,0.24; P=0.19). These conclusions v"ere 
confirmed if the analysis was restricted to the Barthel index only or used the change in 
Barthel index between baseline and follow up. 
RevMan analyses (Review Manager 2004), carried out at the level of the trial and 
stratified by the target of the physiotherapy are shown in Figures 5.3 and 5.4. 
Impairment : Four of the nine trials used the Arm Motricity Index (maximum 393 
subjects at 3 months, 373 subjects at end of follow up), and two of these in addition 
measured Leg Motricity Index (maximum 153 subjects at 3 months, 151 subjects at end 
of follow up). Four studies used the Action Research Arm Test (ARAT). (maximum of 
447 patients available at 3 months, 437 at end of follow up). Five studies used gait 
speed (maximum 398 subjects at 3 months, 354 subjects at end of follow up). 
Forest plots show summary data from each group at 3 months and end of follow up. 
This shows a statistically significant difference (6.6; 95% Cl 0.71 to 12.5; P = 0.03) in 
the upper limb subgroup as measured by Motricity index (arm section)(see Figure 5.5) 
and in the lower limb subgroup (11.7; 95%C1 3.79 to 19.54; P = 0.004) as measured by 
the Motricity index (leg section) at 3 month follow up (see Figure 5.6), with benefit 
with additional physiotherapy intervention. 
At the end of follow up analysis for Motricity index (Arm) and Motricity index (Leg), 
though still in favour of the intervention, the effect size has decreased (Ml Ann 3.03; 
95%Cl -3.31 to 9.36; P=0.3. MI Leg 5.86; 95% Cl -1.96 to 13.67; P=0.14), and the 
pooled result crosses the line of no effect (see Figures 5.7 and Figure 5.8 respectively). 
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The ARAT analysis, though with greater numbers of subjects does not denionstrate 
statistically significant differences between the groups at either time point (Figures 5.9 
and 5.10) ARAT 3 months 3.4 1; 95% CI -0.8 5 to 7.6 7; P=0.12. ARAT end of stud 
1.66; 95% Cl -2.73 to 6.04; P=0.5. 
Similarly, the gait speed analysis does not demonstrate statistically significant 
differences between the groups at either time point (Figures 5.11 and 5.12) Gait speed 3 
months 0.02; 95% Cl -0.04 to 0.07; P=0.6. Gait speed end of study 0.02; 95% Cl 
-0.04 to 0.08; P=0.5. 
We can consider impairment "overall" i. e. when measured using data from all available 
outcome measures including the upper and lower limb. RevMan analysis, carried out at 
the level of the trial for overall impairment at 3 months and stratified by the target of the 
physiotherapy is shown in Figure 5.13. Overall impairment (SMD 0.07; 95% Cl -0.11 
to 0.25; P = 0.48). 
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Secondary analyses 
We carried out analyses for measures of death, change in impairment and disability 
scores (across the Period of the study), treatment success and heterogeneity. 
Death 
Case fatality: There were 32 deaths in 418 subjects who received standard 
physiotherapy (crude death proportion 7.7%) compared with 44 deaths in 533 subjects 
who were randomised to augmented physiotherapy (8.3%) giving an odds ratio for 
death of 0.92 (95% CI 0.55 to 1.52; P=0.81). (See Table 5.8). 
Table 5.8 PINTAS IPD meta-analysis - Case Fatality 
Study n Standard n Augmented 
GAPS 0/35 2/35 
Kwakkel 1/37 0/64 
Lincoln 12/95 29/187 
Miller 0/9 0/12 
Partridge 4/60 2/54 
Richards 0/13 0/9 
Rodgers 7/61 6/62 
Slade 0/40 0/43 
Sunderland 8/68 5/67 
TOTAL 32/418 44/533 
Note that we have not conducted a time-to-event analysis (it proved too difficult to 
establish with certainty at what point every subject in every study died in ternis of days 
post randomisation), and note further that 41 of the 76 deaths (over 50%) occurred in 
one study, and that there were no deaths reported in three of the (smaller, shorter 
duration) studies. 
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Secondary analyses - Change in impairment 
Improvement in arm impairment (Motricity Index Arm): Table 5.9 summarises the 
main arin impairment data. The main effects model estimated the difference in an-n 
Motricity index due to augmented physiotherapy as 5.2 (95% confidence interval 1.5 to 
8.8, P=0.0058) with an identical estimate returned after adjusting for age and gender. 
There was no evidence of a significant change in the treatment effect of augmented over 
standard physiotherapy over time (P=0.27). 
Subgroup analysis: Subgroup analyses (Table 5.10) indicated that improvement in an-n 
Motricity Index score was significantly greater (P=0.02) in higher treatment contrast 
trials 9.6 (95% Cl 3.7 to 15.5; P=0.001) than in lower contrast trials -0.2 (95% Cl -5.4 
to 5.0; P=0.90). 
155 
Chapter 5 
E 
z 
In 
- 
F-. ( 
*c 
$: i U Q) 
m Q Cý C) Iýt C) 
Q) 
06 
6 0 
C'j 
ý: ) , C-) u 'o 
V-) 
00 
CIA 00 Cýl CD 4-. o 
u ý: l ýc 
0 ., ý m m m m m 
00 C'4 00 110 
m tn ýo kn 
00 00 r-- - m N kr) C) C) 
t-- C) 
06 6 C-i r1i 
bi) 
t- N 00 
o l 
1-4 
6 6 
C d u (4i a 
-4 N 
-4 'Tt --4 ýo It 
Cf) 
-4ý ý m m 
m m m 
C) 00 N N, 
- 06 1ý6 06 (:: ý Ic; 
0 
C) "Cý m I: t kf) tr) m 
110 C) 
kn 
m 00 00 
156 
Chapter 5 
Table 5.10 PINTAS IPD meta-analysis - 
Change in arm impairment (Motricity Index arm) - subgroup analysis 
Subgroup Level Augmented- Standard 
(95% Cl) 
P-value Subgroup 
interaction 
Total All groups 5.2 (1.5,8.8) 0.006 
Treatment target Arm Only 3.4 (-1.7,8.6) 0.67 P=0.54 
Leg or Mixed 4.7 (-0.7,10.1) 0.090 
Age <70 6.6 (1.6,11.6) 0.0097 P=0.44 
>70 4.8 (-0.5,10.0) 0.075 
Baseline Barthel >10 -0.4 (-5.3,4.6) 0.89 P=0.21 
dependency 
Barthel:! ý10 6.8 (2.2,11.4) 0.004 
Baseline arm Moderate 3.2 (41,6.5) 0.056 P=0.40 
impairment Severe 6.9 (-0.3,14.0) 0.061 
Total treatment Lower -0.2 (-5.4,5.0) 0.90 P=0.02 
contrast Higher 9.6 (3.7,15.5) 0.001 
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Improvement in leg impairment (Motricity Index Leg): The overall advantage of 
augmented compared with standard physiotherapy was estimated as 6.8 units of lc, -, 
Motricity Index (95% CI 2.2- 11.4, P=0.0042) from a repeated measures model that 
adjusted for age, sex, and baseline leg Motricity Index score (Table 5.11). There was no 
statistically significant evidence of an interaction between treatment and time 
(P=0.087). 
Subgroup analysis: For the pre-specified subgroups of age and disability severity fliere 
was no evidence of any treatment by time interactions, nor of any formally significant 
differences in treatment effect between the levels of the subgroups. The higher 
treatment contrast trials tended to observe greater improvements (higher contrast 12.1; 
4.8-19.4; P=0.004 compared with lower treatment contrast 3.3; -3.4-10.0; P=0.33) but 
subgroup interaction was not quite statistically significant (P=0.08) (Table 5.12). 
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Table 5.12 PINTAS IPD meta-analysis - 
Change in leg impairment (Motricity Index) from baseline - subgroup analysis 
Subgroup Level Augmented- 
Standard (95% CI) 
P-value Subgroup 
interaction 
Total All groups 6.8 (2.2,11.4) 0.004 
Treatment target Ann Only Insiifficient data ---- --- 
Leg or Mixed 
Age <70 7.2 (1.2 to 13.1) 0.018 P>O. 1 
>70 6.7 (-I. l to 14.5) 0.091 
Baseline Barthel >10 -0.7 (-9.2 to 7.7) 0.86 P>O. I 
dependency Barthel:! ý10 7.3 (1.8 to 12.8) 0.010 
Baseline arm Moderate 13.5 (1.7,25.3) 0.024 P=0.87 
impairment Severe 7.2 (-1.4,15.6) 0.097 
Total treatment Lower 3.3 (-3.4,10.0) 0.33 P=0.08 
contrast Higher 12.1 (4.8,19.4) 0.004 
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Change in arm function (Action Research Arm Test (ARAT) scores): Four studies 
reported ARAT scores (Table 5.13)(Full summary in Appendix VIII). The estimated 
effect of augmented physiotherapy compared with standard physiotherapy in change 
over baseline ARAT score was 1.8 (95% confidence interval -1.2 to 4.8, P=-0.25) There 
was no evidence that the effect of augmented physiotherapy in companson with 
standard physiotherapy changed over time (P=0.87). On subgoup analysis (Table 5.14) 
significant interactions were seen with age and baseline severity. Improvements in 
ARAT scores were significantly (P=0.02 for subgroup interaction) greater in younger 
patients (8.9; 95% CI 3.3-14.5; P=0.002) compared with older patients (1.5; 95%CI 
-2.7- 5.7; P=0.49). Improvements were also greater (P=0.04) in patients with a baseline 
Barthel index >10 (5.5; 95% CI -1.5 - 12.4; P=0.12) compared with those with baseline 
Barthel index of <1 1 (0.6; 95% CI -2.8 - 3.9; P=0.74). 
Table 5.13 PINTAS IPD meta-analysis - Mean (SD) ARAT scores 
For 4 Time Standard Augmented Total 
Studies N Mean(SD) N Mean(SD) N Mean(SD) 
0 193 9.6(17.2) 313 8.2(15.4) 506 8.7(16.1) 
1 159 16.9(20.7) 259 18.0(21.0) 418 17.6(20.9) 
3 119 26.2(25.4) 139 29.5(23.7) 258 28.0(24.5) 
6 179 26.1(24.7) 263 26.2(23.8) 442 26.2(24.1) 
12 34 12.2(20.7) 57 20.6(23.3) 91 17.5(22.6) 
(SD = standard deviation) 
Table 5.14 PINTAS IPD meta-analysis - Change in arm function (ARAT score): 
subgroup analysis 
Subgroup Level Augmented- Standard 
(95% Cl) 
P-value Subgroup 
interaction 
Total All groups 1.78 (-1.25,4.81) 0.25 
Treatment target Ann Only 0.93 (-2.58,4.45) 0.52 P=0.30 
Leg or Mixed 1.85 (4.51,8.21) 0.58 
Age <70 8.91 (3.32,14.5) 0.002 P=0.02 
>70 1.49 (-2.71,5.70) 0.49 
Baseline Barthel >I 0 5.45 (-1.52,12.4) 0.12 P=0.04 
dependency Barthel:! ý10 0.57 (-2.81,3.94) 0.74 
Baseline arm Moderate -1.23 (-6.26,3.81) 0.63 P=0.22 
impairment Severe 3.44 (0.29,6.59) 0.032 
Total treatment Lower 0.5 (-5.0,6.1) 0.90 P=0.26 
contrast Higher 7.6 (0.9,14.2) 0.03 
(Cl = confidence interval) 
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Lower limb function (walking speed): 
Five of the nine trials had used walking speed. Available data were converted to metres 
per second for a 10in walk. Some trials used ten metre, six metre or five metre walking 
times. We excluded any measurements that were not a simple walk in a straight line - 
for example, a 3m "there and back" walk which involved a turn (See Table 5.15)(Full 
summary in Appendix VIII). 
There was no evidence that any difference in walking speeds attributable to the intensity 
of physiotherapy changed over time (P=0.51). The estimated magnitude of augmented 
compared with standard physiotherapy in walking speed was an increase of 0.056 m/s 
(95% confidence interval -0.018 to 0.130, P=0.14) in a repeated measures model that 
adjusted for age and gender. The estimated effect of augmented compared with standard 
physiotherapy on walking speed excluding subjects who never walked during the study 
was 0.07 ms- 1 (95% confidence interval -0.02 to 0.16, P=O. 12). 
Table 5.15 PINTAS IPD meta-analysis - Mean walking speed 
Study Time Standard Augmented Difference (Aug. - Std) 
(month) n Mean(SD) n Mean(SD) Mean(95% Cl) P-value 
TOTAL 0 97 0.02(0.14) 118 0.02(0.11) - - 
1 188 0.27(0.38) 215 0.33(0.44) 0.05 (-0.03,0.13) 0.23 
3 133 0.42(0.43) 157 0.50(0.56) 0.07 (-0.04,0.17) 0.23 
6 124 0.48(0.47) 143 0.59(0.54) 0.09 (-0.03,0.21) 0.13 
12 72 0.56(0.51) 89 0.69(0.62) 0.09 (-0.09,0.26) 0.32 
SD = Standard deviation, CI = Confidence interval 
162 
Chapter 5 
Subgroup analysis: For the pre-specified subgroups of age, disability severity, target of 
treatment, and baseline severity of arm impairment there was no evidence of anY 
treatment by time interactions, nor of any formally significant differences in treatment 
effect between the levels of the subgroups (see Table 5.16). The most marked degree of 
subgroup interaction (P=0.21) was with the target of therapy where the improvement in 
walking speed for leg/mixed target trials was 0.09 m/sec (0-00 to 0.18; P=0.047) 
compared with -0.02 (416 to 0.13; P=O. 8 3) for upper limb trials. 
Table 5.16 PINTAS IPD meta-analysis - Change in lower limb function (walking 
speed) 
Subgroup Level Augmented- Standard 
(95% CI) 
P-value Subgroup 
interaction 
Total All groups 0.07 (402,0.16) 0.12 
Treatment target Ann Only -0.02 (-0.16 to 0.13) 0.83 P=0.21 
Leg or Mixed 0.09 (0.00 to 0.18) 0.047 
Age <70 0.07 (405 to 0.19) 0.25 P=0.75 
>70 0.05 (-0.04 to 0.13) 0.28 
Baseline Barthel >10 0.0 1 (-0.14 to 0.16) 0.93 P=0.62 
dependency Barthel:! ý10 0.09 (-0.03 to 0.20) 0.14 
Baseline arm Moderate 0.06 (-0.07 to 0.19) 0.37 P=0.80 
impairment Severe 0.11 (402 to 0.25) 0.10 
Total treatment Lower 0.01 -0.06ý 0.08 0.80 P>0.50 
contrast Higher 0.06 (-0.07,0.18) 0.41 
Cl = Confidence interval 
It should be noted that in the comparison of leg function subgroups for target (mixed / 
lower v ann) the only trial with upper limb focus that provided data for comparison was 
Sunderland (unpublished data). Most data were available for early outcomes, i. e. 
month and 3 months outcome data, for comparison. 
Further information on walking speed is provided in the Statistical Appendix (Appendix 
Vill). 
163 
Chapter 5 
Secondary analysis - Change in disability 
Change in disability measured by Barthel index: Table 5.17 shows the mean change I 
in Barthel index score by treatment group and compares the differences in the groups 
(Full summary in Appendix VIII). The estimated constant across time effect of 
augmented in comparison to standard physiotherapy was 0.15 units of change in Barthel 
index score (95% confidence interval of -0.38 to 0.67, P=0.58). 
Table 5.17 PINTAS IPD meta-analysis - Change over baseline in Barthel index 
score: By randomised treatment group, and difference in change over baseline 
between randomised treatment groups. 
For 8 Time Standa rd Augmented Augmented - Standard* 
studies* (month) n Mean(SD) n Mean(SD) Difference P-value 
1 270 4.1(3.9) 381 4.6(4.0) 0.2(-0.4,0.8) 0.55 
3 305 5.6(4.4) 411 6.1(4.6) 0.3(-0.3,0.9) 0.40 
6 266 6.6(4.7) 355 7.2(4.8) 0.3(-0.4,1.0) 0.47 
12 
tTý 
7.9(4.1) 89 9.6(4.6)_ 1.0(-0.3,2.2) 0.12 
SD = Standard deviation 
* From a separate linear model for each time point that adjusts for study. Otherwise, for each individual 
study, from a separate linear model for each time point. 
Subgroup analyses: These are shown in Table 5.18. Significant subgroup interactions 
were seen for treatment contrast (P=0.04). 
Table 5.18 PINTAS IPD meta-analysis - Improvement in disability (Barthel 
index): subgroup analysis 
Subgroup Level Augmented-Standard 
(95% CI) 
P-value Subgroup 
interaction 
Total All groups 0.15 (-0.38,0.67) 0.58 
Treatment Ann Only 0.10 (460,0.81) 0.77 P>O. I 
target Leg or Mixed 0.67 (410,1.43) 0.086 
Age <70 -0.16 (-0.82,0.50) 0.83 P=0.26 
>70 0.62 (-0.22,1.46) 0.15 
Baseline Barthel >I 0 -0.11 (484,0.62) 0.77 P>O. 1 
dependency _ Barthel:! ý10 0.25 (440,0.91) 0.44 
Baseline arm Moderate 0.08 (-0.78,0.93) 0.86 P=0.91 
impairment Severe 0.18 (-0.61,0.97) 0.66 
Total treatment Lower 0.00 (-0.70,0.70) 0.99 P=0.04 
contrast _ Higher 1.37 (0.30,2.45) 0.01 
CI = Confidence interval 
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Secondary analysis - Length of hospital stay 
We compared the two randomised groups (augmented and standard) for the length of 
hospital stay from five trials (522 patients). Of these, data on the length of sta-Y post 
randomisation were available in 391 (75%) patients. In the 131 (25%) cases ýý'here this 
was not available, we used the total length of hospital stay, which would include a 
period from admission for acute stroke to the beginning of physiotherapy (or 
randomisation, which may be strictly speaking slightly before initiation of therapy). 
For the effect of treatment alone (in a normal linear model with study fitted as a fixed 
effect) we found that augmented physiotherapy resulted in a non-significant increase of 
1.4 days (95% CI -5.6 to 8.3, P=0.70). This result did not alter substantially in 
multivariate models that adjusted for study, gender, age, baseline stroke seventy and 
treatment target. There were no significant subgroup interactions. 
RevMan analysis, carried out at the level of the trial and stratified by the target of 
physiotherapy is shown in Figure 5.14. 
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Secondary outcome - Treatment success: 
The final analysis defined a treatment success as a subject who has a change over 
baseline Barthel index greater than or equal to the stated threshold change over baseline 
(or a subject who has achieved the maximum score on the measure). Treatment success 
was then modelled as a binary outcome in a logistic regression using study, age, gender, 
and treatment group as covariates. These logistic regressions were fitted separately for 
the 3 months data (patterns were similar at I and 6 months). 
We first focussed on treatment effects greater than the median recovery in the control 
group (increase from baseline of 6 or more Barthel units). There was an increased odds 
of an improved recovery in the augmented therapy group which did not reach statistical 
significance (odds ratio 1.33; 95% CI 0.96 - 1.85; P=0.09). 
The second analysis focussed on treatment effects greater than the upper inter-quartile 
level of the control group (increase from baseline of 9 or more Barthel units). There was 
a statistically significant increased odds of an improved recovery in the augmented 
therapy group (odds ratio 1.47; 95% CI 1.03 - 2.05; P=0.04). 
Heterogeneity of studies 
With the same trials included in the meta-analysis, we expect the I'results to be the 
same or very similar to those obtained in Chapter 4. Results are given in Table 5.19. 
The exception is length of stay which was impossible to analyse in the aggregate data 
meta-analysis. This showed 12 to be 39.1%. 
Comparing published data to IPD meta-analyses 
To examine the differences in the methods depending on whether data are gathered 
from published evidence, aggregate data or from individual patient data we carried out a 
published data meta-analysis with just the data that were available in print up to the end 
of as at December 2002 (see Table 5.19). 
Although this is an academic exercise (as clearly we knew about our own and Rodgers 
et al. 's unpublished trials) it was designed to reflect "real life" meta-analysis. The 
results are bound to be different as there will be fewer data in the published data 
analysis. However a comparison should demonstrate the difference between the 
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methods if not actually demonstrate the amount of effort involved in undertaking the 
IPD meta-analysis (Stewart & Pan-nar 1993)(Stewart & Teirney 2002). 
In carrying out this comparison I did not use independent data extraction by two authors 
but simply looked at the effect of removing those trials that were unpublished. 
168 
Chapter 5 
Table 5.19 Comparing results from meta-analyses based on published data to those 
based on individual patient data (IPD) 
Outcome Published data 
only 
individual 
patient data 
Overall 
Disability 
No. of trials 
(n patients) 
6 
n 637 
8 
n= 805 
(at 3 months) SMD 0.17 0.15 
95% Cl -0.04 to 0.38 -0.02 to 0.31 
P 0.11 0.09 
Heterogeneity 
12 (%) 
33.4 21.5 
Overall 
Impairment 
No. of trials 
(n patients) 
6 
n=535 
8 
n= 703 
(at 3 months) SMD 0.03 0.07 
95% Cl -0.19 to 0.25 -0.11 to 0.25 
P 0.78 0.48 
Heterogeneity 
12 (%) 
30.9 23.4 
Death No. of trials 
(n patients) 
7 
n= 823 
9 
n=951 
OR 0.85 0.92 
95% CI 0.37 to 1.95 0.55 to 1.52 
P 0.69 0.81 
Heterogeneity 
12 (%) 
23.9 0 
Length of stay No. of trials 
(n patients) 
2 
n= 202 
5 
n= 518 
SMD Not estimable -0.14 
95% CI -6.55 to 6.27 
P I 
Heterogeneity 
12 (%) 
39.1 
SMD = Standardised men difference, OR = odds ratio, Cl = Confidence interval 
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Interpretation of results 
We found no statistically significant differences in the patient groups receiving standard 
or augmented intensity of physiotherapy, in terms of our primary outcomes: overall 
disability or impairment or of our secondary outcomes; length of hospital stay and case 
fatality. 
There is a statistically significant difference between the groups in impairment outcome 
(as measured by the Motricity Index Arm and Leg sections) in the short terni 
months). 
It is perhaps not surprising that the improvements seen in the Barthel index are modest, 
as the scale has recognised limitations in its measurement properties. However, we were 
attracted by the ready availability of data when testing for a treatment effect. Most 
physiotherapy intervention trials have impainnent as their primary outcome but 
standardised outcome measures have not been universally adopted. 
While being wary of the problems of multiple subgroup comparisons (Counsell et al. 
1994, Mulrow & Oxman 1997) the real benefit of IPD meta-analysis is the ability to 
carry out subgroup and exploratory analyses. We have highlighted subgroups of patients 
with stroke that may benefit ftom increased intensity of treatment: 
a). Patients who might show a major decrease in disability (measured by BI). 
Those making large gains in Barthel index score over the short terin (3 months) i. e. 
making a rapid functional recovery ("good" and "excellent" recovery) may benefit from 
more intensive physiotherapy treatment. This may be due to additional physiotherapy 
treatment enhancing natural recovery in the short term. 
b). Patients who might show a decrease in impairment. 
Benefit in terms of upper and lower limb impairment (measured by the Motricity Index 
Arm and Leg sections) can be seen in those patients receiving more intensive therapy in 
the high contrast trials. There are also benefits in terrns of impairment assessed by 
change in ARAT score for younger (< 70 years) patients and those with less initial 
disability (a baseline Barthel index score > 10). 
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However the evidence from the subgroup analyses is not consistent, nor is there a 
consistent effect with targeting of therapy although for some outcomes e. g. walking 
speed there was a non statistically- significant trend indicating a targeting effect. 
What was more convincing was the pattern of higher treatment contrast trials observing 
greater effects of augmented physiotherapy. 
There were little demonstrable differences in length of hospital stay and therefore 
inpatient costs are unlikely to be significantly reduced. 
Our survival analysis did not show significant differences but at least demonstrated 
additional physiotherapy (as delivered in our selected trials) to be a reasonably safe 
intervention when used to improve patients' mobility. 
In some of the plots, outlying data from Kwakkel et al. may be explained by their ability 
to provide early intervention and maintain treatment contrast by immobilising the limbs 
of the patients in the control group. 
When considering our results we need to be able to make judgements as to whether 
benefits have clinical significance not just statistical significance. We investigated this 
by exploring the use of abridged versions of the Barthel index. Changes in scores at the 
level most collaborators might consider to be "clinically significant" did not appear to 
reach statistically significance. This analysis is made more complex by variable baseline 
scores and a measure with an acknowledged "ceiling" effect that may not be sensitive to 
the intervention. 
We can see from Table 5.20 that there is variable heterogeneity between the studies 
entered into the analyses. (Higgins et al. 2003). Using this as a guide most of our 
selected analyses would be considered to have "mild" or "moderate" heterogeneity. 
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Discussion 
By carrying out this IPD meta-analysis, using clearly defined methods, we haN'e been 
able to thoroughly explore the available data from the trials of intensity of 
physiotherapy. To do so required a considerable amount of data handling and 
interpretation in order to guide the analyses. Despite our inclusive methods the available 
data were still limited. One major limitation is that key variables may cluster at the level 
of the trial resulting in co-variance of results. 
We are also limited by not having recognized measures of co-morbidity and at present 
we would not look to convert available data into a recognized co-morbidity score. Age 
could be used as a proxy measure along with any available data on pre-stroke disability 
or handicap e. g. Pre-stroke Rankin score - though few trials had these data or excluded 
patients with previous disability. 
By perforining published and individual patient data meta-analyses we were able to 
compare the results obtained by both methods. At this point there was little difference in 
any conclusion one might draw from the results from the main outcome measures. The 
accuracy of the estimate has improved with smaller P values and narrower confidence 
intervals but this may partly reflect the additional number of studies available for the 
fPD meta-analysis. However, the main benefit of the rPD method in our case is that it 
allows the exploration of the subgroups. Without this we would not have the results that 
indicate there may be particular benefit to certain groups of patients with stroke. We 
should however remain cautious of generalizing from results based on exploratory 
analyses of secondary outcomes (Counsell et al. 1994). 
Trials in the future in this area should carefully select their outcome measures especially 
those sensitive to impairment. This may help to accurately target those groups we 
identified as benefiting from increased treatment, and allow further pooling of data in 
meta-analysis. 
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Conclusions 
Bearing in mind our initial hypotheses, a number of conclusions can be drawn: 
1) We found no statistically significant impact of augmented physiotherapy on our 
primary outcome of disability. 
2) We did not identify any consistent effect with targeting of therapy although for 
some outcomes (e. g. walking speed) there was a trend indicating a targeWig 
effect. 
3) There was no consistent evidence that any subgroup of patients would gain a 
greater or lesser benefit from augmented physiotherapy. 
4) There were no significant differences in length of stay or case fatality. 
Additionally, 
5) For those trials that recorded the Motricity Index, there was a statistically 
significant improvement in impain-nent (both in the Arm and Leg scores). 
6) There was a consistent pattern of higher treatment contrast trials observing 
greater effects of augmented physiotherapy. 
7) Our IPD estimate improved on information that was available had we only relied 
on published data up to the end of 2002. 
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Summary 
* We set out to carry out an EPD meta-analys's and set up a collaborative group of 
primary authors. 
* We searched the literature as before, obtaining data from the authors. These 
were entered into a combined database and the analysis strategy and questions 
were discussed and agreed at the Collaborators meeting. 
With availability of data in mind, we selected overall disability as our primary 
outcome and overall impairment, death and length of stay as secondary 
outcomes. We had the opportunity to explore the subgroups of patients derived 
from our original questions. 
* No statistically significant difference was seen between the augmented and 
standard groups, in overall disability as measured by ADL scale, length of stay 
or case fatality. 
* There was a lack of consistency between the results obtained from different 
outcome measures used in the subgroup analyses. 
0 Generally, effects were most notable in those trials that started early and 
featured a high contrast between the groups. Effects were more marked in the 
short-ten-n than the long-tenn. 
9 There was only mild heterogeneity between the included trials for most of the 
analyses. 
0 Comparing the type of meta-analysis highlighted some benefits of undertaking 
the lPD meta-analysis. 
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CHAPTER 6 
CONCLUSION 
Introduction 
In this chapter I look back on the components of the thesis and return to my original 
hypothesis. I have attempted to address this using a van nncy the iety of methods, explo *0 
benefits and limitations of each, before progressing to the next method. The results at 
each stage have helped to build up infon-nation on the intensity of physiotherapy after 
stroke. 
Aims 
In this chapter I aim to: 
1). Reflect on the available results in relation to my original research questions. 
2). Consider the lessons learned from carrying out the work. 
3). Identify areas for development in the future. 
4). Make recommendations. 
1) The results 
I put forward the hypothesis that intensive physiotherapy after stroke will produce 
benefits that would: 
a). speed recovery in terms of impairment and disability. 
Neither the GAPS study randomised controlled trial nor the PINTAS IPD meta-analysis 
identified statistically significant benefits in terins of overall disability (see Figure 5.3, 
page 143), overall impairment (see Figure 5.13, page 153), death (see Table 5.8, page 
154) or length of hospital stay (see Figure 5.14, page 166) with increased intensity of 
physiotherapy. Perhaps the disability and death results are to be expected, given that 
physiotherapy may not always be directed at reducing disability or preventing death. 
The Barthel index was widely used, but may not be sensitive to physiotherapy 
intervention. Even if the intervention was shown to be effective, the scale of the 
improvement looks likely to be, at best, modest. Although this may be of some 
significance to individual patients, the "clinically relevance" remains unclear. 
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Impairment on the other hand, is often the focus of physiotherapy treatment, ýýet takell 
overall, we could not show clear benefit with increased intensity. This may reflect the 
ability of the available outcome measures to detect modest treatment effects. 
When we studied subgroups in our meta-analysis, patients receiving more intensiVc 
treatment in the high contrast trials showed greater improvements in upper and lower 
limb impairment when it was measured by the Motricity index. Younger patients NN"llo 
were less disabled at baseline also demonstrated greater improvements in upper limb 
impairment when measured on the ARAT. Increased intensity may also assist rapid 
recovery in the subgroup of patients making large improvements in their ADL scores 
(>9 points on the BI). There was however, a lack of consistent benefit across the 
subgroup analyses. 
b). are greater when targeted (e. g. on upper limb recovery). 
Similarly, there was a lack of consistency in the effects of targeting augmented 
physiotherapy. The trend is positive (but not statistically significant) for some areas 
such as walking, but is not clear for the others. 
c). are greaterfor patients with moderate impairment and little co-morbidity. 
In our subgroup analyses there were no statistically significant subgroup interactions for 
those patients considered to have moderate baseline arm impairment (categorized by 
Motricity index (Ann) or ARAT). 
There is a lack of accepted measures of co-morbidity that are routinely collected and 
obtaining accurate data about pre-morbid states can be difficult. Consequently, we were 
unable to carry out analyses based on co-morbidity. 
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d). are greater in the shorter (3 months) than longer term (6 - 12 months). 
In our selected trials, long-terrn follow up is the exception, with Just two of our studies 
following patients to 12 months. Available data for these analyses Nk'ere therefore 
limited. Differences in impairment between groups, though still in favour of the 
augmented group, appeared to diminish over time and lost any statistical significance. 
Although some acute intervention studies of stroke have followed-up subjects for up to 
ten years after intervention (Indredavik et al. 1999), they require sizable treatment 
effects for them to be worthwhile. The longer-term effects (> 12 months) of acute 
physiotherapy interventions remain unclear. 
e). result in a reduced duration of inpatient rehabilitation. 
Although the GAPS study showed a non-significant reduction In length of hospital stay, 
and Slade et al. (Slade et al. 2002) found a reduction in hospital stay, overall there was 
little sign of benefit. Consequently, there was no consistent evidence of economic 
benefits arising from shorter admissions. 
The overall direction of benefit with increased intensity fits with the picture developing 
from other studies: the late intervention studies (e. g. Duncan et al. 2003, Green et al. 
2004); suggestions of benefit from repeated practice of functional tasks in the motor 
relearning programme (Langhammer & Stanghelle 2000) and possible benefits with 
constraint-induced therapy (forced use) (Taub et al. 2002). Benefit was also seen in a 
recent published-data meta-analysis of "exercise therapy" i. e. physiotherapy and 
occupational therapy (Kwakkel et al. 2004). This meta-analysis, with broad inclusion 
criteria (including most of the trials in our meta-analysis), demonstrated benefit overall 
and suggested greater benefit in trials with at least 16 hours of contrast between groups. 
Whilst our results show promise for selected subgroups of patients with stroke, the 
results cannot yet be generalized. 
There may be a critical threshold above which we start to see benefit - this is suggested 
by the subgroups with greater contrast showing greater benefit. This may be relevant to 
any "some versus none" trials. Although the contrast may be high, the trial may not be 
able to demonstrate benefit as the intervention group may not reach a threshold of 
treatment effect. 
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heterogeneity of our studies 
Some authors recommend routinely carrying out sensitivity analysis and creating a I funnel plot when undertaking meta-analyses (Egger & Davey Smith 1998). We dId not 
do this as the number of trials was small and we found only mild and moderate 
heterogeneity when considering most of our outcomes. 
2) Lessons from our randomised controlled trial 
To sustain a robust and complex trial with sound methodology over three sites f-61- a 
period of 18 months, with limited resources, required considerable effort aiid 
enthusiasm from the research group and the staff members involved. 
Despite having carried out feasibility studies, our recruitment rate was lower than 
anticipated. To try to address this we extended the period of the trial as much as funding 
allowed. Though we would have liked to extend the recruitment further it seemed 
unlikely that this would alter our sample size significantly. Although attempting to run 
the trial over a larger number of centres with more staff members might have allowed 
more rapid recruitment, this would have been costly and more complex to organize and 
sustain. The lesson is that recruitment rates do not always reach the levels expected or 
required, despite best efforts. 
Recognising that our one trial would be unlikely to influence clinical decision-making 
or to be generalized to the majority of patients, we gathered a broad range of data from 
our subjects. Planning in this way allowed us the opportunity to examine a large number 
of outcomes in the meta-analysis. 
Lessons from Meta-analysis 
Size 
Our meta-analyses had limitations in terms of the numbers of subjects, number of trials 
and the size of the subgroups, along with heterogeneous Outcome measures and 
interventions. Clearly we would have preferred to have a larger number of subjects from 
more homogeneous trials. 
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The needfor collaboration 
With the EPD meta-analysis we were fortunate to secure the co-operation of all of the 
trialists. This strengthened the data set and allowed the group to be involved in the 
interpretation, dissemination and publication of results and planning of further studies. 
Our collaborative group's formal meeting helped to focus our analysis and agree the 
limitations of the data. Unfortunately, we did not budget for holding a second meeting. 
This might have been a useful forum in which to discuss the interpretation and 
dissemination of the results, the future of the group and further work. It may have also 
been useful in helping to keep the project running to timetable. 
Managing the data was a challenge, requiring considerable communication and 
interpretation of the data, as IPD was a new venture for most of the collaborative group 
members. As noted by Stewart and Clarke (Stewart & Clarke 1995), it is important not 
to underestimate the length of time required for EPD meta-analysis. Our project was 
time-consuming and may have benefited from the availability of full-time dedicated 
staff members for data management in order to maintain consistency and momentum. 
Such resources are, of course, expensive. 
Treatment contrast 
We want to direct future research to target specific groups, with as much treatment 
contrast as possible. Yet, there are definite challenges in delivering and maintaining a 
strict treatment protocol in a clinical setting. In the trial by Rodgers et al. "competitive 
therapy" bias was encountered (Rodgers et al. 2003). Therapists involved in delivering 
treatment to their control group provided additional therapy as "compensation" to those 
patients allocated to receive standard amounts of treatment. Unfortunately this resulted 
in a significantly reduced treatment contrast ratio. The ability to maintain this contrast 
may be the reason we saw such an outstanding treatment effect in the trial of Kwakkel 
et al. that featured both early intervention and the maintenance of a high treatment 
contrast with the use of splints to immobilize the control group (Kwakkel et al. 1999). 
179 
Chapter 6 
Importance ofpre-determined analysis plan 
It was important to have a clearly deten-nined and recorded analysis plan at the start of 
each phase and prior to the analysis. This reduces the risk of significant results beirig 
discovered by chance and helps to keep the focus of the question during, often complex, 
analyses. While it is tempting to perform further analyses in the light of available 
results, these should be regarded as exploratory and treated with caution. 
Limitations of available data 
One advantage of IPD meta-analysis is the potential to perform "time to event" 
analyses. The difficulty we encountered was the lack of consistent outcome gathering 
across the trials e. g. we could have selected the Mobility Milestones, discharge from 
hospital, first recorded ability to perform 10-metre walk. This made selecting outcomes 
difficult and the number of missing data considerable. 
Similarly, we would have liked to carry out a "dose response" analysis, however the 
data were so limited that this proved impossible. This highlighted the lack of standard 
methods of describing and recording physiotherapy interventions in trials. This sort of 
level of detail, if available, is not often published and trialists need to be contacted to 
obtain information. 
Ultimately, the quality of the data will be reflected in the analysis, results and 
conclusions. 
The real benefit of IPD meta-analysis 
Having carried out an IIPD meta-analysis, we wanted to assess whether it was worth the 
considerable additional resources (Stewart & Parmar 1993). We compared results from 
the different methods on our selected outcomes. Whilst this showed some benefit in 
terms of the accuracy of the estimates, the obvious point is that without carrying out the 
IPD meta-analysis, none of the subgroup analyses would be possible with just published 
data. Our conclusions are likely to have been the same or similar, but the real benefit 
was the ability to explore and examine these subgroups. 
180 
Chapter 6 
3) Identifying areas for development in the future 
Maintaining the database 
Although a definitive large-scale multi-centre RCT of intensity might be possible, It 
seems unlikely to happen in the near future. We will therefore consider maintaining the 
database and updating it on a regular basis. This may be useful, but it is important not to 
underestimate the complexity of the data management and analysis 
Stewart and Tierney describe EPD as having a number of benefits but also raise the issue 
of "price tags" on data sets and possible difficulties of sharing data due to data 
protection legislation (Stewart & Tierney 2002). These were not a problem for our 
group but could alter the direction and possibilities offered by this method. 
Recent publications 
We repeated our literature search up to the start of May 2005 but failed to find trials that 
fit our inclusion criteria or look to significantly alter our results. We are not aware of 
any current large-scale randomized trials of physiotherapy intensity after stroke. 
Of the trials that have been published, one small study (n = 30), using additional 
physiotherapy sessions delivered to inpatients in a circuit class fonnat, showed variable 
results dependent on the focus of the intervention (Blennerhassett & Dite 2004). While 
preliminary results from another small study (n = 22) in acute stroke patients (Kreisel et 
al. 2005) suggest similar results to our meta-analysis with modest non-statistically 
significant improvements in motor scores when measured by the Motricity index. 
In a larger, Chinese trial with 156 participants, Fang et al. set out to carry out a RCT but 
their comparison has a number of difficulties (Fang et al. 2003). Their control group 
appears to receive no therapy, which though it increases their treatment contrast, may be 
unusual for many acute stroke patients in Western countries. In addition, their 
intervention group lost large numbers of subjects to follow up. This reflects that these 
trials are not easy to deliver, though with a highly-selected group and high loss to 
follow up (36% of intervention group lost at 3 months and 85% lost at 6 months) their 
results are difficult to analyse and generalize. 
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Other trials may not necessarily have been focused on intensity of physiotherapy e. g. 
Martinsson et al. (Martinsson et al. 2003), investigating the combination of intensive 
physiotherapy and amphetamine in severely disabled patients. 
Further data extraction 
Until further relevant trials are available we could attempt to maximise the use of 
existing data by using missing data techniques (such as multiple imputation or last 
observation carry forward) to explore the robustness of the findings to missing data. We 
could also consider converting data from the trials by Partridge et al. and Miller et al. to 
obtain estimated Barthel index scores. 
Developing standard methods of describing and defining physiotherapy interventions in 
trials 
We could investigate the properties of the record of physiotherapy input (Appendix 1) 
used in the GAPS study. At the start of the study there did not appear to be recognised 
measures of physiotherapy input available. Though we gathered considerable detail of 
treatment, we utilised only a small component of this (the amount of time spent by the 
therapist). It would be useful to establish the reliability and validity of this method of 
data collection. If it proved to be a valid measure it might be useful in studies examining 
content of treatment as well as dosage. 
Tyson and Selley have recently developed an intervention recording tool for use with 
stroke (Tyson & Selley 2004) and further work is expected from an international 
comparison of physiotherapy practice in stroke rehabilitation (CERISE 2005). 
Meanwhile a study in Sweden has looked at the characteristics of physiotherapy 
intervention from both therapists' and patients' perspectives (Wottnch et al. 2004). 
Exploring predictors of recovery 
We could further explore the data by examining predictors of recovery and exploring 
the features of patients who make a very good or very poor recovery. Having the IPD 
database puts us in a good position to carry out what can be a complex analysis 
(Thompson & Higgins 2005). However, we must be cautious of carrying out multiple 
subgroup analyses (Counsell et al. 1994) and recognise that numbers of available data 
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are likely to be small. These exploratory analyses, though likely to have limited 
conclusions, might be useful in generating new hypotheses. 
Disseminating our recommendations 
Our results have been made available to a wide audience (see Appendix IX) and furtlier 
dissemination is planned through presentations and publication in a variety of media. 
The PINTAS Collaborative group could consider registering the meta-analysis as a 
Cochrane Review in order to help disseminate our findings and stimulate continued 
interest in this area of stroke rehabilitation. 
Future research 
In the larger research context, in order to obtain a better understanding of the "black 
box" of rehabilitation, we may have to adopt several different strategies in order to 
describe and test what is happening e. g. Campbell et al. 's framework for complex 
interventions (Campbell et al. 2000). 
Optimum delivery of treatment 
While none of the trials in our analyses reported serious adverse events attributable to 
the intervention or raised concerns about safety, one of the reasons treatment contrast 
cannot be maintained is poor tolerance of the intervention. We should consider methods 
of optimal delivery of interventions. 
We have just looked at intensity, but other treatment factors should be considered such 
as: the method in which the additional therapy is delivered e. g. by one longer treatment 
session or a number of shorter sessions; the timing of the intervention e. g. the early 
intervention trials appear to demonstrate benefits but timing could be further explored, 
along with the content of intervention (Page 2003)(Van Peppen et al. 2004). 
Such studies might be aided by the development of technical equipment. For example 
the activity monitor used in the GAPS study continues to be developed and may help to 
provide objective outcome data. 
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General v specific questions 
We need to maintain a balance between questions addressing "tbe big picture" of 
rehabilitation and small specific questions. 
Although a recent, published-data meta-analys's (Kwakkel et al. 2004) reported a 
positive treatment effect with increased "exercise therapy" we believe our trial selection 
was more specific and representative of "physiotherapy" intervention. Although our 
meta-analysis is smaller it allows us to be more specific when defining the intervention 
and generalising our results. Other rehabilitation interventions, e. g. occupational 
therapy, face similar difficulties, with a diverse gToup of patients and heterogeneous 
interventions that are poorly defined and understood. However, pooling studies across 
the interventions may limit the extent to which specific questions can be addressed. 
There may be less incentive to examine physiotherapy intensity in terms of length of 
hospital stay with co-ordinated early supported discharge (ESD) services proven to be 
an effective intervention (Langhorne et al. 2005). However, all of the trials included in 
this EPD meta-analysis of ESD, featured physiotherapy, and it is still worth investigating 
the effective components of ESD. 
In other chronic diseases e. g. head injury, researchers are attempting to tackle the 
intensity question and are likely to come across similar difficulties and challenges to 
those mentioned in Chapter 2 (Shell et al. 2001). Slade et al. had carried out a trial with 
a mixed patient group, though we only included data from stroke patients. Although this 
method may reflect service delivery in some rehabilitation settings it is obviously less 
specific and results may be difficult to generalize. 
Despite our focus being intervention delivered by a physiotherapist, it may be activity 
(regardless of how it is delivered), that is the beneficial factor that should be 
investigated. Current and future levels of patient contact with physiotherapists are likely 
to be limited. Therefore, there has been recent interest in early mobilization trials that 
involve interventions with a rehabilitation approach that encourages activity and 
repeated practise of mobility, whether delivered by physiotherapists or others (Berhardt 
et al., Kwakkel et al. - personal communication). Such broad treatment approaches rnaý' 
be complex to investigate as increasing the number of components of the intervention 
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may lead to contamination. Consequently, strict monitoring and large numbers of 
subjects are likely to be required. 
4) Recommendations 
Finally, I want to make some recommendations based on the work in the thesis: 
The results of our investigations should not lead to a change in clinical practice or 
service delivery, though our findings support a general pattern in results towards benefit 
to patients with stroke with increased physiotherapy input. 
The main impact of the work is likely to be in infon-ning future research in this area. 
Recommendations could be made to encourage researchers to use a core standard of 
methods and outcomes that would facilitate further meta-analyses. 
Although we must be cautious when interpreting results based on subgroup analyses of 
secondary outcomes, there are several recommendations that can be made: 
a) Future trials should carefully select their outcome measures to reflect the alms of 
physiotherapy. 
b) The greatest impact is likely to be at the level of impainnent. 
c) The greatest impact is likely to be seen at higher treatment contrasts (more than 
15 hours difference between groups). 
d) There may be value in targeting some aspects of therapy (e. g. lower limb focus 
to improve walking speed) but our data are inconclusive. 
We would encourage registration of new trials in trials registers to allow access to data 
and inclusion in collaborative efforts (Egger & Davey Smith 1998). 
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Conclusion 
In conclusion, I consider I have addressed my research questions as completely as 
possible. Using sound methods, the analyses have provided some answers and raised a 
number of issues around the methods and available data. 
The GAPS study, though inconclusive, had many methodological strengths. It was a 
logical progression to pool the data we obtained with the other studies in order to pursue 
our questions. This also provided the opportunity to examine the benefits of the 
different methods of meta-analysis. 
There appears to be justification in considering IPD meta-analysis as the "gold 
standard" as it maximizes the use of available data. However, although WD meta- 
analysis is a strong method, it will not compensate for poor quality data or lack of data. 
We have produced useful results and recommendations that will contribute to the design 
of physiotherapy research in the future and been able to direct further work based on the 
project. Considered in these terms, the project has been a success, tackling a complex 
issue and providing information to further this area of rehabilitation research. 
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Summary 
I return to the questions in my hypothesis to consider to what extent they have 
been addressed by the results from the RCT and FPD meta-analysis. 
Our results should not lead to changes in clinical practice or service deliverY. 
However, they provide estimates of the modest treatment effect likely in t1le 
domains we examined. Modest increases in the intensity of physiotlicrapy after 
stroke did not produce substantial changes in any of the primary outcomes in my 
hypothesis. 
* Targeted additional therapy in selected patients may lead to some improvement 
in limb impairment and walking speed. Treatment effects were greater in those 
trials with higher treatment contrast (> 15 hours) that started intervention at an 
earlier stage after stroke. 
91 discuss issues arising from the randomised controlled trial and the meta- 
analyses 
9 Individual patient data meta-analyses, maximize the use of available data and 
provide the opportunity to explore subgroups in order to address clinically 
relevant questions and guide further research. 
9 Large numbers of subjects are required for randomised controlled trials (RCTs) 
of intensity of physiotherapy. I make recommendations to those designing such 
trials to use higher treatment contrasts in order to detect modest treatment effects 
and similar outcome measures in order to facilitate future meta-analysis. 
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Appendix I 
APPENDIX I 
GAPS studyg Physiotherapy input data collection form 
GAPS Study 
Description of Physiotherapy 
Version 1.0 
Random No Initials Date of Session 
ET= [I]/[: = D0MMyY. 
NB RETURN ONE FORM FOR EACH INTERVENTION 
A- PATIENrS NAME 
B. WHICH PHYSIOTHERAPY SESSION OF THE DAY? (I=lst, 2=2nd, etc. ) 
[J 
C. TREATMENT ALLOCATION Standard nl Augmented f 2] 
D. AMOUNT OF PHYSIOTHERAPY TIME THIS SESSION (minutes) 
Tj-ý 
mins 1. Total indirect contact time 
r- 
2. Total direct contact time mins 
3. Combined physiotherapy time mins 
E. TOTAL TIME SPENT ON (minutes) 
1. Gait re-education 
2. Upper limb re-education 
3. Discussion / Explanation / Reassurance 
4. Postural set (minutes) 
5. Focus of Treatment (Yes/No) 
Circle as appropriate 
Initial assessment 
Tone 
Posture 
Balance 
UIL function 
LIL function 
Transfers 
Other 
F. TREATMENTS USED 
1. Which of the follovving were used? 
(a) Trunk mobilisations * 
(b) Wheelchair education/use 
(c) Splints for the upper limb 
(d) Splints for the lower limb 
(e) Education (pabent, relatives, staff) 
mins 
mins 
mins 
Lying Side Lying Sifting Standing Other 
Yes 
E] 
13 
No 
F? ] 
Yes 
E] 
1. 
No 
[j] 
Yes 
5] 
No 
[j] 
Yes 
[j] 
No 
[j] 
Yes 
[j] 
No 
[2] 
El El El F91 El EO El El El E0 
El El El El El Eil F-1 El ' El Eil 
El 1ý E F21 E] E] ] E2 E [A 
Ell El El El El El El El El 1ý 
rjý E] Ej E] El ] 
F21 El 51 
51 Q [E Q Eil [A FT, [A 
' 
E Q 
' El 1ý El [ý E Eý El El El EO 
Yes F-11 No F21 
Yes f 1ý No r12 
Yes F-11 NoF21 
Yes FI] NoF2j 
YesFl-] No [jý 
201 
Appendix I 
GAPS Study 
Description of Physiotherapy continued... 
Version 1.0 
Random No Initials Date of Session 
1 EIIý =-I: Y= 
G. PHYSIOTHERAPIST DETAILS 
1. Who completed this form? 
2. Lead Physiotherapist 
3. Number of physiotherapists involved 
H. TYPE OF PHYSIOTHERAPISTS INVOLVED 
1. Lead therapist 
2. Seniortherapist 
3. Junior grade therapist 
4. Assistant therapist 
5. Student therapist 
ri 
Yes 1-11 NoF21 
y 
Yes F-11 NoF-21 
Yes 1-11 No [21 
YesFl] NoF2] 
1. 
Yes F-l1No [21 
1. COMMENTS 
1. Any comments/problems/complir-atons? 
For Office Use Only 
Signature: 
Date: 
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APPENDIX 11 
GAPS study, Outcome assessment forms (example of 3 month form) 
GAPS Study 
Resource Use Since Hospital Discharge 
Draft 01 
3 Month Assessment, Page 
Random No Initials Assessor Code Date of Visit 
A. PLACE OF RESIDENCE 
Private address alone rq 
Private address not alone 
Sheltered housing 
Residential care 41 F 
Nursing home 
Other 
If Other, specify 
B. AIDS AND APPLIANCES 
1. Are any aids or appliances 
required? YesFIj No F9--I Lýj 
If Yes, specify which 
(a) Standing/walking support 
Zimmer frame Yes F11 No M 
Rollator YesF1] NoF21 
Tripod/quad stick Yes ni No M 
Delta frame Yes P1 No M 
Two sticks Yes 
0 No 
Crutches Yes n1 No ff] 
One stick Yes n1 No 
Other Yes F1] No F21 
If Other, specify 
(b) Splints/Slings 
AFO Yes E No 
Knee splint Yes 
n1 No [21 
I 
Hand splint Yes 
n1 NoF21 
Shoulder Sling YesF-11 No F4 
Other Yes n1 NoF21 
If Other, specifY .7 
(c) Adaptive equipment and alterations 
to property? YesF11 No 
If Yes, specify which 
Bathing aids Yes 1-11 No Ifl 
Kitchen aids YesF'] No 
Grab rails YesF1] No 
Kitchen trolley Yes No 
Stair rail Yes No 
Stair lift YesF1] No 
Other Yes n1 No [fl 
ff Other, specify 
(d) Wheelchair, or waifing for a 
wheelchair'? YesF11 No M 
(i) ff Yes, specify 
For outdoor use only F1 I 
Sometimes use indoors Ifl 
Always use/unable to walk Ifl 
(ii) Type of wheelchair 
Electric 
Aftendant propelled 
Self-propelled 
C. CARER INFORMATION 
1. Has anyone had to stop work to look 
after the patient? YesFqNo 
If Yes, what job did they do? 
Signature: 
Date: 
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GAPS Study 
Resource Use Since Hospital Discharge 
Draft 01 
3 Month Assessment, Page 2 
Random No Initials Assessor Code Date of Visit 
FT-1 
A. SERVICES 
Once 2 times >2 times 
No or twice Weekly per week per wee$ 
(a) Home help M F4] Fq 
(b) District nursing F3] M Fq 
(c) Day hospital n4 [q 
(d) Outpatient 
physiotherapy F31 n4 rq 
(e) Outpatient 
occupational 
therapy M Efl F41 [9 
(0 Outpatient S&LT[fl n4 
(g) Physiotherapy 
home visit [fl M F31 F41 Fq 
(h) Occupational 
therapy home 
visit 
F4] RI 
(i) Social work F31 M Fq 
0) Health visitor F2] (N [ý] Fq 
(k) GP F4] [fl 
(1) Stroke Clinic El M [N M M 
(m) Day Centre EI M M M rq 
(n) Meals on wheels n4 
rq 
(o) Living with a 
stroke/Disability 
resource centre 
(p) Other Fq [1] f-41 M 
specify 
Signature: 
Date. 
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GAPS Study 
Adverse outcomes 
Draft 01 
Random No Initials Assessor Code Date of Visit 
EFT71 11111 M 
MwDDMMyY. 
A. FALLS 
1. Since discharge from hospital, has 
the patient suffered any falls? Yes 0 No 
If Yes, give details 
Fall Severity Code Date of Fall 
(a) 1-1 
D0MMyY. 
(b) 11 ME= DDMMyY. 
(c) F-I EL]4--IEVEI[--] DDMM. y-Y, 
(d) 1: 1== 
DDMMyY, 
(e) C=Y 
Y. DDMM 
Fall Severity Code Box 
No injury Ffl 
Minor injury Pi 
Major injury Ifl- 
Signature: 
3 Month Assessment, Page 3 
B. OTHER PROBLEMS/ILLNESSES 
Any other problems or illnesses 
since hospital discharge? Yes n1 No 
If Yes, give details Event 
Description Code Date of Event 
205 
DDmmyY. 
mmyY. 
DDmmyY. 
EI: Xl= DDmmyY. 
DD AA MyY. 
ED Er-14--EVI= 
0DmmyY. m E: ix= 
DDmmyY. 
M EEM: = DDmmyY. 
DVT 1 
PTE 
UTI 
Chest infection 
Other infecton 
Fracture 
Depression 
Anxiety 
Confusion 
Pressure sore 
Painful shoulder 
Other pain [q2 
Recurrence/extension 
of stroke 
Other pain 
Date: 
Appendix 11 
UAPS Study 3 Month Assessment, Page 4 
Current Disability: Rankin Scale, Mobility and Barthel Index 
Draft 01 
Random No Initials Assessor Code Date of Visit 
[T= 
A. CURRENT RANKIN OXFORD HANDICAP SCALE 
1. 'Rankin'Oxford Handicap Scale 
Well, no symptoms 
Minor symptoms affecting lifestyle 
Minor handicap but independent in self care 
Moderate handicap, needing a little help with ADL 
Needing a lot of help with ADL El 
Needing constant attention day and night 
B. POST-STROKE MOBILITY 
Able to walk 200m outside m 
Able to walk indoors 
Unable to without help 
C. BARTHEL INDEX 
1. Bowels 
Incontinent or needs to be given enema 
Occasional accident (once a week) 
Continent 
2. Bladder 
Incontinent or catheterised and unable to 
manage alone 
Occasional accident (maximum once per week) F1 I 
Continent 
6. Transfer (bed to chair and back) 
Unable, no sitting balance 1fl 
Major help (one or two people, physical), can sit m 
Minor help (verbal or physical) Efl 
Independent FI-2-1 
Lfi 
7. Mobility 
Immobile Iq 
Wheelchair independent including comers FI 
Walks with help of one person (verbal or physical) M 
Independent (but may use any aid, eg. stick) 
8. Dressing 
Dependent Fq 
Needs help but can do about half unaided 
Independent (including buttons, zips, laces, etc) 
9. Stairs 
Unable 
Needs help (verbal, physical, carrying aid) 
Independent 
10. Bathing 
Dependent 
Independent (or in shower) 
3. Grooming 
Needs help with personal care 
Indepenclant face/hairtteeth/shaving (implements 
provided) 
4. Toilet use 
Dependent Ffl 
Needs some help, but can do something alone 
Independent (on and off, dressing and wiping) 
TOTAL SCORE 
S. Feeding 
Unable Fq 
Needs help cuffing, spreading butter, etc. 
m 
Independent f-21 
Signature: 
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GAPS Study 3 Month Assessment, Page 5 
Current Disability: Rivermead Mobility Index 
Draft 01 
Random No Initials Assessor Code Date of Visit 
FQ 1134 = ;: Q 
- . 
A. RIVERMEAD MOBILITY INDEX 9. Walking outside (even ground) 
Instructions Do you walk around outside, on 
The patient is asked the following 15 questions, and pavements without help? Yes P1 No 
observed (for item 5). A score of I is given for each 
)(es'answer. 10. Walking inside, with no aid 
Do you walk 10 metres inside with 
1. Turning over in bed no caliper, splint, or aid, and no 
Do you turn over from your back to standby 
help? Yes 19 No 
your side without help? Yes M No ff] 11. Picking off floor 
2. Lying to sifting If you drop something on the floor, 
From lying in bed, do you get up to 
sit on the edge of bed on your own? YesFq No ffl 
do you manage to walk 5 metres, 
pick it up and then walk back? Yes 1fl No 
3. Sitting balance 12. Walking outside (uneven ground) 
Do you sit on the edge of the bed Do you walk over uneven ground 
without holding on for 10 seconds? Yes M No [fl (grass, gravel, dirt, snow, ice, etc. ) 
without help? Yes P1 No 
4. Sitting to standing 
Do you stand up (from any chair) in 
13. Bathing 
less than 15 seconds, and stand Do you get in/out of bath or shower 
there for 15 seconds (using hands, unsupervised and wash self? Yes E] No M 
and with an aid if necessary)? Yes [i] No Ffl 
14. Up and down four steps 
5. Standing unsupported 
Do you manage to go up and down 
Observe standing for 10 seconds 
without any aid. Yes 
M No 
four steps with no rail, but using an 
aid if necessary? Yes El NoF01 
6. Transfer 15. Running 
Do you manage to move from bed 
to chair and back without any help? Yes No 
Do you run 10 metres; without 
f t lk as wa limping in four seconds ( 
7. Walking inside, with an aid if needed 
is acceptable)? YesrqNo 
Do you walk 10 metres, with an aid 
if necessary, but with no standby 
help? Yes No 
8. Stairs 
Do you manage a flight of stairs 
? Yes ith t hel No w ou p 
Signature: Date: 
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GAPS Study 
Current Disability Motricity Index 
3 Month Assessment, Page 6 
Draft 01 
Random No Initials Assessor Code Date of Visit 
ITTTI 
A. MOTRICITY INDEX 
(i) Tests 
ARM 
1. Pinch grip; 2.5crn cube between thumb 
and forefinger 
No movement 
Beginnings of prehension (any movement of 
finger or thumb) 
Grips cube, but unable to hold against gravity 
Grips cube, held against gravity, but not against 
weak pull 
Grips cube against pull, but weaker than other 
side 
Normal pinch grip 
Fol 
fli 
F q- 
P21 
P-61 
m 
2. Elbow flexion; from 90 degrees, voluntary 
contraction/movement 
No movement 161 
Palpable contraction in muscle, but no movement 
Movement seen, but not full range/not against 
gravity fq4 
Movement; full range against gravity, not against 
resistance IN 
Movement against resistance, but weaker than 
other side 2q P 
Normal power fl3 
3. Shoulder abduction; from against chest 
No movement 10-1 
Palpable contraction in muscle, but no movement ffl 
Movement seen, but not full range/not against 
gravity fl-41 
Movement full range against gravity, not against 
resistance nig 
Movement against resistance, but weaker than 
other side ff5] 
Normalpower [ýJ] 
LEG 
4. Ankle dorsiflexion; from plantar flexed position 
No movement M 
Palpable contraction in muscle, but no movement f 9-1 
Movement seen, but not full range/not against 
gravity 
Movement; full range against gravity, not against 
resistance 
Movement against resistance, but weaker than 
other side 
Normal power F', -13 1 11"I 
S. Knee extension; from 90 degrees, voluntary 
contraction/movement 
No movement FbI 
Palpable contraction in muscle, but no movement LII 
Movement seen, but not full range/not against 
gravity r4 
Movement; full range against gravity, not against 
resistance M19 
Movement against resistance, but weaker than 
other side P5 
Normal power M33 
6. Hip flexion; usually from 90 degrees 
No movement MO 
Palpable contraction in muscle, but no movement 
Fo-I 
I,, 
Movement seen. but not full range/not against 
gravity F4] 
Movement full range against gravity, not against 
resistance ri -al 1 -1 
Movement against resistance, but weaker than 
other side 
F251 
Normalpower [R3] 
Signature: 
Date: 
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GAPS Study 3 Month Assessment, Page 7 
Trunk Control Test, Walking Test, Mobility Milestones & Functional Reach 
Draft 01 
Random No Initials Assessor Code Date of Visit 
ETTT-1 
DDMMyY. 
A. TRUNK CONTROL TEST B. MOBILITY MILESTONES 
(i) Tests 
1. Independent standing balance Yes No 1. Rolling to weak side 
Unable to do on own [01 
L__j 
2. Able to walk 10 paces Yes No 
Able to do, but only with non-muscular help-for 3. Able to walk 10 metres Yes No 
example, pulling on bed clothes, using arms to 
steady self when sifting, pulling up on rope or 
monkey pole, etc. F2] C. FUNCTIONAL REACH 
Able to complete normally 
1. Able to perform functional reach? Yes No 
2. Rolling to strong side If Yes, specify 0 cm Unable to do on own 
Able to do, but only with non-muscular help-for 
example, pulling on bed clothes, using arms to 
D. RMI-confirmation of question 5. 
steady self when sitting, pulling up on rope or Standinq unsupported 
monkey pole, etc. 1. Can the patient stand unsupported 
Able to complete normally 1ý51 for 10 seconds without any aid? 
(Observe) YesP] No 1fl 
3. Sitting up from lying down 
Unable to do on own E. TIMED 10 METRE WALKING TEST 
Able to do, but only with non-muscular help-for 1. Was the patient able to perform the 
example, pulling on bed clothes, using arms to test? Yes No rfl 
steady self when siding, pulling up on rope or 
monkey pole, etc. If Yes, specify the time in seconds secs 
Able to complete normally P51 
2. Aid used 
4. Balance in sitting position (on side of bed) None 
Unable to do on own One stick 
Able to do, but only with non-muscular help-for Two sticks 
example, pulling on bed clothes, using arms to Quad or tripod stick 
F-21 
LLJ 
steady self when sitting, pulling up on rope or 
Zimmer frame El 
monkey pole, etc. 
F21 
Able to complete normally 
Rollator 
Other 
if Other, specify 
Signature: Date: 
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GAPS Study 3 Month Assessment, Page 8 
Current Disability: Nottingham Extended Activities of Daily Living Index 
Draft 01 
Random No Initials Assessor Code Date of Visit 
EQ 
DO YOU... Not With Alone with Alone 
A. MOBILITY at all help difficulty easily 
- walk around outside? M [fl Fq M 
- climb stairs? 
- get in and out of the car? Ffl 
- walk over uneven ground? Ffl 
- cross roads? 
- travel on public transport? 
B. IN THE KITCHEN 
- manage to feed yourself? 
- make yourself a hot drink? [2] [3] 
- take hot drinks from one room to another? M 1ý 
- do the washing up? Efl [1] M 
- make yourself a hot snack? 
[2] 
C. DOMESTIC TASKS 
- manage your own money when out? 
- wash small items of clothing? [fl Fq F1 1ý 
- do your own shopping? 
rfl 1ý 
- do a full clothes wash? 
[2] 
D. MOBILITY 
- read newspaper and books? 
1ý 
- use the telephone? 
- write letters? 
- go out socially? 
- manage your own garden? 
- drive a car? 
Signature: DaW 
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GAPS Study 3 Month Assessment, Page 9 
Current Disability. Rivermead Visual Gait Assessment 
Draft 01 
Random No Initials Assessor Code Date of Visit 
FTTýQ EQ DDMMyY. 
Scoring: 0 =normal Deviations: I= mild 2= moderate 3= severe (please cide) 
Upper Limb Position 
1. Shoulder Depressed/Retracted/Elevated 
2. Elbow flexed :5 450 (=O) 450 to 900 (=1) >900 (=2) 
Stance Phase For trunk deviations, 0= midline 
3. Trunk flexedlextended M RI [i] M PI M RI 
Inclinded. backward forward 
4. Trunk side flexed 
S. Trunk and pelvis: lateral displacement 
6. Contralateral drop pelvis 
7. Hip extension decreased 
8. 
9A. Knee flexion excessive: 
IOA. 
OR 
9B. Knee extension excessive: 
IOB. 
I IA. Ankle in excess plantar flexion 
OR 
IIB. Ankle in excess dors! flexion 
12. Inversion excessive 
13. Plantar flexion decreased at toe-off 
[N M [11 M Eq M [n 
. 
Direction: left right 
In M PI M M M M 
Amount: excessive reduced 
PI Ffl M M 
M [! ] M [ -3] 
with backward rotation P] M PI M 
at initial contact 
throughout range 
at initial contact 
throughout range 
M Fq MM 
M FqF21 M 
[fl F2] M 
Fq MM 
M [1] F21 M 
M [fl M 
IE! lEfl 
Signature: 
Date: 
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GAPS Study 3 Month Assessment, Page 10 
Current Disability: Rivermead Visual Gait Assessment continued... 
Draft 01 
Random No Initials Assessor Code Date of Visit 
EFT11 E 1; K. =. 
Swing Phase 
14. Trunk flexed 
Direction: 
15. Trunk side flexed 
Direction: 
16. Hike pelvis (elevation) 
17. Backward rotation pelvis. 
18. Decreased hip flexion 
19. Decreased knee flexion 
20. Ankle In excess plantar flexion 
Any other deviations noted 
21. Support required 
AFO 
Knee splint 
For trunk deviations, 0= midline 
MM Fq M P] [72] M 
backward forward 
mM m m 
left - right 
m PI m In 
M DI 21 F M 
m PI m m 
m PI m m 
M M m m 
m PI m m 
M Eq MM 
Yes rqNo [-2] 
Yes Fl] No M 
Signature: 
Date: 
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GAPS Study 3 Month Assessment, Page 
Current Disability: Body Worn Gait Analysis and Nine Hole Peg Test 
Draft 01 
I- Random No 
FI-1-1-1 
Initials 
E= 
A. SIDE AFFECTED Left ni Right 
B. ABILITY TO UNDERGO GAIT ANALYSIS 
1. Was the patient able to undergo 
gait analysis? Yes r1] No m 
If No, specify reason 
Patent unfit to undergo gait analysis 
Patent refused to undergo gait analysis 
Unable to walk 10 rnetres 
Equipment failure 
Other 
If Other, specify 
rq 
Fq 
M 
Ifl 
1ý 
Assessor Code Date of Visit 
EQ 
I 
=.. =., 
" 
S. Symmetry 
(Ratio of swing phase) 
6. Speed 
D. AID USED 
None 
One stick 
Two sticks 
Quad or tripod stick 
Zimmer frame 
Rollator 
Other 
EM% 
O. EL] nVsec 
Fq 
rq 
1ý 
tf Other, specify 
w 
C. RESULTS OF TEST 
1. Number of scuffs 
(fast contact during swing) 
(a) Affected side 
(b) Unaffected side 
2. Heel Strike 
(% of total foot contact time) 
(a) Affected side 
(b) Unaffected side 
EFT-1 
1 1-1. 
12 
3. Inversion 
(% of metatarsal head contact time with 
only Sth head in contact) 
(a) Affected side % 
(b) Unaffected side % 
4. Average Stride Length 
(Average speed x Average time 
for stride) crn 
E. NINE HOLE PEG TEST 
1. Time of test 24 hour) 
clock 
2. Results for unaffected side 
Able to attempt test? YesF11 No M 
If Yes, either 
rime to place all pegs Msecs 
or 
If > So seconds, number 
of pegs placed in 50 seconds Elpegs 
3. Results for affected side 
Able to attempt test? Yes 
n' No 
If Yes, either 
Time to place all pegs ELI secs 
or 
If > 50 seconds, number 
of pegs placed in 50 seconds pegs 
Signature: 
Date: 
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GAPS Study 3 Month Assessment, Page 12 
Current Disability: Action Research Arm Test (Unaffected Side) 
Draft 01 
Random No Initials Assessor Code Date of Visit - 
FIX- 
DDMMYY. 
A. RESULTS FOR UNAFFECTED SIDE 
Grasp 
1. Pick up 10cm cube, block of wood 
(if score = 3, total = 18 and go to GRIP) 
2. Pick up 2.5cm cube, block of wo(W 
(if score = 0, total =0 and go to GRIP) D 
3. Pick up Scm cube, block of wood Fý 
4. Pick up 7.5cm cube, block of wood 
0 
5. Pick up cricket ball, 7.5cm diameter El 
6. Pick up sharpening stone 10 x 2.5 xI cm 
TOTAL SCORE 
Grip 
1. Pour water from glass to glass 
(plastic tumbler half full (100 m1s; of water)) 
(if score = 3, total = 12 and go to PINCH) 
2. Lift tube 2.25cm from one peg to another peg 
on shelf (if score = 0, total =0 and go to PINCH)Fj 
3. Lift tube I cm from one peg to another peg 
on shelf F] 
4. Lift washer 3.5cm in diameter from table and 
place over bolt on table 
TOTAL SCORE 
Pinch 
1. Pick up 6mm ball bearing between 3rd finger 
and thumb from 10cm dish on table to 10cm 
dish on shelf (if score = 3, total = 18 and go 
to GROSSMT) 
2. Pick up I. Scm marble between first finger and 
thunib from dish to dish 
(if score = 0, total =0 and go to GROSSMT) 
3. Pick up ball bearing between 2nd finger 
and thumb 
4. Pick up ball bearing between Ist finger 
and thumb 
5. Pick up marble between 3rd finger and 
thumb 
6. Pick up marble between 2nd finger and 
thumb 
Gross Movement 
SCORING CODE BOX 
Performs test normally 
Completes test, but long time or great difficulty 2 R 
Performs test partially , 
Can perform no part of test 
Mo 
Signature: 
Dateý 
TOTAL SCORE 
1. Place hand behind head 
(if score = 3, total =9 and finish) 
(if score = 0, total =0 and finish) 
2. Place hand on top of head 
3. Lift hand to mouth 
TOTAL SCORE 
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GAPS Study 3 Month Assessment, Page 13 
Current Disability: Action Research Arm Test (Affected Side) 
Draft 01 
Random No Initials Assessor Code Date of Visit 
B. RESULTS FOR AFFECTED SIDE 
Grasp 
1. Pick up 10cm cube, block of wood 
(if score = 3, total = 18 and go to GRIP) 
2. Pick up 2.5cm cube, block of wood 
(if score = 0, total =0 and go to GRIP) 
3. Pick up Scm cube, block of wood F1 
4. Pick up 7.5cm cube, block of wood F1 
5. Pick up cricket ball, 7.5cm diame. ter F-1 
6. Pick up sharpening stone 10 x 2.5 x 1cm F] 
TOTAL SCORE 
Grip 
1. Pour water from glass to glass 
(plastic tumbler half full (100 mls of water)) 
(if score = 3, total = 12 and go to PINCH) F] 
2. Lift tube 2.25cm from one peg to another peg 
on shelf (if score = 0, total =0 and go to PINCH) 
3. Lift tube I cm from one peg to another peg 
on shelf 
4. Lift washer 3.5cm in diameter from table and 
place over bolt on table 
TOTAL SCORE 
Pinch 
I. Pick up 6mm ball bearing between 3rd finger 
and thumb from 10cm dish on table to 10cm 
dish on shelf (if score = 3, total = 18 and go 
to GROSSMT) 
2. Pick up I. Scm marble between first finger and 
thurrýb from dish to dish 
(if score = 0, total =0 and go to GROSSMT) F1 
3. Pick up ball bearing between 2nd finger 
and thumb F! 
4. Pick up ball bearing between 1st finger 
and thumb 
5. Pick up marble between 3rd finger and 
thumb 
6. Pick up marble between 2nd finger and 
thumb 
TOTAL SCORE FU 
Gross Movement 
1. Place hand behind head 
(if score = 3, total =9 and finish) 
(if score = 0, total =0 and finish) 
2. Place hand on top of head 
3. Lift hand to mouth 
TOTAL SCORE 
SCORING CODE BOX 
Performs test normally 
Completes test but long time or great difficulty 2 M 
Performs test partially 1 
Can perform no part of test 
RI 
Signature: 
Date: 
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GAPS Study 3 Month Assessment, Page 14 
Draft 01 
Random No Initials Assessor Code Date of Visit 
ET-M 
Codinq Difficulties 
1. Have there been any problems 
coding the data for this visit? Yes [ý] No M 
If Yes, specify 
Patient no longer at the rehabilitation centre Fq 
Patient unable to attend assessment Ill 
Patient refused for part of the assessment RI 
Patient refused for all of the assessment 31 F 
Assessor unavailable [4-1 
Assessor unblinded [q 
Equipment problem rq 
Other 
specify 
Signature: 
Date'. 
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Rationale for selection Of Outcome measures used in the GAPS study (listed 
alphabetically) 
Action Research Arm Test (ARAT) (Lyle 1981) 
This is a measure of upper limb disability with 4 sections (grasp, grip, pinch aiid 
gross movement), scored 0- 57 (0 = no arm function, 57 == normal arm ftinction). 
It is a detailed and sensitive measure of a variety of upper limb functions over a 
broad spectrum of functional levels. Although it is relatively complex and requires 
special equipment, we included it because it provides more information than the 9 
Hole Peg Test and has been used in other intensity trials. 
Activity Monitoring (Suckalingham 1993) 
We measured patient activity using a "high-tech" monitor (Figure 3.1, page 49) that 
attached a sensor to the patient's unaffected leg and recorded the frequency of 
changes in posture. We had hoped that the equipment would measure the 
proportion of time spent lying, sitting, standing and walking. It records the amount 
of time spent in an upright position and the number of changes of the patient's 
position from sitting to standing. The monitor was worn on a single occasion (for a 
day, 3 weeks after randomisation). Data were downloaded from the data logger 
onto a portable computer for analysis. 
It was able to provided limited information in terms of the percentage of the 
patients' "waking day" that is spent in an "upright position" e. g. standing or 
walking. More time spent upright was assumed to be more active. The monitor 
allowed us to analyse levels of activity at specific periods during the day e. g. to 
examine how active are patients in the evening when there are no therapists on 
duty? 
Adverse Effects 
The patients were monitored for falls, fatigue, shoulder pain and other pain oil a Nveeklý' 
basis until discharge (maximum of 10 weeks) by interview. 
The patient Nvas also 
interviewed at the 3 and 6 month assessments regarding hospital adnilssions, 
falls and 
other illnesses or problems. Similar information was gathered at 
the casenote review 
when the patient was discharge fi7om inpatient rehabilitation. 
We could not confirni this 
inforination with the patients' General Practitioners 
due to limited resources. 
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Barthel Index (Mahoney & Barthel 1965) 
This is a 20-point scale over 10 items (bowel, bladder, grooming, toilet use, 
feeding, transfers, mobility, dressing, stairs and bathing) (0 = dependent, 20 = 
independent) measuring dependency in activities of daily living (ADL). It is 
probably the most commonly used measure of "disability" or "dependency- M both 
clinical practice and research. 
Originally designed to measure "dependency" this frequently used questionnaire is used 
as an indication of activity limitation in activities if daily living. It has been adapted, 
but we used its original version. It has well recognised limitations in its floor and 
ceiling effects and that it does not address the domains of communication or cognitivc 
ftniction. It is simple, quick and, if necessary, could be adi-ninistered over the telephone 
for limited follow up with non-compliant patients or patients in institutional care (proxy 
answers by a member of stafo. 
Body-worn gait analysis (Granat et al. 1995) 
This was used to measure impairment of quality of gait. The patients wear their normal 
footwear with a pressure sensitive insole fitted inside. Information from the insole is 
recorded on a data logger. The test was performed in the fourth week, three months and 
six months after randomisation. The patients walked 8m with a 2m acceleration and 
deceleration period at each end. They were assessed on the same carpeted surface on 
each site. Data were gathered on average stride length, speed, symmetry of gait, degree 
of excessive inversion or eversion, and the duration of heel contact. 
Elderly Mobility Scale (EMS) (Smith 1994) 
This is a 7-item measure of fimctional mobility disability, scored 0- 20 (0 = poor 
mobility, 20 = independent mobility). It is increasingly used, both clinically and iii 
research. It is simple to administer, the majority of its items being covered by the other 
scales we used. It has been validated for elderly patients but not yet specifically 
for 
stroke patients. The functional reach test within the scale 
has been sho'xn to be 
indicative of dynamic balance and is predictive of falls. 
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EuroQol (Dorman et al. 1997) 
This measure of health related quality of life contains 6 items and a ý, ertical N-isual 
44 analogue scale (scored 0- 100,0 = "worst imaginable" health state, 100 = best 
imaginable" health state). It is relatively short and has acceptable validity with 
patients after stroke. It was completed at interview in order to assist any patients 
with motor or visual deficits to complete the form. 
Functional Reach Test (Duncan et al. 1990) 
The patients' ability to reach forward whilst standing without support, was measured III 
centimetres, then categorised (under 8cm or unable, 8- 16cm, over 16cm). This is a 
valid test of the patients' balance in the standing position. Balance had not specifically 
been addressed in the other measures used. The test is included within the Elderly 
Mobility Scale (see above) and has been shown to be indicative of dynamic balance and 
predictive of falls in elderly patients (Smith 1994). 
Mobility Milestones (Smith & Baer 1999) (Baer et al. 2003) 
This is a measure of functional mobility based on recognised patterns of recovery. 
The hierarchical scale gives clearly defined criteria for the assessment of each 
66milestone" - ability to sit unsupported for a minute; ability to stand unsupported 
for 10 seconds; ability to take 10 steps and the ability to walk 10 metres. It has face 
validity and has been investigated for reliability. It is used in a number of clinical 
settings. The items seem to forrn an obvious hierarchy, however the definitions first 
published prevented subjects using a walking aid in their attempts at 10 paces 
though an aid was permitted for the 10 metre walk. This resulted in some patients 
being scored as "able to walk 10 in but not able to take 10 independent steps". We 
kept the original definitions throughout our study. The scale is reliable and Nralid 
but has a ceiling effect. All our patients were required to have sitting balance 
before 
being considered eligible for the study. 
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Motricity Index (Demeurisse et al. 1980) 
This index combines scores from 3 tests each in the arm and leg to give a score for the 
left and right side of the body (0 = no movement, 100 = normal). The arm score is 
derived from scores (0 - 33) for 3 tasks, +I= score out of maximum 100, similarly, the 
leg has 3 scores (0 -3 3), +1 = score out of maximum 1 oo. 
Side score = (arm score + leg score) / 2. The patients are scored for both their sides. 
It is a measure of impairment, taking into account general upper and lower 11nib 
function. It is quick to administer and has been tested for validity and rellabilitY and 
is sensitive to change in stroke recovery (Wade 1992). 
Nine Hole Peg Test (9HPT) (Mathiowetz et al. 1985) 
This measure of disability, specifically of the upper limb, requires the patient to place 
nine wooden pegs in holes in a small board under standard conditions. We timed the 
placing of the pegs. The patients were allowed a maximum of 50 seconds to complete 
the task. If the test was not completed in 50 seconds, the number of pegs placed was 
scored. The number of seconds taken to place each peg was calculated. Both hands 
were tested. It is a quick and easy assessment, frequently used in clinical practice and 
research. 
Nottingham Extended Activities of Daily Living (NEADL) Index (Noun & 
Lincoln 1987) 
This is a 22-item measure of handicap (participation limitation) in 4 sections 
(mobility, in the kitchen, domestic tasks and leisure activities) scored 0- 66 (0 = 
inactive, 66 = very active). The sections form a hierarchy with stroke patients 
(Wade 1992) and the scoring dichotomises responses into those items the patient 
can participate in alone and those items with which they need help or are unable to 
perfon-n. 
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Patient Satisfaction Questionnaire (Pound et al. 1994) 
This is a 13 item questionnaire measuring patient satisfaction with "hospital care 
and treatment" and "discharge and after". The patients were sent the questionnaire 
by post, four weeks after being discharged as inpatients from the rehabilitation 
hospital. It has proven reliability and validity and contains specific items on the 
type and amount of "therapy" the patient received. Relatives or carers were able to 
help the patient complete the questionnaire but the views expressed should havc 
been those of the patient. Patients that were discharged Erom rehabilitation hospital 
to institutional care were not sent the questionnaire. 
'Rankin' Oxford Handicap Scale (Rankin 1957) 
This is a 6-point scale (0 = no symptoms, 5= severe handicap) that measures 
"handicap". We used the cut off point of 3 and above to indicate dependence oil 
others. Many consider it to be more of a measure of impairment and disability 
(especially mobility disability). The Rankin score is, however, quick to administer 
and is widely used in stroke research. It was included to compare pre- and post- 
stroke handicap. 
Resource Use 
Information regarding use of health and social services was gathered by patient 
interview at the 3 and 6 month assessments. We also recorded follow up that ý, V, as 
planned at the point of discharge from inpatient rehabilitation in a review of the 
patients' hospital records. This information could not confirmed with the patients' 
General Practitioners or the services concerned due to limited resources. 
Rivermead Mobility Index (RMI) (Collen et al. 1991) 
This is a 15-itern measure, scored 0- 15 (0 = poor mobility, 15 = good mobility). 
It 
includes one directly observed item. It measures disability (activity impairment). 
specifically mobility disability. It is frequently used in research and clinical practice. 
It 
has established measurement properties and is simple to administer, providing a 
hierarchy of mobility that covers a broad range of abilities 
from turning in bed to 
running. 
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Rivermead Visual Gait Analysis (Lord et al. 1998) 
This is a 20 item measure of gait impairment scored from 0- 59 (0 = normal gait, 59 = 
grossly abnormal gait). It was a recently developed tool and has not been widel", used 
in other studies, however it is valid, reliable and sensitive to change in mobilitý'. We 
used it as a back-up measure for the high-tech assessment of the quality of gait though 
in practice it was difficult to use with very disabled patients. The amount of data Nve 
gathered and our analyses were limited and results are not presented in this thesis. 
Trunk Control Test (In Wade 1992) 
This is a 4-item measure of impainnent of (proximal) trunk stability, scored out of 
100 (0 = unable to move, 100 = non-nal). It is commonly administered in 
conjunction with the Motricity Index (above) and is simple and quick. 
Walking speed (Bradstater et al 1983) 
We measured the patients' walking speed several different ways. They are quoted 
in metres per second. We measured the patients "preferred" walking speed as 
opposed to their maximum walking speed. We took the measurement using a 
stopwatch and also by electronic timing in the form of the gait analysis equipment. 
We used standardised instructions for the patients and carried out the assessment on 
different surfaces both "normal" hospital floor (linoleum or wooden) or on carpet. 
Measures of gait speed have been shown to be valid and reliable and are widely 
used in clinical practice and research. 
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APPENDIX III 
Glasgow Augmented Physiotherapy After Stroke (GAPS) study 
Collaborative group and staff members 
Steering group 
Professor Peter Langhorne (principal grant holder), Academic Section of Geriatric 
Medicine, Royal Infirmary, Glasgow. 
Dr Jon Macdonald, Consultant in geriatric medicine, Drunichapel Hospital, 
Glasgow. 
Dr Christine McAlpine, Consultant in geriatric medicine, Stobhill Hospital, 
Glasgow. 
Dr Malcolm Granat, Senior lecturer, Department of Bioengineering, University of 
Strathclyde. 
Mr John NoMe, Deputy director, Robertson Centre for Biostatistics, University 
of Glasgow. 
Mrs Gisela Creed, Superintendent physiotherapist, Royal Infirmary, Glasgow. 
Miss Margaret Nutter, Superintendent physiotherapist, Drunichapel Hospital, 
Glasgow. 
Mrs June Lawrie, Superintendent physiotherapist, Stobhill Hospital, Glasgow. 
Mr Ian Wellwood, research physiotherapist, (study co-ordinator). 
Ms Thorlene Egerton, research physiotherapist, (principal assessor). 
Staff members 
Mrs Fiona Moffat, research physiotherapist, Diumchapel Hospital, Glasgow. 
Miss Patricia Hagen, research physiotherapist, Stobhill Hospital, Glasgow. 
Supportftom Strathclyde University 
Dr Douglas Maxwell 
SUPPortftom Robertson Centrefor Biostatistics 
Miss Heather Bailley 
Dr Janet Love 
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APPENDIXIV 
Table A4.1 Considerations in choosing a method of meta-analysis. 
(Deeks et al. 2001) 
Choice of summary statistic depends upon: 
the type of data being analysed (binary, continuous, time-to-event) 
the consistence of estimates of the treatment effect across trials and subgroups 
0 the ease of interpretation of the summary statistic 
Choice of weighted method depend upon: 
* the reliability of the method when sample sizes are small (may exclude invci-sc 
variance method). 
0 the reliability of the method if the events are very rare (may exclude inverse 
variance and Mantel-Haenszel methods). 
* the degree of imbalance in allocation ratios in the trials (may exclude the Peto 
method). 
* the reliability of the method when treatment effects are large (may exclude the 
Peto method). 
224 
Appendix V 
APPENDIX V 
Literature search 
Main search strategy (MEDLINE database) used for PINTAS meta- 
analysis 
1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or 
exp brain ischemia/ or exp carotid artery diseases/ or cerebrovascular accident' 
or exp brain infarction/ or exp cerebrovascular trauma/ or exp hypoxIa-Ischemia, 
brain/ or exp intracranial arterial diseases/ or intracranial arteriovenous 
malformations/ or exp "intracranial embolism and thrombosis"/ or exp 
intracranial hemorrhages/ or vasospasm, intracranial/ or vertebral artery 
dissection/ 
2. (stroke or poststroke or post-stroke or cerebrovasc$ or cerebral vascS or cvaS 
or apoplexy). tw. 
3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj 10 
(isch? emi$ or infarct$ or thrombo$ or emboli$ or occlus$)). tw. 
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or subarachnold) 
adj 10 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or 
bleed$)). tw. 
5. ((brain or intracranial) adj 10 (vascular adj 5 (disease$ or disorder or accldcnt 
or injur$ or insult or event or attack))). tw. 
6. ((isch? emic or apoplectic) adJ5 (event or events or insult or attack$)). tw. 
7. hemiplegia/ or exp paresis/ 
8. (hemipleg$ or hemipar$ or paresis or paretic or acquired brain injur$). tw. 
9. or/1-8 
10. exp Physical Therapy Techniques/ 
11. "Physical Therapy (Specialty)"/ 
12. Physical Therapy Department, Hospital/ 
13. exp Exercise Movement Techniques/ 
14. rehabilitation/ or "activities of daily living"/ or early ambulation/ 
15. Motor Activity/ 
16. "Recovery of Function"/ 
17. (physiotherap$ or physical therap$ or exercise or rehabilitation or physical 
activity). tw. 
18. or/10-17 
19.9 and 18 
20. cerebrovascular disorders/rh or exp basal ganglia cerebrovascular disease/rh 
or exp brain ischemia/rh or exp carotid artery diseases/rh or cerebrovascular 
accident/rh or exp brain infarction/rh or exp cerebrovascular trauma/rh or exp 
hypoxia-ischemia, brain/rh or exp intracranial arterial diseases/rh or intracranial 
arteriovenous malformations/rh or exp "intracranial embolism and iU thrombosis"/rh or exp intracranial hemorrhages/rh or vasospasm, intracrania 'Fh 
or vertebral artery dissection/rh or (hemiplegia/rh or exp paresis/rh) 
21.19 or 20 
22. (intensive or intensity or augment$ or accelerate$ or additional or 
dosage or 
dose-response or ftequency or amount or quantity)-tw. 
23.21 and 22 
24. Randomized Controlled Trials/ 
25. random allocation/ 
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26. Controlled Clinical Trials/ 
27. control groups/ 
28. clinical trials/ or clinical trials, phase i/ or clinical th ii/ or clinical trials, phase iii/ or clinical trials, phase iv/ 
phase 
29. Placebos/ 
30. placebo effect/ 
3 1. Research Design/ 
32. Program Evaluation/ 
33. evaluation studies/ 
34. randomized controlled trial. pt. 
35. controlled clinical trial. pt. 
36. clinical trial. pt. 
37. evaluation studies. pt. 
38. meta analysis. pt. 
39. meta-analysis/ 
40. random$. tw. 
41. (controlled adJ5 (trial$ or stud$)). tw. 
42. (clinical$ adJ5 trial$). tw. 
43. ((control or treatment or experiment$ or intervention) adJ5 (group$ or 
subject$ or patient$)). tw. 
44. (quasi-random$ or quasi randorn$ or pseudo-random$ or pseudo 
random$). tw. 
45. ((control or experiment$ or conservative) adJ5 (treatment or therapy or 
procedure or manage$)). tw. 
46. (coin adJ5 (flip or flipped or toss$)). tw. 
47. latin square. tw. 
48. versus. tw. 
49. placebo$. tw. 
50. sham. tw. 
5 1. (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline). tw. 
52. controls. tw. 
53. (meta-analy$ or metaanaly$ or meta analy$ or systematic review or 
systematic overview). tw. 
54. or/24-53 
55.21 and 54 
56.55 not 23 
57. limit 23 to human 
58. limit 56 to human 
DOWNLOAD SETS 57 AND 58 
We searched the following databases up until the end of 2002: 
Medline 1966 onwards; EMBASE 1980 onwards; BIOSIS 1969 onwards; Psych 
INFO 1967 onwards; Derwent Drug File 1964 onwards-, Scisearch 1974 
onwards; AMED 1985 onwards; CINAHL 1982 onwards and Cochrane 
Strokc 
Group Trials Register to last quarter of 2002. 
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Table A5.1 Trials retrieved for detailed evaluation 
Altschuler et al. 1999 
Carey 1990 
Duncan et al. 1998 
Feys et al. 1998 
GAPS 2000 (abstract) 
Green et al. 2002 
Kwakkel et al. 1999 
Kwakkel and Wagenar 2002 
Lincoln et al. 1999 
Lincoln et al. 1999 
Logigian et al. 1983 
Malouin 1993 
Miller et al. 2000 (abstract) 
Nugent et al. 1994 
Parry et al. 1999(a) 
Parry et al. 1999(b) 
Partridge et al. 2000 
Peacock et al. 1972 
Pollock et al. 2002 
Rodgers et al. (in press, subsequently published 2003) 
Rapoport & Judd-van Eerd 1989 
Richards et al. 1993 
Ruff et al. 1999 
Sivenius et al. 1985 
Slade et al. 1999 (abstract) 
Slade et al. 2002 
Smith et al. 1981 
Stem et al. 1970 
Sunderland et al. 1992 
Sunderland et al. 1994 
Wade et al. 1992 
Walker et al. 2000 
Werner and Kessler 1996 
Ongoing 
Ng & Williams (pilot) 
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Trials excluded from the PINTAS meta-analysis 
We excluded a number of trials because they focused only on outpatient 
interventions (Smith et al. 1981)(Duncan et al. 1998) and (Wemer and 
Kessler 1996) or were examining late interventions outwith the hospital 
setting (Green et al. 2002) (Wade et al. 1992). Two studies were excluded 
because they were quasi-randomised (Rappaport & Judd van Eerd 
1989)(Ruff et al. 1999). 
Some studies were confounded because they compared stroke unit care to 
some other form of care (usually general medical ward care)(Peacock et al, 
1972)(Stern et al. 1970)(Sivenius et al. 1985). Evidence from the Stroke 
Unit Trialists Collaboration Overview (Stroke Unit Trialists 2003) suggests 
that any treatment effect in these studies might reasonably be attributed to 
the effect of Stroke Unit care rather than the effect of increased intensity of 
physical therapy. 
Some studies had unusual interventions that we did not consider to reflect 
physiotherapy practice in the UK healthcare system: using a rocking-chair 
and a splint to give sensory-motor stimulation (Feys et al. 1998); patients 
practising arm movement on their own with the use of a mirror (Altschuller 
et al. 1999) and self-practise of rising from the chair (Pollock et al. 2000). 
The others identified by our search were excluded as they appeared to be 
more focused on investigating the intervention rather than the intensity of 
the intervention (Logigian et al. 1983)(Carey 1990)(Altschuller et al. 
1999)(Walker et al. 2000). 
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Table A5.2 Reasons for excluding studies from PINTAS systematic review 
Study Reason for exclusion 
Altschuler et al. (1999) Late intervention, focus Nvas inten-entioii, 
not intensity 
Carey (1990) Focus was intervention not intensitv 
Duncan et al. (1998) Home based intervention 
Feys et al. (1998) Novel intervention 
Green et al. 2002 Late intervention, community based 
Logigian et al. (1983) Focus was intervention, not intensity 
Ng & Williams Ongoing exploratory pilot study 
Nugent et al. (1994) Non randomised 
Peacock et al. (1972) Confounded - different settings (no 
record of intensity) 
Pollock et al. (2002) Focus was novel intervention not 
intensity 
Rapoport & Judd-van Eerd (1989) Quasi-randomised 
Ruff et al. (1999) Quasi-randomised 
Sivenius et al. (1985) Methodological problems, confounded - 
different settings 
Smith et al. (19 8 1) Part of intervention was outpatient based 
and data were not available 
Stem et al. (1970) Confounded, difficulties witli 
randomisation, incomparable treatments 
Wade et al. (1992) Late intervention, community based 
Walker et al. (2000) Focus was intervention not intensity. 
Werner &Kessler (1996) Intervention was outpatient based 
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APPENDIX VI 
Review criteria used by Scottish Intercollegiate Guidelines Neftv, ork (SIGN 2004) 
Table A6.1 
SIGN Review Criteria - Evaluation of internal validity of selected studies 
Evaluation criterion 
Does the study address an appropriate and clearly focused ýu--estion? 
Was the assignment of subjects to treatment groups randomised? 
Were the treatment and control groups similar at the start of the 
trial? 
Was an adequate concealment method used? 
Were subjects and investigators kept blind to treatment allocation? 
Are all relevant outcomes measured in a standard, valid and reliable 
way? 
Apart from the treatment under investigation, were the groups 
treated equally? 
What % of the individuals or clusters recruited into the study are 
included in the analysis? 
Were all the subjects analysed in the groups to which they were 
randomly allocated? 
Are the results homogeneous between sites? 
Table A6.2 Overall assessment of selected studies 
Evaluation criterion 
How well has the study done to minimise bias? 
Code ++, +, or - 
If coded + or - what is the likely direction in which bias might 
affect the study results? 
Taking into account clinical considerations, your evaluation of the 
methodology used and the statistical power of the study, are you 
certain that the overall effect is due to the study intervention? 
Gradings for overall assessment of selected studies (meta-analyses) 
Well covered 
Adequately addressed 
Poorly addressed 
Not addressed (i. e. not mentioned, or indicates that this aspect of study 
design was 
ignored) 
Not reported (i. e. mentioned , but 
insufficient detail to allow assessment to be niade) 
Not applicable 
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Internal Validity 
Does the review address an appropriate and clearly focused question? 
Does the review include a description of the methodology used? 
Was the literature search sufficiently rigourous to identify all relevant studies? 
Was study quality assessed and taken into account? 
Does the review include all the potential benefits and harms of the intervention? 
Was it reasonable to combine the studies? 
Do the conclusions flow from the evidence reviewed? 
Overall assessment of the study 
How well has the study done to minimise bias? 
Code ++, +, or - 
If coded as +, or - what is the likely direction in which bias might affect the study 
results? 
Are the results of the study directly applicable to the patient group targeted by this 
guideline? 
Selected studies are described and tabulated with the following headings 
Study 
Intervention 
Outcome measures used 
Number of patients 
Scale and direction of measured effect 
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Table A6.3 Kev to the Evidence Statement.,.. 
Levels of Evidence Inclusion criteria ::: 
1++ High quality meta-analyses, systematic rc\-iexvs of 
ý 
, randomised controlled trials (RCTs), or RCTs with a vei-%, low risk of bias 
1+ Well-conducted meta-analyses, systematic reviews of 
RCTs, or RCTs with a low risk of bias 
1- Meta-analyses, systematic reviews of RCTs, or RCTs NN-ith 
a high risk of bias 
2++ High quality systematic reviews of case control or cohort 
studies. 
High quality case control or cohort studies xvith a vci-y lo\\- 
risk of confounding or bias and a high probability that the 
relationship is causal. 
2+ Well conducted case control or cohort studies with a low 
risk of confounding or bias and a moderate probability that 
the relationship is causal. 
2- Case control or cohort studies with a high risk of 
confounding or bias and a significant risk that the 
relationship is not causal. 
3 Non-analytic studies, case reports, case series. 
4 Expert opinion. 
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APPENDIX VIII 
PINTAS meta-analysis - Additional data and statistical comments 
This appendix contains information on database management and reports oil 
additional analyses carried out on the Barthel index data and walking speed data that 
are not covered in the main report. 
Forming the database and database management 
Collaborators provided data which we cleaned to form a workable database with 
information on field structure, labelling, data assumptions and handling / coding of 
missing values. 
We incorporated data from the 9 studies, totalling 951 subjects. The data were read ,, to 
a master datafile containing data on: 
Patient identification (ID) number (both the original study ID and an assigned 
PINTAS ID) 
" Gender 
" Age 
" Randomised treatment group 
" Treatment target 
" Date of onset of stroke 
" Barthel at baseline, 1,3,6, and 12 months 
" ARAT at baseline, 1,3ý 6 and 12 months 
" Motricity Ann Index at baseline, 1,3,6, and 12 months 
Motricity Leg Index at baseline, 1,3,6, and 12 months 
Motricity Total Index at baseline, 1,3,6, and 12 months 
Standardisation of visits 
For the Barthel index, ARAT and Motricity Index measurements, althouizh most studies 
measured at common times, we chose to standardise the measurement times at 1,3' 
6 
and 12 months for all studies. So if, for example, a study had a measurement at 
6 Ný'eeks, 
this was assigned to the I month slot, being the nearest standard time. 
If additional 
measurements were made over and above the standard times e. g. at 20 ýeeks. thell 
these 
were used if the nearest standard time was missing e. g. 
if a6 month i-cading was 
missing, the 20 week (- 5 month) reading was imputed as the 
6 month readim, 
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Measurement scales 
The scale of each of the measurements for each of the studies NN-as checked. For 
example, most studies reported the Barthel index on a scale of 0-20, but some reported 
on a scale of 0-100, with each point of the 0-20 scale worth 5 points. For this example 
re-scaling the 0-100 to the 0-20 scale is a simple division by 5. There was one study t1lat 
appeared to be on the 0-100 scale - it had values of 88 and 99 - but on closer inspectioll 
the distribution was entirely within the range 0-20, with 88 and 99 appearin- to be 
special codes (e. g. not done, or lost). The Action Research Ann Test (ARAT) values 
were more difficult: the usual range is 0-57, with 4 subscales - two each with a total of 
18 points, one at 12 and one at 9 (Lyle 1981). 
Missing values 
Missing values are an important issue. As in the example given above, if an impossible 
value has been reserved for the missing data, there is usually not a problem - it call be 
identified quite readily and changed to missing in the analysis database. The cxanlplc 
above does however illustrate that when combining studies, an impossible value on one 
scale (88 and 99 on a scale 0-20) can become a legitimate value on another scale for tile 
same measurement (0-100). The most difficult situation to spot is when a legitimate 
value is used as a missing value, most commonly, particularly when using Excel as tllc 
datafile, the value zero. We have assumed throughout that the zeroes on the file are all 
legitimate values, unless the context clearly indicates otherwise. It should be noted that 
the appearance of zero as a missing value can happen unexpectedly, for example, if data 
are transferred from one version to an update, or to another platform via an import tool, 
or a database translation tool. 
Missing data - analysis issues 
There is a further issue of the handling of missing data in the analysis. The analý'ses 
presented here are on the basis of all available information. That is, we 
have iiot 
attempted to fill in any of the missing data, with the exception of the 
'near adjacclit 
values' algorithm stated above. 
Take for example the Barthel index scores. There will have 
been subjects in probably all 
in of the studies that will have missing Barthel index scores 
for a defi ite reason - at one 
extreme, they are so independent that they have stopped participating 
it, the study. at dic 
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other extreme, they died early in the trial e. g. after 2 weeks. Somewhere in-between rnaý' 
be the subjects who suffered a setback (e. g. a further stroke) that meant theý, NN ere not 
receiving physiotherapy or fit to be assessed. All of these subjects have missing data that 
may be informative (in a statistical sense) i. e. it is not missing at random, or missing 
completely at random. If there were any difference in this "missingn wn e ,, - ess" 
do to th 
randomised treatment, then there is a potential problem of bias. If auggirierited 
physiotherapy had a propensity to kill people (an extreme example), and further to kill 
people who were more severely disabled, or to hospitalise people, or evell to cause 
people to withdraw more often than on standard treatment, the current analý'sls would 
potentially be biased in favour of augmented physiotherapy by excluding these subjects. 
Barthel index scores were censured at death to avoid zero scores being recorded in 
further analyses. 
The duration of in-patient rehabilitation time was measured in days. There were a 
variety of possible definitions of inpatient rehabilitation. Some say that rehabilitation 
starts on first entering hospital after acute stroke, alternatively we could take the date of 
transfer to an area designated as a rehabilitation or stroke unit, alternatively wc could 
look just at the date of randomisation or the date of commencing the intervention. Wc 
decided to compare the groups from the date the patient was admitted to hospital until 
they were either discharged home or to another institution for continuing care. This was 
chosen based on availability and clarity of definition. 
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Exploring thresholds of improvement in Barthel Index scores 
One feature of using the mean change in Barthel index score is that if there are sublects 
who do worse on treatment, they tend to cancel out the subjects \vho do better o1i 
treatment. This may or may not be a desirable feature for an outcome measure. If for 
example, those who did worse on treatment (either augmented or standard) WOUld be 
taken out and treated differently e. g. physiotherapy was suspended, then it m1glit bc 
better to use an outcome that focussed on treatment successes. 
Tables A8.1 and A8.2 show the results for just such an approach based on 3 month 
and 6 month follow up data respectively. There were no differences at any threshold 
at I month follow up (data not shown). 
We defined as a treatment success a subject who either (a) has a change ova baselitie is 
greater than or equal to the stated threshold change over baseline Barthel index score or 
(b), or a subject who has achieved the maximum score on the measure (and so cannot 
improve further). Treatment success is than modelled as a binary outconie in a logistic 
regression using study, age, gender, and treatment group as covanates. These logistic 
regressions were fitted separately for months 3 and 6 (See Figure A8.1). The data for 
month 12 were so sparse that no analysis was done for this time. 
Table A8.1 Defining treatment success at different stated thresholds of change in 
Barthel index score at 3 month follow uP 
Threshold 
Month 3 
N(ST) N(AU) OR(95%Cl) p 
7 137(45%) 213(52%) 1.33(0.96,1.85) 0.086 
8 122(40%) 184(45%) 1.24(0.89,1.72) 0.20 
9 99(32%) 163(40%) 1.47(l. 04,2.06) 0.027 
10 86(28%) 143(35%) 
--.. 
1.47(1.03ý 2.08) 
-- ý1 -1 - -- .*- f-T - 
0.033 
C-f-itipnre 
ST =Standard physiotherapy, AU = AugmentecipIlYSIOUICIapy, 
interval 
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Table A8.2 Defining treatment success at different stated thresholds of chanýCe Barthel index score at 6 month follow up I. 
Threshold Month 6 
N(ST) N(AU) OR(95%Cl) -P 
>7 144(54%) 223(63%) 1.40(0.99, -2.00)0.06')- 
8 130(49%) 200(56%) 1.37(0.97,1.94) 0.0-7-9- 
9 117(44%) 185(52%) 
- 
1.41(0.99,1.99) ý! o. ()-ý--4- 
10 101(38%) 16ý (46%) 1.44(1.01-, -2.05-) -- To o4ý, 
ST = Standard physiotherapy, AU = Augmented physiotherapy, OR = Odds ratio, Cl = Confidelice 
interval 
The data shown are the number of subjects (%) in each randomised treatment aroup 0 
who have a change over baseline Barthel index score at least as great as the stated 
threshold, and the Odds Ratio (OR), adjusted for study, age and gender, with 95% 
confidence interval and associated P-value for augmented vs. standard 
physiotherapy. 
Figure A8.1 Exploration of threshold of change in Barthel index score in PINTAS 
database in order to define "Treatment success" 
P=0.028 
1.5 AN 
1.4 
P=0.038 
C1 
1.3 
1 .2- 
. , A, - ý . 11r, ý- 
it 
C13 
7ý 0.9 
0.8 M onth 3 -L- NI onth 6 
0.7 
6 78 9 
10 
Threshold (if change over baseline Barthel 
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We focussed only on large treatment effects of a change over baseline of - units of 
Barthel index or greater. At the earlier time of 3 months there appears an advantage for 
augmented over standard physiotherapy at very large treatment effects of 9 units of 
Barthel index or higher, with an increase in odds of almost 50% (Odds Ratio [OR] 1.47, 
95% confidence interval 1.04 to 2.06, P=0.027 for a change ýýt9, P=0-033 for a change 
ý!! 10). 
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"Clinically significant" change in Barthel index score 
Following the Collaborators' meeting and in order to aid interpretation of our rcsLi ts t-)r IL 
the Barthel index analyses, we wanted to find the Collaborative group members' opinion 
of what might be a "clinically" significant change in BI score. 
Before they were aware of the above results we sent a short questionnaire to all 
members of the collaborative group, asking their opinion on the folloNN'ing questions: 
"at do you consider to be a "clinically significant " change in the BI score? 
e. g. a change in score, 
percentage improvement over baseline 
or give a clinical cut offpoint e. g. 10120 or 16120for categorizing patients. 
We also asked for comments and for the group to identify which items on the BI wcre 
most likely to be influenced by physiotherapy intervention, which might reflect overall 
impairment, which might reflect upper limb impairment and which might reflect lowcr 
limb impairment. 
All but one collaborator responded and there were a wide variety of comments from this 
small group. 
Changes in score varied from I to 10 points with "significant clinical thresholds" e.,, 
the difference between dependent and independent living, varying from 15 - 18 points 
Dn the Barthel index. 
It was difficult to generalize from the groups' open comments, 
but all were lookim-, for 
far greater change than we saw in results from our analyses. 
It was acknoxvIedged that 
3mall changes may still be clinically significant for Indiv, 
dual patients especially where 
-hese took them from dependence to Independence even In one Itern on 
the Bl. 
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Additional data summaries for "Change in outcome score" analyses in Chapter 5. 
Additional data are given from the available trials for change in NRAT score, walking 
speed and change in Barthel index score. 
Table A8.3 Mean (SD) Action Research Arm Test (ARAT) scores in PINTAS meta 
analysis 
Study Time Standard Augmented Total 
N Mean(SD) N Mean(SD) N Mean(SD) 
o 
1 35 25.0(22-9) 34 27.7(20.5) 69 26.3(21.6) 
3 33 28.9(23.0) 32 31.5(21.0) 65 30.2(21.9) 
6 33 28.2(24.2) 28 30.3(20.6) 61 29.2(22.5) 
12 - -kw-akkel 0 37 1.3(3.1) 64 4.1(10.1) 101 3.0(8.3) 
1 35 7.3(15.4) 59 13.7(20.0) 94 11.3(18.6) 1 
3 35 8.7(17.7) 53 19.4(22.9) 88 15.1(21.6)---- 
6 37 10.2(19.5) 59 21.7(23.9) 96 , 17.3(22.9) 
12 34 12.2(20.7) 57 20.6(23.2) 91 17.5(22.6) 
Lincoln 0 95 7.2(13.6) 187 5.9(12.3) 282 6.4(12.7) 
1 89 17.4(20.3) 166 17.6(21.0) 255 17.5(20.7) 
3 61 22.9(22.7) 128 22.7(23.0) 189 22.8(22.9) 
6 
12 
Rodgers 0 61 18.5(22.8) 62 19.1(22.0) 123 18.8(22.3) 
1 
3 51 36.5(25.3) 54 38.3(22.6) 105 37.4(23.8) 
6 48 40.8(22.9) 48 38.6(23.5) 96 39.7(23.1) 
12 - 
TOTAL 0 193 9.6(17.2) 313 8.2(15.4) 506 8.7(16.1) 
1 159 16.9(20.7) 259 18.0(21.0) 418 17.6(20-9) 
3 119 26.2(25.4) 139 29.5(23.7) 258 28.0(24.5) 
6 179 26.1(24.7) 263 26.2(23.8) 442 26.2(24.1) 
12 34 12.2(20.7) 57 20.6(23.3) 91 17.5(22.6) 
SD = Standard deviation 
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Table A8.4 Mean walking speed in PINTAS meta-analysis 
Study Time Standard Augme ted Difference A-S 
n Mean(SD) n Mean(SD) 
_ _Mean(9-5'lo 
Cl) P-value 
GAPS 0 - 
1 35 0.36(0.37) 0.45(0.43) 
_ 
0.09 (-0.10,0.28) 
3 35 1 0.49(0.37) 32 0.54(0.34) 0.06 (412,0.23) 0.5 
6 34 0.48(0.36) 29 0.59(0.36) J. 11 (408,0.29) 0.24 
-- 
12 - - - - - akkel Tw 0 37 . 05(0.22) 0 
Z 4 0.04(0.14) -- 
1 35 0.28(0.54) 57 0.42(0.63) 0.13 (-0.12,0.39) 
3 32 1 0.50(0.58) 56 0.64(0.66) 0.14 (-0.14 ý 0.4 2) 6 36 0.66(0.59) 59 0.73(0.65) 0.08 (-0.18ý 0.34) 1 0.54 
12 33 0.70(0.58) 53 0.81(0.67) 0.11 (-0.17,0.39) 0.43 
Partridge 0 60 0.01(0.06) 54 o(o) - - 1 56 0.15(0.22) 52 0.15(0.19) 
_0.00 
(-0.07,0,08) - 0.92 
3 
6 
12 
Richards 0 
1 7 0.24(0.15) 15 0.28(0.17) 0.04 (412,0.19) 0.60 
3 7 0.34(0.22) 15 0.32(0.18) -0.02 (-0.21, 
0.17) 
0.84 
6 
12 
Sunderland 0 
1 55 0.33(0.38) 57 0.33(0.37) 0.00 (-0.14,0.14) 0.96 
3 59 0.36(0.38) 54 0.39(0.41) 0.03 (-0.12,0.18) 0.68 
6 54 0.35(0.40) 55 0.45(0.44) 0.09 (-0.07,0.25) 0.25 
12 39 0.44(0.41) 36 0.50(0.48) 0.06 (-0.15,0.26) 0.58 
TOTAL 0 97 0.02(0.14) 118 0.02(0.11) - - 
1 188 0.27(0.38) 215 0.33(0.44) 0.05 (-0.03,0.13) 0.23 
3 133 0.42(0.43) 157 0.50(0.56) 0.07 (-0.04,0.17) 0.23 
6 124 0.48(0.47) 143 0.59(0.54) 0.09 (-0.03,0.21) 0.13 
12 72 0.56(0.51) 89 0.69(0.62) 0.09 (-0,09,0.26) 0.32 
SD = Standard deviation, CI = Confidence interval 
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Table A8.5. PINTAS meta-analysis: Change over baseline in Barthel index score. By randomised treatment group, and difference in change over baseline between 
randomised treatment groups 
Study Time Standard Augme ted Augmented - Standard* n Mean(SD) n 
- 
Mean(SD) - 
- 
- Difference (95Oo P-value 
CI) 
GAPS 1 34 4.0(3.0) 3 3 2.9(2.6) 
3 33 5.7(4.0) 32 5.1(3.3) -0.6(-2.4,1.2) Ul 6 34 5.9(4.1) 31 5.1(3.7) - -0.9(-2.8, -1.1) 0.3", 
- -- 
12 - - 
akkel k w 1 36 4.8(3.1) 60 6.0(4.4) 1.2(4428) 0.1 ý 
3 35 1 7.4(3.9) 56 9.5(3.8) 2.2(0.5,3.8) 0.009- 
6 37 9.7(4.1) 58 11.1(3.9) 1.4(-0.3,3.0) 0.1-0 
12 34 10.1(3.9) 54 10.7(4.0) 0.6(-1.2,2.1) 0.51 
Lincoln 1 89 5.1(4.4) 168 5.1(3.9) 0(- 1.1,1.0) 0.98 
3 83 6.6(4.0) 157 6.1(3.9) -0.5(-1.5,0.6) 0.35 
6 79 7.3(4.6) 151 1 7.1(4.2) -0.2(-1.4, -1.0) 0.7, 
12 - -I - 
- 
- - Richards 1 7 1 8.9(5.8) 15 7.5(4.9) -1.4(-6.3,3.6) U7 
3 7 10.5(5.0) 15 10.7(4.1) 0.2(-4.0,4.4) 0. ()', 
6 
12 
Rodgers 1 
3 51 4.5(5.6) 51 4.0(5.5) -0.5(-2.7,1.6) 0.62 
6 48 4.7(5.5) 45 5.5(4.8) 0.8(-1.3,2.9) 04, 
12 - - --- Slade 1 39 1.7(2.0) 40 2.0(2.0) 0.3(-0.6,1.2) 0.40_ 
3 28 1.3(2.2) 37 2.6(3.1) 1.3(-0.1,2.6) 0,07-1 
6 7 0.3(0.7) 9 0.9(l. 6) 0.6(-0.8,2.0) 0.40 
12 2 1.9(l. 8) 0(-) -1.9(-20,20) U5 
Sunderland 1 65 3.4(3.9) 65 4.0(4.1) 0.6(-0.8,2.0) 0.3 8 
3 68 5.3(3.8) 63 6.2(4.9) 0.9(-0.6,2.4) 0.24 
6 61 6.5(3.6) 61 6.9(5.2) 0.4(-1.2,2.0) 0.63 
12 44 6.5(3.5) 34 8.1(4.9) 1.6(-0.3,3.5) 0.10 
TOTAL* 1 270 4.1(3.9) 381 4.6(4.0) 0.2(-0.4,0.8) 
- - 
0. ýs 
3 305 5.6(4.4) 411 6.1(4.6) 0.3(-0.3,6 .9 ) 
0,40 
6 266 6.6(4.7) 55 
_ 
7.2(4.8) 0.3(-0.4,1.0) 0.47 
12 80 7.9(4.1) q 
+ 
9 83 9.6(1ý6) 1.0(-0.3,2.2) 1 0.12 
SD = Standard deviation, Cl = Confidence interval 
* For the TOTAL, from a separate linear model for each time point that adjusts 
for 
study. Otherwise, for each individual study, from a separate linear model 
for each time 
point. 
243 
Appendix VIII 
Shortened versions of the Barthel index 
There is a suggestion that some of the 10 elements of the Barthel index are not likely to 
be clinically relevant to post stroke physiotherapy inten, ention. Following 
. 
the 
investigations of Hobart and Thompson (Hobart and Thompson 2001). we adopted two 
shortened versions of the Barthel index: first, a score using just 3 categWrles (tile 
transfer, stairs and mobility questions), and then a score using 6 categories (tile 
previously listed plus dressing, toilet use, and bathing). Results for these versions arc 
given in table A8.6 and table A8.7 respectively. 
Table A8.6 PINTAS meta-analysis. Using a 3-item shortened Barthel index 
(transfer, stairs, mobility) - number of subjects, mean and standard deviation over 
time 
Time Standard Augmented 
N Mean SD N Mean SD 
Baseline 226 2.02 1.84 345 1.86 1.77 
1 -month 198 4.00 2.70 301 3.83 2.72 
3-month 232 4.67 2.58 336 4.85 
_2.63 6-month 205 5.37 2.47 297 5.51 2.55 
SD = Standard deviation 
There was no statistical evidence of a development of the change over baseline in 
the 3-category shortened Barthel index between augmented and standard 
physiotherapy groups: P=0.92 in a test for interaction from a repeated measures 
model as previously specified for the full 10 category Barthel index. The estimated 
treatment effect due to augmented physiotherapy compared with standard 
physiotherapy was 0.16 (95% confidence interval -0-23 to 0.56, P=0.41). 
Table A8.7 PINTAS meta-analysis - Using a 6-item shortened 
Barthel index 
(transfer, stairs, mobility, dressingg toilet use, bathing) - number of subjects' mean 
and standard deviation over time 
Time Standard 
N Mean SD 
Baseline 226 3.11 
_2.86 1 -month 198 6.37 - 
4.11 
3-month 232 7.87 4.12 
6-month 205 8.77 3.99 
Augmented 
N Mean SD 
345 2.80 
- ----, --1.84 -- 301 6.06 
- 1ý 
4.06 
ý 
336 1 7.4 
4.2 5 9 
-- 20 
ýk879 
14.05 
SD = Standard deviation 
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There was no statistical evidence of a development of the change over baseline in 
the 6-category shortened Barthel index between augmented and standard 
physiotherapy groups: P=0.87 in a test for interaction from a repeated rneastires 
model as previously specified for the full 10 category Barthel index. The estinlated 
treatment effect due to augmented physiotherapy compared with standard 
physiotherapy was 0.23 (95% confidence interval -0.40 to 0.85, P=0.48). 
Additional analysis of walking speed, excluding subjects who were not obser%, ed to 
walk at any time during the study 
An additional analysis of the walking speed data was undertaken, in which subjects 
who did not show any evidence of walking at any point in the study werc cxcluded. 
The aim here was to take out any effect of subjects for whom no amount of 
physiotherapy, augmented or standard, was having an effect, and so allow a more 
precise estimate of what the possible advantage of intensive physiotherapy might 
have in the subset of subjects for whom an improvement through the use of 
physiotherapy might be anticipated. This analysis therefore attempts to mirror what 
might happen in practice in the management of a patient, with those for whom 
physiotherapy is inappropriate or impossible, and/or for those who physiotherapy is 
showing consistently no progress from a start point of not walking not considered 
for further physiotherapy until an improvement occurs. 
This strategy of excluding subjects who never showed any evidence of a non-zero 
walking speed resulted in the omission of n=63 subjects receiving standard 
physiotherapy and n=58 subjects receiving augmented physiotherapy. That similar 
numbers were excluded from each group is encouraging in that we can 
be someývhat 
reassured that the resulting comparison is not likely to be seriously 
blased either for 
or against augmented physiotherapy. If, for example, augmented physiotherapy 
worked well for some but was damaging for others, one might expect 
to see the 
latter type of subjects contributing to more exclusions 
from the augmented 
physiotherapy group. If on the other hand augmented physiotherapy was 
particularly 
beneficial for getting the non-walkers started again at NN'alkin,, one 
might expcct to 
see fewer patients excluded from the augmented group than 
the comparison group. 
245 
Appendix VHI 
Results are given in Table A8.8 below. 
Table A8.8 PINTAS meta-analysis: Walking speed (with subjects who never 
walked excluded) by month and treatment group. 
Time Standard ugm nted Difference A-S I 
- 
N Mean(SD) N Mean(SD) Mean(95% CI) p 
0 54 0.04(0.19) 78_ 0.03(0.13) - 
1 131 0.39(0.40) 164 0.43(0.45) 0.05 (-0.05,0.15) -0-35 
3 105 0.54(0.42) 132 0.60(0.49) 0.06 (-0.06,0.18) 0.33 
6 99 0.60(0.45) 114 
. 
0.7 5 (0.5 0) 0.12 (-0.01,0.25) 0.061 
12 59 0.68(0.48) 72 0.85(0.57) 0.13 (-0.06,0.32) 0.17 
SD = Standard cleviation, Ul = Uonlidence mterval 
There was no evidence of a treatment by time interaction (P=0.41). The estimated effect 
of augmented compared with standard physiotherapy on walking speed amongst the 
subjects who walked at some point in the study was 0.07 rns-I (95% CI -0.02 to 0.16, 
P=O. 12). 
For the pre-specified subgroups of age, disability severity, target of treatment, and 
baseline severity of arm impairment there was no evidence of any treatment by time 
interactions, nor of any formally significant differences in treatment effect between the 
levels of the subgroups. Table A8.9 below surnmarises these results: 
Table A8.9 PINTAS meta-analysis: Walking speed (with subjects who never 
walked excluded) by subgroup. 
Subgroup Level Augmented-Standard (95% 
CI) 
- 
P-value 
Barthel :! ý10 0.11 (0.03 to 0.24) 0.12 
>10 0.01 (-0.13 to 0.16) 0.86 
Target Arm Only 0.05 (-0.12 to 0.23) 0.23 
Leg or Mixed 0.08 (403 to 0.19) 0.16 
Age <70 years 0.11 (0.03 to 0.25) 0.13 
>70 years 0.04 (407 to 0.15) 0.51 
Arm impairment Moderate 0.11 (-0.0 1 to 0.24) 0.079 
Severe 0.14(-0.03toO. 31) _ 
0.095 
CI = Confidence interval 
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